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The high association of substance use and mental health has been extensively 
researched, however there remains conflicting evidence in the temporal direction of this 
relationship. This thesis aims to investigate this association using a range of different 
methods to examine the direction of association between substance use and mental health 
problems in adolescence, and whether these are likely to be causal. I also examined the 
possible role of social cognition in this relationship due to its common associations with both 
substance use and mental health problems. 
First, systematic review is used to identify any patterns in the current mental health 
and substance use literature. Here, I find the evidence is largely mixed and there is a 
general lack of bidirectional studies and null results reported. Secondly, I conducted a series 
of longitudinal studies in the Avon Longitudinal Study of Parents and Children (ALSPAC) 
comparing trends of substance use, mental health, and social cognition in both temporal 
directions. My results suggested two possible pathways (a) substance use impairs social 
cognitive performance via poor mental health or (b) substance use independently impairs 
both social cognitive performance and mental health. Finally, to investigate the causality of 
these associations I conducted a Mendelian randomisation analyses in the most robust 
observational results (tobacco initiation, externalising behaviour, and social communication). 
Here, I found some evidence of an association that genetic risk of tobacco initiation is 
causally associated with externalising disorders, but no evidence of a causal association of 
genetic risk of tobacco initiation with social cognition.  
The evidence here suggests some evidence of a causal association of tobacco 
initiation with externalising behavior. However, the observed associations of tobacco on 
social cognition may be due to environmental or confounding factors. This thesis further 
highlights the importance of using range of difference methodological and statistical 
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1. Chapter One: Introduction 
1.1. Adolescent substance use 
Using recreational drugs (i.e. chemical substances ingested to induce euphoria or an 
altered state or of consciousness) at any point in one’s lifetime may result in negative health 
outcomes. However, initiation and frequent use during adolescence has particularly 
damaging consequences, both short and long-term as adolescence is a period of 
developmental plasticity. Adolescence is defined as the transition period from childhood to 
adulthood, and the start (in mammalian species) is generally characterized by the start of 
sexual maturation. Additionally, this period may differ slightly across sociocultural regions, 
but approximately ranges from ages twelve to eighteen. This transitional period is 
characterized by behavioral changes including increased sensation seeking and risk-taking 
(Spear, 2000, 2013; Yuan, Cross, Loughlin, & Leslie, 2015), resulting from pre-pubertal 
increased neuroactive adrenal steroids (Forbes & Dahl, 2010; Halasz, Aspan, Bozsik, 
Gadoros, & Inantsy-Pap, 2013). During this time, the brain is particularly sensitive to 
experience-dependent plasticity within decision making and executive control areas, 
specifically the prefrontal cortex (Bernheim, Halfon, & Boutrel, 2013). Adolescence is a 
period of increased susceptibility to drug use (Agrawal et al., 2006; K. M. King & Chassin, 
2007; Rhee et al., 2003), and is the time most individuals’ initiate substance use (Hanna, Yi, 
Dufour, & Whitmore, 2001; S. H. Lai, Lai, Page, & McCoy, 2000). Adolescents typically 
begin to experiment with alcohol and tobacco, and progress to cannabis and other illicit 
drugs at later ages (Hanna et al., 2001; S. H. Lai et al., 2000). In England and Wales alone, 
~18% of adolescents reported using substances within the past year and ~25% of 15 year-
olds reported ever trying illicit substances (Centre, 2016b). Additionally, ~38% of school age 
children (11 -15) reported ever drinking alcohol (Centre, 2016a), ~35% of 15 year-olds 
reported ever smoking tobacco (Centre, 2016c), and ~83% of 15 year-olds reported using 
cannabis in the past year (Centre, 2016b). 
1.1.1. Alcohol 
Alcohol is a recreational drug containing ethanol (C2H5OH), a chemical compound 
produced through the fermentation of sugar by yeast. Alcoholic beverages are categorised 
into three classes: beer, wines, and spirits, containing between approximately 3% to 40% 
alcohol by volume. The effects of alcohol on the brain are dependent upon an individual’s 
blood alcohol concentration (BAC), with low doses producing stimulating effects and high 
doses depressive effects (Oscar-Berman & Marinkovic, 2007). Furthermore, the 
pharmacokinetics of alcohol varies greatly as a function of a variety of situational factors 
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(Bjork & Gilman, 2014), including time since ingestion (Pohorecky & Brick, 1977), drinking 
rate, metabolic rate, ingestion with food, concentration of alcohol, tolerance, subjective, 
physiological, motor, cognitive, and additional measures such as age, sex or genetic 
variations (Bjork & Gilman, 2014; Reed, 1985). Ingestion of alcohol has a range of effects, 
with acute effects including cognitive impairment and impaired motor coordination and 
chronic effects including tolerance and dependence (Davies, 2003; R. A. Harris, 1999; Lobo 
& Harris, 2008). Ethanol is water-soluble and therefore rapidly crosses cell membranes 
(Marco & Kelen, 1990), being primarily absorbed in the proximal intestinal tract. Alcohol 
influences a variety of neurotransmitter systems (Bjork & Gilman, 2014; Eckardt et al., 
1998), including gamma-aminobutyric acid (GABA), glutamate, serotonin, dopamine, and 
acetylcholine. At higher concentrations, alcohol binds to cell membranes subsequently 
altering phospholipid components of cell membranes, while at intoxication levels alcohol 
interacts with N-methyl D-aspartate (NMDA) and GABAA receptors to alter ion transport 
across cell membranes (Bjork & Gilman, 2014; Fadda & Rossetti, 1998). Low doses have 
stimulating effects, resulting in feelings of euphoria and disinhibition (Brust, 2010), while 
higher doses lead to depressive effects and stupor (Brust, 2010). A review of acute alcohol 
intoxication found effects to be strongest and consistent on visuomotor control, divided 
attention, focused attention, and subjective rating of ‘high.’ Impairments on response 
inhibition reaction time, and working memory were consistently observed in doses over 
0.07% BAC (Zoethout, Delgado, Ippel, Dahan, & van Gerven, 2011).  
Adolescence is a period of neural development and synaptic plasticity; it is therefore 
unsurprising that adolescents are more sensitive to the rewarding aspects of acute 
intoxication (Donovan, 2004; Kyzar, Floreani, Teppen, & Pandey, 2016). Additionally, 
following periods of binge drinking, adolescents experience greater neural reorganisation 
and degeneration compared to adults (Kyzar et al., 2016; Vetreno, Broadwater, Liu, Spear, 
& Crews, 2014) suggesting their cellular and molecular mechanisms have differential 
developmental responses to ethanol. Early onset alcohol use in adolescence is associated 
with high rates of binge drinking in late adolescence (i.e. high school and college age) and 
increased risk of later life abuse (Spear, 2015). The estimated chances of becoming 
addicted to alcohol following the first year of use is 2% (Lopez-Quintero et al., 2011). Alcohol 
dependence rates are four times higher for individuals whom begin drinking prior to the age 
of fourteen (Grant & Dawson, 1997). Additionally, age eighteen binge drinking behaviour is a 
strong predictor of dependency levels at age thirty-five (Merline, Jager, & Schulenberg, 
2008). Furthermore, early alcohol use is associated with a range of problems including 
impaired memory, and executive and visuospatial functioning, as well as decreased grey 
matter associate with cognitive tasks (Jacobus & Tapert, 2013; Spear, 2014).  
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1.1.2. Tobacco 
Tobacco is a recreational drug, whose primary constituent is nicotine (C10H14N2), 
among other chemicals, heavy metals, and free radicals (Swan & Lessov-Schlaggar, 2007). 
Tobacco is primarily smoked in cigarettes, cigars, or pipes although can also be consumed 
in smokeless forms (e.g. chewing, dipping, snus). Tobacco use is highly addictive; the 
estimated chances of becoming dependent following the first year of onset is 2%, and  
(Lopez-Quintero et al., 2011). Tobacco is associated with a range of poor health outcomes, 
including lung cancer and cardiovascular disease (Doll & Hill, 1950). The World Health 
Organization, has named tobacco as the world single greatest cause of preventable death 
(Organisation, 2008; Organization, 2016). Acute nicotine intoxication is associated with 
increased cognitive performance including reaction time, selective attention, working 
memory and recognition memory (Swan & Lessov-Schlaggar, 2007). Nicotine enters the 
brain and binds to presynaptic nicotinic acetylcholine receptors (nAChRs), releasing 
numerous neurotransmitters involved in cognitive processes including serotonin, dopamine, 
and glutamate (Di Matteo, Pierucci, Di Giovanni, Benigno, & Esposito, 2007; Heishman, 
Kleykamp, & Singleton, 2010). Additionally, cholinergic neurons in the prefrontal cortex send 
projections to numerous cortical and subcortical regions, influencing cognitive functioning 
and motor control (Heishman et al., 2010; Woolf, 1991). 
Adolescents are more susceptible to the rewarding effects of tobacco, and may report 
dependence at low levels of consumption (Colby, Tiffany, Shiffman, & Niaura, 2000; D. B. 
Kandel & Chen, 2000). Highly susceptible individuals may report problems quitting before 
consumption reaches two cigarettes per day (DiFranza, Savageau, Fletcher, O'Loughlin, et 
al., 2007). Tobacco has increased rewarding effects, and decreased negative withdrawal 
effects on adolescents (compared to adult smokers) (O'Dell, 2009). Rodent and pre-clinical 
studies have identified differences in nicotinic activity in adolescent versus adult brains. 
Adolescent have higher binging and expression of 42 and 7 nAChRs compared to adults 
(Adriani et al., 2003; Doura, Gold, Keller, & Perry, 2008), including increased activity in the 
thalamus, hippocampus, and striatum (Britton, Vann, & Robinson, 2007; Kota, Martin, 
Robinson, & Damaj, 2007). Nicotine-enhanced neuronal activity is more robust than adults in 
multiple reward-related regions including the ventral tegmental area, basolateral amygdala, 
and nucleus accumbens shell (Dao, McQuown, Loughlin, Belluzzi, & Leslie, 2011; Shram, 
Funk, Li, & Le, 2007). In adolescence, dopamine neurones in the ventral tegmental area are 
more sensitive to nicotine-induce potentiation (Placzek, Zhang, & Dani, 2009). Acute 
nicotine exposure in adolescence, is associated with increased extracellular serotonin 
overflow in the nucleolus accumbens shell and decreased dopamine and serotonin in medial 
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prefrontal cortex (Shearman, Fallon, Sershen, & Lajtha, 2008). Adolescents are susceptible 
to increased self-administration (Adriani, Macri, Pacifici, & Laviola, 2002), intake more 
nicotine than adults (H. Chen, Matta, & Sharp, 2007; Levin et al., 2007; Natividad, Torres, 
Friedman, & O'Dell, 2013), and show less aversion to higher doses (Adriani et al., 2002; 
Shram, Funk, Li, & Le, 2006; Torres, Tejeda, Natividad, & O'Dell, 2008). 
1.1.3. Cannabis 
Cannabis (alternatively known as marijuana or weed, among a variety of other names) 
is a recreational drug, whose legality varies across countries. In the United Kingdom 
cannabis is ranked as a ‘Class B’ drug under the Misuse of Drugs Act (Office, 2002). 
However, other countries have decimalised cannabis use, and as of 2017 seventeen 
countries and some US states have legalised cannabis (C. Rodriguez, 2017). Cannabis is 
commonly inhaled in by smoking through pipes or rolled into joints. In some areas of the 
world, such as the United Kingdom, it is most common to roll cannabis together with tobacco 
to smoke. Additionally, cannabis can be made into food form and ingested. There are 
approximately one hundred constituents of cannabis, known as cannabinoids. The two most 
prominent of which are 9-tetrahydrocannabinol (9-THC) and cannabinol (CBD) (Curran et 
al., 2016). Interestingly, these compounds have differing effects on the body, as 9-THC 
increases anxiety and psychotic-like experiences, and impairs cognition, while CBD 
decreases anxiety, has anti-psychotic effects, and can aid learning (Curran et al., 2016; 
Englund et al., 2013; Morgan, Schafer, Freeman, & Curran, 2010). 9-THC acts as a partial 
cannabinoid 1 receptor agonist (CB1R), while CBD has a range of pharmacological effects. 
CBD attenuates CB1R agonist effects and reduces cellular reuptake of endogenous 
cannabinoids (endocannabinoid and anandamide) in the brain (Alfaro et al., 2017; Curran et 
al., 2016; Pertwee, 2008). Current street cannabis contains much higher levels of 9-THC 
comparable to CBD (ElSohly et al., 2016). Cannabis ‘high’ has a range of effects including 
feelings of euphoria, heighted senses, and increased appetite (Pertwee, 2014). The 
estimated chances of becoming addicted to cannabis following the first year of use is 2% 
(Lopez-Quintero et al., 2011). 
  There appears to be some age-related effects of cannabis, suggesting in some 
circumstances, it may be more hazardous to use in adolescence. The endocannabinoid 
(eCB) system regulates neurodevelopmental processes during adolescence including white-
matter development and synaptic pruning. Exogenous cannabinoids may affect the 
functioning of the eCB system, suggesting chronic use during adolescence may disrupt 
these maturational processes (Lubman, Cheetham, & Yucel, 2015). Additionally, rodent 
studies have indicated that exposure of 9-THC to adolescent brains results in impaired 
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object recognition memory (Quinn et al., 2008; Schneider & Koch, 2007), spatial, and non-
spatial learning, comparative to adult brains (Cha, White, Kuhn, Wilson, & Swartzwelder, 
2006). Additionally, imaging studies suggest individuals whom initiate cannabis use in 
adolescence display greater recruitment of neural resources, possibly reflecting 
compensatory activity during task-activity (Curran et al., 2016). Finally, cannabis is 
commonly considered a ‘gateway’ drug to more harmful drugs (i.e. cocaine), suggesting 
there is a sequential progression from ‘softer’ to ‘harder’ drugs (those with more detrimental 
effect on the individual and society as a whole) (D. B. Kandel, 2002). However, the evidence 
is mixed on this hypothesis. 
1.1.4. Multi-substance use 
Finally, it should be noted that substance use during adolescence often involves the use of 
multiple substances, as opposed to each substance individually. This may result from 
several reasons, one being the purely explorative and sensation seeking nature of the 
adolescent period (Collins, Ellickson, & Bell, 1998; Maddahian, Newcomb, & Bentler, 1985). 
Additionally, some substance use behaviours may increase the likelihood of other 
behaviours (e.g. individuals may be more prone to smoke cigarettes or cannabis after 
already drinking alcohol) (Martin, Arria, Mezzich, & Bukstein, 1993).   
1.2. Substance use and mental health  
Previous evidence suggests approximately 64% to 88% of adolescents with substance 
use disorders (SUDs) have at least one (often more) comorbid mental health problem 
(Brewer, Godley, & Hulvershorn, 2017; Chan, Dennis, & Funk, 2008; Deas & Brown, 2006; 
Rowe, Liddle, Greenbaum, & Henderson, 2004; Shane, Jasiukaitis, & Green, 2003; Wu, 
Gersing, Burchett, Woody, & Blazer, 2011). Adolescents with dual diagnoses (DD) 
experience exaggerated substance use behaviours, including earlier age of onset, heavier 
and more frequent use, and higher rates of dependency (Cadoret, Cain, & Crowe, 1983; 
Shane et al., 2003). Additionally, DD adolescents typically experience family, school, and 
legal problems (Grella, Hser, Joshi, & Rounds-Bryant, 2001; Horigian et al., 2013), and even 
with treatment are more likely to experience relapse (Tomlinson, Brown, & Abrantes, 2004). 
Comparably, adolescents with SUDs that do not have mental health problems respond 
better to treatment (Rowe et al., 2004).   
1.2.1. Internalising disorders 
Internalising disorders are grouped into two sub-categories ‘distress’: depression, 
anxiety, dysthymia, and ‘fear’: panic disorder, social phobia, and specific phobia (Hasin & 
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Kilcoyne, 2012). A recent review estimated that the prevalence of comorbid depression and 
SUDs in community samples of adolescence ranged from 11.1% to 32% with comorbid 
anxiety and SUD ranging from 7% to 40% (O'Neil, Conner, & Kendall, 2011). Rates of 
comorbidity in youth may additionally vary by sex, with higher rates of girls diagnosed with 
comorbid depression or anxiety and SUD at the age of 16 (E. J. Costello, Erkanli, Federman, 
& Angold, 1999). 
1.2.2. Externalising disorders 
Externalising disorders are characterised by aggressive, impulsive, hyperactive, and 
disruptive behaviours (Hinshaw, 1987). These include attention-deficit hyperactivity disorder 
(ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), and antisocial 
behaviour personality disorder (ASPD). A literature review found higher rates of comorbid 
externalising and SUD diagnoses (ADHD prevalence ranging 3% to 38%; CD prevalence 
ranging 24% to 82%; ADHD-CD prevalence ranging 27% to 30%) compared to internalising 
and other mood disorders, with higher rates of diagnosis for males (Couwenbergh et al., 
2006).  
1.2.3. Psychosis-like disorders 
Psychotic disorders are characterised by hallucinations, delusions, and disorganised 
thought and cognition alongside negative or manic symptoms. These include schizophrenia, 
schizotypal personality disorder, schizoaffective disorder, bipolar disorder, and delusional 
disorder (Barkus & Murray, 2010; Heckers et al., 2013). Individuals in the United States with 
schizophrenia use are 4.6 times more likely to use substances compared to the general 
population.  
1.2.4. Current hypotheses  
There are multiple hypotheses surrounding the relationship between mental health 
disorders and substance use. The ‘self-medication’ theory states that individuals already 
suffering from mental health disorders (or prodromal symptoms) are drawn to use 
substances in the belief it may alleviate their symptoms (i.e., self-medication) (Boden, 
Fergusson, & Horwood, 2010; Chaiton, Cohen, O'Loughlin, & Rehm, 2009; G. Taylor et al., 
2014). Other theories suggest prolonged substance use results in changes in neurocircuitry 
over time and subsequently interferes with emotional and psychological functioning 
(Johnson & Kaplan, 1990; D. B. Kandel & Davies, 1986a; Markou, Kosten, & Koob, 1998). 
These theories are not necessarily mutually exclusive, and this association may be 
bidirectional; for instance, alcohol-abuse and anxiety disorders may initiate and/or trigger 
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one another (Kushner, Abrams, & Borchardt, 2000). Finally, there may be no causal 
association between mental health and substance use, and the relationships may be a 
product of shared risk factors (e.g., common genetic factors) (Munafo & Araya, 2010) or 
confounding which arises when an extraneous variable (such as sex or socioeconomic 
position) influences both the exposure and outcome, either directly or indirectly (S. H. Gage, 
Munafo, & Davey Smith, 2015). 
1.3. Social cognition 
Social cognition refers to the psychological processes involved in social interaction, 
comprising self-knowledge, perception of others, and motivational understanding (Brizio, 
Gabbatore, Tirassa, & Bosco, 2015; C. D. Frith, 2008). Largely, the study of social cognition 
is centered around childhood, specifically the diagnosis of autism, as autistic individuals are 
characterized by moderate to severe early onset social cognitive deficits (M. C. Lai, 
Lombardo, & Baron-Cohen, 2014; Thompson, 1996). However, other life periods, while less 
studied, are additionally relevant for the understanding of social cognitive functioning. In 
particular, adolescence, which is a biological and neurodevelopmental phase. Adolescence 
is a period that individuals begin to make sense of their own self including their feelings, 
desires, reactions to situations, and ways of reasoning, and need for control (Brizio et al., 
2015). Furthermore, few studies examine possible decline of social cognitive ability during 
childhood through early adulthood (Brizio et al., 2015). Poor social cognitive ability is 
independently associated with both substance use and mental health problems, which may 
give insight into a previously unstudied variable in the association of mental health and 
substance use. While there exists a range of social cognitive abilities, this thesis investigates 
the following three: non-verbal communication, social communication, and theory of mind/ 
social reciprocity.  
1.3.1. Non-verbal communication 
 Communication and social interaction does not solely occur through spoken 
language. Individuals may use body language to relay messages to one another, adding an 
additional layer of communication upon the verbal messages being delivered (Thompson, 
1996). An important aspect of social communication is appropriately identifying these non-
verbal signals and adequately returning them alongside verbal conversation (Thompson, 
1996). These signals may include posture, gestures, or facial expressions (Gallese, 
Keysers, & Rizzolatti, 2004; Thompson, 1996). Here, gestures or facial expressions could be 
used to reinforce verbal messages (behaviour echoing conversation) or contradict them 
(stating ‘I’m fine’ but expressing irritation or frustration). Non-verbal communication may be 
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used as a substitution (nodding instead of ‘yes’), or to completing speech (smiling while 
delivering good news). This can be used to accentuate a point (shaking head while stating 
‘No’), or regulating conversation (hand gestures to speed up conversation) (Thompson, 
1996). Furthermore, accurately identifying facial emotions helps to identify others internal 
states (Elfenbein, Foo, White, Tan, & Aik, 2007). While an entire array of emotions can be 
expressed facially, a number appear to be universally common including happiness, 
contempt, sadness, surprise, disgust, fear, and anger (Cole, Jenkins, & Shott, 1989; Galati, 
Miceli, & Sini, 2001; Galati, Sini, Schmidt, & Tinti, 2003; Matsumoto & Willingham, 2009). 
Additionally, the expressive intensity of these emotions is may vary from the full emotional 
expression to a weaker emotionally ambiguous version or a mixture of two emotions (i.e. 
fear and disgust) (Adams, Penton-Voak, Harmer, Holmes, & Munafo, 2013; De Sonneville et 
al., 2002; Ekman, 1992). Individuals able to successfully interpret and reciprocate non-verbal 
cues alongside verbal communication will be more successful in social situations and 
understanding other’s intentions. 
1.3.2. Social communication 
 Social communication or pragmatic language is another aspect of social cognition 
allowing individuals to verbally transmit their thoughts and feelings to one another. These 
language-based verbal skills include appropriate use of structure, grammar, and vocabulary 
(Gibson, Adams, Lockton, & Green, 2013; Gilmour, Hill, Place, & Skuse, 2004; Leonard, 
1998). Additionally, speech, tone, and connotation are all used to efficiently portray a 
message from one individual to another. Speech should be clear, articulate and fluid, while 
using producing correct sounds in the grammatically correct order (Bishop & Baird, 2001; 
Gilmour et al., 2004). Conversation should flow effortlessly between individuals without 
either being interrupted and should be coherent and intelligible (Bishop & Baird, 2001; 
Gilmour et al., 2004). The context of conversations generally should exist around interest to 
the listener, and responses should be based and appropriated adjusted on one another’s’ 
cues (i.e. reaction to sarcasm)(Bishop & Baird, 2001; Gilmour et al., 2004).This facilitates 
social reciprocity, or the back-and-forth flow of conversation, in which two individually can 
effortlessly influence the next one’s behavior (Constantino & Todd, 2000). Individuals with 
poor social communication skills may have difficulties understanding forming strong social 
bonds depending on the severity of their impairments  
1.3.3. Theory of mind  
Theory of Mind (ToM), or mentalising, is the understanding that others’ behaviors are 
based from their own thoughts and minds (C. Frith & Frith, 2005), and to understand this we 
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must project ourselves ‘into their shoes.’ Understanding that others, like ourselves, have 
their own knowledge, desires, beliefs, and at times these systems will be in conflict (with our 
own) (C. Frith & Frith, 2005). This enables us to understand that another’s knowledge may 
be different from ours due to the information provided to them. For example, if John places a 
candy in a cupboard then leaves a room, and Jane enters the room and moves the candy to 
the shelf. Where would John look when he returned to the room? An individual with good 
ToM skills would suggest John would still look in the cupboard for his candy as he would 
have no knowledge that Jane had entered the room and moved the location, only an 
observer has this additional knowledge (C. Frith & Frith, 2005; Mahy, Moses, & Pfeifer, 
2014). ToM is associated with a range of important social developmental interactions 
including deception, false beliefs, teaching, and capacity to empathize (C. Frith & Frith, 
2005).  
 
1.3.4. Social cognition and substance use 
Substance use is associated with impaired social cognitive performance. Studies 
indicate that alcohol, tobacco, and cannabis may disrupt non-verbal communication. Acute 
intoxication from alcohol is associated with decreased reactivity to threat cues (Curtin, 
Patrick, Lang, Cacioppo, & Birbaume, 2001), and alcohol dependent individuals display 
reduced accuracy in judging sadness and disgust and require greater emotional intensity to 
detect fear and anger (Donadon & Osorio Fde, 2014). These impairments persist when 
alcohol dependent individuals are detoxified (Townshend & Duka, 2003) and can be 
sustained up to two months into sobriety (Kornreich et al., 2001). In daily cigarette smokers, 
deficits become apparent when individuals are tobacco deprived. Acute withdrawal in 
smokers is associated with reduced processing of happy faces relative to neutral faces 
(Leventhal et al., 2012) and disrupted attentional bias to facial stimuli (Adams, Attwood, & 
Munafo, 2014). Chronic cannabis use is associated with a reduced ability in emotion 
identification, specifically negative emotions (Bayrakci et al., 2015). However, the acute 
effects of different cannabinoids are distinct, as THC impairs affect recognition, but CBD 
improves affect recognition (Hindocha et al., 2015).  
Experimental studies also display acute alcohol intoxication results in impaired ToM 
(Mitchell, Beck, Boyal, & Edwards, 2011). Alcohol dependent individual display ToM deficits, 
as they have difficulty identifying their own mental states and those of social partners 
(Bosco, Capozzi, Colle, Marostica, & Tirassa, 2014; Nandrino et al., 2014). Chronic 
cannabis users display no change in ToM during task performance compared to healthy 
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controls. However, when compared at the neuroanatomical level they show differential 
network activation. Heavy cannabis users display less activation in the left parahippocampal 
gyrus, right precuneus and cuneus, but greater activation in the left cuneus and right anterior 
cingulate gyrus, suggesting changes at the physiological level (Roser et al., 2012). This 
indicates aberrant or greater activity of ToM network, and similar changes have been 
observed in at-risk psychosis populations (Marjoram et al., 2006; Roser et al., 2012). Long-
term cannabinoid exposure may result in changes and functionality of the endocannabinoid 
system, and subsequent desensitization of CB1 receptors and may explain the 
compensatory elevated CB1 receptors elsewhere in the striatum (Romero et al., 1997)  
observed in heavy cannabis users compared to controls (Sim-Selley, 2003).  
1.3.5. Social cognition and mental health 
Many of the same mental health conditions that are highly comorbid with substance use 
behaviours, are also characterized by poor social cognitive performance. Children or 
adolescents with internalising or externalising disorders show decreased recognition of facial 
affect and lower performance on ToM tasks compared to controls (Happe & Frith, 2014; 
Miers, Blote, de Rooij, Bokhorst, & Westenberg, 2013; Wagner, Muller, Helmreich, Huss, & 
Tadic, 2015). Psychotic disorders, which often manifest in adolescence, are characterised 
by multiple social cognitive deficits, and these often remain present even when the acute 
illness is in remission, continuing to impair social adjustment (Mercedes Perez-Rodriguez, 
Mahon, Russo, Ungar, & Burdick, 2015). Therefore, understanding different facets of social 
cognition in relation to these disorders and substance use behaviours, in order to 
understand whether social cognition plays a larger role in the relationship between mental 
health and substance use.  
1.4. Causality 
Ideally, to determine the effects an exposure has on an outcome we would run a 
randomised controlled trial (RCT). Here, individuals would be randomly assorted into an 
exposure or control group. Follow up over time would display any differences between 
groups which may be attributed to the exposure (S. H. Gage, Munafo, et al., 2015). 
However, particularly in substance use research, RCTs are typically impossible due to 
obvious ethical and practical constraints. Therefore, observational data are used, and 
exposure-outcome relationships examined through patterns in the general population (S. H. 
Gage, Munafo, et al., 2015) using analyses such as case-control, cross- sectional, 
longitudinal, cohort, and ecological studies. However, when the ability to randomise is lost, 
we lose control over the exposure of interest and the associations that arise may not be 
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causal. Therefore, any observed associations that arise may be due to reverse causation, 
residual confounding, or bias (Smith & Ebrahim, 2002). Reverse causation questions the 
temporality of the exposure and outcome of interest- while the two may be associated, it is 
possible this association exists in the opposing direction of the research question (i.e. the 
outcome may be influencing the exposure). For example, self-medication of one’s mental 
health problems (exposure) may lead to subsequent substance use (outcome) problems; 
alternatively, prolonged substance use (exposure) resulting in neurological changes may 
subsequently decrease one’s mental health (outcome). Confounding arises when an 
extraneous variable influences both the exposure and outcome either directly or indirectly 
(S. H. Gage, Munafo, et al., 2015) (e.g. gender is associated with both smoking behaviour 
and mental health problems.) Studies may address confounding by adjusting for known 
covariates within the analysis; however, this will always be incomplete due to any 
unknown/unmeasured confounders that may exist or measurement error (Fewell, Davey 
Smith, & Sterne, 2007; Phillips & Smith, 1992; Smith & Phillips, 1992). Selection bias arises 
from the nature of recruitment and measurement in observational research (Ebrahim & 
Smith, 2013) (e.g. drug users are less likely to be in the demographic that participate in 
cohort and survey data).To improve causal inference, there are a range of alternative 
statistical methods that attempt to address the problems inherent in observational data. 
These include instrument variable analysis, negative controls, cross-contextual, and family 
studies.  
This thesis implements the use of a type of instrumental variable analysis called 
Mendelian randomisation (MR). MR analysis uses genetic variants robustly predicting a 
phenotype as an unconfounded proxy for that exposure (Burgess et al., 2015). It is based on 
the principle that individuals’ inherit a random assortment of genes from their parents, and 
these genes should not be associated with potential confounders (Munafo & Araya, 2010). 
Therefore, in theory, a robust genetic influence to a particular exposure (e.g., smoking) 
would be comparable to a randomised trial in which individuals are assigned to a high or low 
exposure group (S. H. Gage, Smith, Zammit, Hickman, & Munafo, 2013). In addition, 
environmental factors cannot affect the genes that an individual is born with so analyses are 
not subject to reverse causality or residual confounding (Bowden, Davey Smith, & Burgess, 
2015; S. H. Gage, Munafo, et al., 2015). There are some limitations to MR; this approach will 
be unavailable if there are no known genetic associations with a phenotype of interest. Large 
sample sizes are required to observe associations between genetic variants and outcomes. 
Finally, the genetic instrument may have pleiotropic effects (i.e. one gene effects multiple 
phenotypes) on the outcome and exposure, resulting in spurious findings (Bowden et al., 
2015).  
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1.5.  Aims of this thesis 
The primary aim of this thesis is to determine the direction of effects, and causality of 
substance use behaviours and mental health outcomes in the adolescent period, and 
whether these effects are mediated or exacerbated by social cognitive deficits. While 
substance use and mental health has been studied extensively before, this attempts to 
address a few important issues.  
First, I attempted to identify trends and/or gaps in the current substance use and mental 
health literature. Secondly, I attempted to use observational analyses to identify poor social 
cognitive performance as an additional contributing factor in either temporal direction due to 
its common association with both poor mental health and substance use behaviour. Finally, I 
attempted to use Mendelian randomisation analysis to identify any possible causal effects in 
previous observational analyses. Overall, this thesis examines the effects of mental health, 
substance use, and social cognition in adolescence as opposed to that of hardened users 
commonly observed in substance use literature. This thesis largely examines tobacco use, 
however integrates effects of alcohol and cannabis where possible to determine any 
patterns across the three highest globally consumed drugs. Finally, I implemented a range of 
methodologies allowing me to triangulate evidence across differing statistical and analytical 
approaches (S. H. Gage, Munafo, et al., 2015; Taylor & Munafo, 2016). 
1.5.1. Systematic review (Chapter 2) 
Through systematic review I sought to evaluate the current literature on the direction of 
tobacco use and internalising disorders (depression and anxiety). I examined longitudinal 
studies with tobacco use as an exposure and depression/anxiety as outcome or vice versa. 
My primary aims were to determine if there is a dominant temporal direction in the literature, 
including bidirectional. My secondary aims were to determine whether there were any gaps 
in the current literature. 
1.5.2. Observational studies (Chapter 4 & 5) 
I used a series of observational analyses conduced in the Avon Longitudinal Study of 
Parents and Children (ALSPAC) to investigate associations of substance use, mental health 
disorders, and social cognitive performance. I examined the temporal associations of mental 
health and substance use, and paralleled each analysis replacing the outcome with social 
cognition to identify any similar trends in the directionality.  
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1.5.3. Genetic Epidemiology (Chapters 6 & 7) 
In the final two analyses, I used genetic variants associated with tobacco initiation to 
conduct Mendelian randomisation analyses to identify any possible causal effects of 
associations identified in our observational analyses.  
1.6. Hypotheses  
I hypothesize there will be an association of poor social cognitive performance with 
substance use and mental health problems, specifically mediating both temporal directions. 
Substance use will be associated with decreased social cognitive performance, this 
decreased ability to communicate and comprehend others’ intentions and emotions will in 
turn result in decreased mental health.  Additionally, poor mental health problems will be 
associated with poor social communicative and emotional behaviours and subsequently 
substance use to self-medicate or as compensatory methods.  
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2. Chapter Two: Systematic Review 
2.1. Introduction 
2.1.1. Systematic Review  
Systematic reviews comprehensively appraise a specific research question and 
synthesises the relevant research to date to provide a conclusion of the current clinical 
standpoints (J. D. Harris, Quatman, Manring, Siston, & Flanigan, 2014; Moher, Liberati, 
Tetzlaff, Altman, & Group, 2009). They represent the gold standard for evaluating health 
care evidence and are commonly used to develop clinical guidelines and practice (Moher et 
al., 2015). By 2011, approximately 11 systematic reviews were being published daily 
(Bastian, Glasziou, & Chalmers, 2010). Systematic reviews are based on strict pre-defined 
protocols listing inclusion/exclusion criteria and methods, ensuring careful planning, 
transparency, and research integrity. The Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA), is a 27-item checklist developed in 2009 to improve reporting 
across systematic reviews (Moher et al., 2009). PRIMSA have additionally developed a flow-
diagram and analysis protocol all publicly available (http://www.prisma-statement.org/) on 
their website. This standardisation of systematic reviews ensures the completeness, 
accuracy and transparency required to synthesise clinical data.  
2.1.2. Background 
The high co-occurrence of smoking and mental illness is a major public health concern, 
and smoking accounts for much of the reduction in life expectancy associated with mental 
illness (Royal College of Physicians, 2013). Many studies report a positive association 
between smoking and mental illness, with smoking rates increasing with the severity of the 
disease (M. Farrell et al., 1998; Meltzer H, 1996). Individuals with mental illness also tend to 
start smoking at an earlier age, smoke more heavily, and are more addicted to cigarettes 
than the general population. For example, a recent survey suggests that 42% of all 
cigarettes consumed in England are consumed by those with mental illness, although this 
includes substance use disorders (McManus S, 2010). Additionally, while cigarette 
consumption in the general population has shown a sustained decrease over the past 20 
years, consumption among smokers with mental illness has remained relatively unchanged 
(Royal College of Physicians, 2013). There is therefore a pressing need to understand the 
mechanisms underlying the high rate of smoking in people with mental illness. Here we 
focus specifically on the relationship between cigarette smoking, and depression and 
anxiety. 
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 Currently, there are several hypotheses that have been proposed to explain the high 
rates of smoking in people with depression and anxiety. The self-medication hypothesis 
postulates that individuals turn to smoking to alleviate their symptoms (Boden et al., 2010; 
Chaiton et al., 2009; G. Taylor et al., 2014), and therefore suggests that symptoms of 
depression and anxiety may lead to smoking. An alternative hypothesis is that smoking may 
lead to depression or anxiety, through effects on an individual’s neurocircuitry that increases 
susceptibility to environmental stressors. Animal models indicate that prolonged nicotine 
exposure dysregulates the hypothalamic-pituitary-adrenal system, resulting in 
hypersecretion of cortisol and alterations in the activity of the associated monoamine 
neurotransmitter system, whose function is to regulate reactions to stressors (Markou et al., 
1998), an effect that appears to normalise after nicotine withdrawal (Rose, Behm, Ramsey, 
& Ritchie, 2001). The association between smoking and depression/anxiety may also be 
bidirectional, with occasional smoking initially used to alleviate symptoms, but in fact 
worsening them over time (Munafo & Araya, 2010). Finally, there may in fact be no causal 
relationship between smoking and depression/anxiety. Instead, the association may be a 
product of shared risk factors (e.g., common genetic influences) (Kendler et al., 1993; 
Munafo & Araya, 2010) or confounding. Smokers may also report that cigarettes alleviate 
their symptoms due to the misattribution of withdrawal relief. Given the short half-life of 
nicotine, which results in withdrawal symptoms (including mood symptoms) after a short 
period of abstinence, smokers may misattribute the relief of short-term withdrawal as 
reflecting a genuine anxiolytic effect of smoking (G. Taylor et al., 2014). That is, withdrawal 
symptoms of increased anxiety and negative affect may be misattributed as reflecting 
genuine mood symptoms, which would lead to the impression that smoking improves mood. 
 We are therefore presented with multiple different hypotheses regarding whether 
there is a causal relationship between smoking and depression/anxiety, and if so what the 
direction of causality underlying this relationship is. While experimental studies are generally 
not possible, for both practical and ethical reasons, longitudinal studies may help inform our 
understanding of the causal relationship between smoking and depression/anxiety by 
clarifying the temporal association. This study aimed to systematically review the literature 
comprising longitudinal studies of the associations between smoking and depression/anxiety 
and conduct meta-analyses where possible. To the best of our knowledge this is the first 
systematic review of this literature. 
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2.1.3. Chapter aims 
This chapter uses systematic review to examine longitudinal association of cigarette 
smoking with depression and/or anxiety in both temporal directions. Here, my main goals are 
to identify any major trends or gaps in the current literature.  
This chapter Is largely based on a published manuscript:  Fluharty, M., Taylor, A. E., 
Grabski, M., & Munafò, M. R. (2017). The Association of Cigarette Smoking with Depression 
and Anxiety: A Systematic Review. Nicotine & Tobacco Research, 19(1), 3–13. 
http://doi.org/10.1093/ntr/ntw140 
2.2. Methods 
2.2.1. Identification of studies 
We searched PubMed, Scopus, and Web of Science up until 1th August 2015 using the 
following search terms: depressi*, anxi*, smok*, tobacco, nicotine, cigarette, caus*, cohort, 
prospective, longitudinal. The term animal* was specified for exclusion. Two authors (MF 
and AT) reviewed the electronic abstracts, selecting the full-text articles to be included.  
2.2.2. Selection criteria 
Studies were included in the review if they met the following criteria: 1) human 
participants, 2) smoking as the exposure variable and depression and/or anxiety as the 
outcome variable or vice versa (depression and/or anxiety as the exposure variable and 
smoking as the outcome variable), 3) longitudinal study design, and 4) reported primary data 
not previously reported elsewhere. Studies involving cessation, withdrawal, suicide, or 
trauma, that recruited participants who were pregnant or diagnosed with a psychiatric illness 
other than depression or anxiety, or included participants with depression and anxiety 
comorbid with another psychiatric illness, were excluded. Studies not utilising a validated 
diagnostic test for depression or anxiety were excluded. Studies investigating the 
association of parental smoking on offspring outcomes were also excluded, as were all 
experimental studies (e.g., randomised controlled trials [RCTs] of smoking cessation 
interventions). RCTs as well as secondary analyses of RCTs were excluded. 
2.2.3. Data Extraction 
The following information was extracted from each of the included studies: type of 
depression/anxiety (major depression; generalised anxiety disorder; mixed major depression 
and generalised anxiety disorder), method of measuring depression/anxiety (self-report via 
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diagnostic test, clinical interview, or physician diagnosis) and scale used (continuous or 
categorical), smoking behaviour (age of smoking onset; smoking status; heaviness of 
smoking; tobacco dependence; smoking trajectory), sample size, mean age of participants 
and sex distribution of participants, population sampled (e.g., general or clinical), and length 
of follow up. A 100% data check was performed by the main author (MF) and a 10% data 
check was independently performed by second author (MG) to identify data extraction 
errors. Any errors identified were resolved by mutual consent.  
2.2.4. Rationale for not conducting meta-analysis 
A meta-analysis was not conducted as, even within the general population samples 
available, there was substantial heterogeneity (age, location, covariates used, time to follow-
up, number of times and frequency of outcomes sampled). Additionally, the studies included 
were not limited to only those examining an a priori hypothesis of mental health and 
smoking; studies were included if they contained the desired outcome and exposure 
variables within their dataset. 
2.3. Results 
2.3.1. Characteristics of Included Studies 
Of the 6,232 abstracts reviewed, 5,514 were excluded on the basis of title and 404 after 
reviewing the abstract. In total, 314 articles were retrieved and assessed for eligibility, and 
148 met inclusion criteria (Figure 2.1). Details of included studies and excluded full text 
studies are provided in the appendix (see Appendix A pages 148 & 163). 
Studies ranged in sample size from 59 to 90,627 participants, and in length of follow up 
from 2 months to 36 years. Of the 148 included studies, 99 (67%) recruited male and female 
participants, 16 (11%) recruited only females and 7 (5%) recruited only males, while 26 
(18%) did not report the sex of the participants. In addition, 101 studies (70%) sampled 
participants from the general population, 15 (10%) from clinical populations and 16 (10%) 
from particular ethnic groups, while 16 (10%) had other selection criteria (see Appendix A 
page 148) 
Unless otherwise stated, the associations described refer to a positive relationship between 
smoking and depression/anxiety (i.e., smoking is associated with increased 
























































































2.3.2. Smoking Categories  
Studies were categorised based on the smoking behaviour(s) they assessed: smoking 
onset, smoking status, smoking heaviness, tobacco dependence, and smoking trajectory. 
Studies with measures of daily or weekly cigarette use were included in the smoking 
heaviness category. Studies that were able to establish the onset of smoking from an initially 
non-smoking population were included in the smoking onset category. Studies that 
measured tobacco dependence, for example through the DSM-IV ( Diagnostic and statistical 
manual of mental disorders, 2000) or the Fagerström Test for Nicotine Dependence 
(Fagerstrom, Heatherton, & Kozlowski, 1990), were included in the tobacco dependence 
category. Studies that tracked the different paths of cigarette smoking uptake and use in a 
cohort were included in the smoking trajectory category, and studies that defined smokers in 
purely categorical terms (e.g., current, former, never) were included in the smoking status 
category. Table 2.1 summarises the directions of associations investigated within the studies 
in each smoking category. 
Table 2.1: Directions of associations investigated by smoking category. 
Category 
Depression Anxiety 



















13 0 1 4 0 2 5 0 1 
Smoking 
status 
29 40 8 0 4 1 1 7 0 
Smoking 
heaviness 
9 7 2 1 1 0 0 1 0 
Tobacco 
dependence 
12 2 1 6 0 0 5 1 0 
Smoking 
trajectory 




70 51 12 12 5 3 12 10 1 
The number of studies investigating each direction(s) of association for each smoking category is shown. Studies 
investigating multiple directions are repeated within smoking category. Please note, these only include directions 
investigated and differ from the overall findings within smoking groups detailed in Figure 2. MH = mental health 
outcome. 
 
2.3.3. Smoking Onset 
A total of 14 studies investigated the association of baseline depression with 
subsequent smoking onset, of which 10 (71%) found evidence to support this association 
(Breslau, Peterson, Schultz, Chilcoat, & Andreski, 1998; Brown, Lewinsohn, Seeley, & 
Wagner, 1996; Carvajal & Granillo, 2006; J. Chen et al., 2013; Fuemmeler et al., 2013; 
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Holahan et al., 2011; Killen et al., 1997; S. M. King, Iacono, & McGue, 2004; Naicker, 
Galambos, Zeng, Senthilselvan, & Colman, 2013; Weiss, Mouttapa, Cen, Johnson, & Unger, 
2011) while 4 (29%) found no evidence of an association (E. Goodman & Capitman, 2000; 
O'Loughlin, Karp, Koulis, Paradis, & DiFranza, 2009; Senol, Donmez, Turkay, & Aktekin, 
2006; Wiesner & Ittel, 2002). Five studies investigated the association of baseline anxiety on 
smoking onset, of which 4 (80%) found evidence to support an association with increased 
risk of smoking onset (Cuijpers, Smit, ten Have, & de Graaf, 2007; Marmorstein, White, 
Loeber, & Stouthamer-Loeber, 2010; Senol et al., 2006; Swendsen et al., 2010) and 1 (20%) 
found no evidence of an association (Brown et al., 1996). Six studies investigated the 
association of comorbid depression and anxiety with later smoking onset, of which 2 (33%) 
found evidence to support this association (Escobedo, Reddy, & Giovino, 1998; Patton et al., 
1998), while 1 (17%) reported comorbid depression and anxiety was associated with 
reduced risk of smoking onset (Fischer, Najman, Williams, & Clavarino, 2012) and 3 (50%) 
found no evidence of an association (Hayatbakhsh, Mamun, Williams, O'Callaghan, & 
Najman, 2013; Leff et al., 2003; Pedersen & von Soest, 2009). One study investigated the 
association of smoking onset with later depression, finding evidence for this association 
(Breslau et al., 1998). One study investigated the association of smoking onset with later 
anxiety, finding no evidence for this association (Brown et al., 1996). Additionally, one study 
investigated the association of smoking onset with later comorbid depression and anxiety, 
finding no evidence for this association (Patton et al., 1998). These findings are summarised 
in Figure 2.2. 
Figure 2.2 Main outcomes by smoking category 
The main findings for each smoking category, and whether the association was found to be positive, negative or 
null for each direction of association investigated, is shown 
2.3.4. Smoking Status 
A total of 37 studies investigated the association of baseline depression with subsequent 
smoking status, of which 33 (89%) found evidence to support this association (Anda et al., 
1990; Appleton et al., 2013; Audrain-McGovern, Lerman, Wileyto, Rodriguez, & Shields, 
2004; Audrain-McGovern, Rodriguez, & Kassel, 2009; Audrain-McGovern, Rodriguez, 
Rodgers, & Cuevas, 2011; Black, Sussman, Johnson, & Milam, 2012; Bomba, 
Modrzejewska, Pilecki, & Ślosarczyk, 2004; Braithwaite et al., 2015; J. S. Brook, Balka, 
Ning, Whiteman, & Finch, 2006; Brown et al., 1996; Brummett et al., 2003; Byers et al., 
2012; Carvajal, 2012; H. K. Clark, Ringwalt, & Shamblen, 2011; Coogan et al., 2014; 
Fleming, Mason, Mazza, Abbott, & Catalano, 2008; Franko et al., 2005; Gritz et al., 2003; D. 
B. Kandel & Davies, 1986b; Knekt et al., 1996; Leiferman, 2002; Leung, Gartner, Hall, 
Lucke, & Dobson, 2012; Leve, Harold, Van Ryzin, Elam, & Chamberlain, 2012; Mendel, 
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Berg, Windle, & Windle, 2012; Miller-Johnson, Lochman, Coie, Terry, & Hyman, 1998; 
Needham, 2007; Niemela et al., 2009; Park, Weaver, & Romer, 2009; Prinstein & La Greca, 
2009; Repetto, Caldwell, & Zimmerman, 2005; Wickrama & Wickrama, 2010), while 4 (11%) 
found no evidence of an association (Audrain-McGovern et al., 2006; Kang & Lee, 2010; van 
Gool et al., 2007; Wang, Fitzhugh, Turner, Fu, & Westerfield, 1996). One study investigated 
the association of anxiety with later smoking status, finding evidence of an association 
(Cuijpers et al., 2007). One study investigated the association of comorbid depression and 
anxiety with later smoking status, finding no evidence of an association (Ferdinand, Blum, & 
Verhulst, 2001). 
A total of 51 studies investigated the association of smoking status with later depression, of 
which 37 (73%) found evidence to support this association (Albers & Biener, 2002; Almeida 
et al., 2013; Audrain-McGovern et al., 2009; Batterham, Christensen, & Mackinnon, 2009; J. 
S. Brook, Schuster, & Zhang, 2004; Brown et al., 1996; Buckner & Mandell, 1990; Choi, 
Patten, Gillin, Kaplan, & Pierce, 1997; Clyde, Smith, Gariepy, & Schmitz, 2014; Colman et 
al., 2011; D. M. Costello, Swendsen, Rose, & Dierker, 2008; de Jonge et al., 2006; Dugan, 
Bromberger, Segawa, Avery, & Sternfeld, 2014; Duncan & Rees, 2005; Flensborg-Madsen 
et al., 2011; E. Goodman & Capitman, 2000; Gravely-Witte, Stewart, Suskin, & Grace, 2009; 
Green et al., 1992; Kang & Lee, 2010; Khaled et al., 2012; Klungsoyr, Nygard, Sorensen, & 
Sandanger, 2006; Kocer, Wachter, Zellweger, Piazzalonga, & Hoffmann, 2011; Korhonen et 
al., 2007; Leung et al., 2012; Meng & D'Arcy, 2014; Moon, Mo, & Basham, 2010; Needham, 
2007; Paffenbarger, Lee, & Leung, 1994; Pasco et al., 2008; S. B. Patten et al., 2010; D. 
Rodriguez, Moss, & Audrain-McGovern, 2005; Schrader, Cheok, Hordacre, & Guiver, 2004; 
Schrader, Cheok, Hordacre, & Marker, 2006; Silberg, Rutter, D'Onofrio, & Eaves, 2003; 
Stein, Newcomb, & Bentler, 1996; Sweeting, West, & Der, 2007; Tanaka, Sasazawa, 
Suzuki, Nakazawa, & Koyama, 2011), while 14 (27%) found no evidence of this association 
(Aneshensel & Huba, 1983; Anstey, von Sanden, Sargent-Cox, & Luszcz, 2007; Braithwaite 
et al., 2015; C. Clark et al., 2007; Cuijpers et al., 2007; S. H. Gage, Hickman, et al., 2015; 
Julian et al., 2011; Munafo, Hitsman, Rende, Metcalfe, & Niaura, 2008; Park et al., 2009; 
Repetto et al., 2005; Strong, Juon, & Ensminger, 2014; Takeuchi, Nakao, & Yano, 2004; 
Wang et al., 1996; Weyerer et al., 2013). Four studies investigated the association of 
smoking status with later anxiety, of which 2 (50%) found evidence to support this 
association (Cuijpers et al., 2007; Moylan et al., 2013), while 2 (50%) found no evidence of 
an association (Brown et al., 1996; S. H. Gage, Hickman, et al., 2015). Seven studies 
investigated the association of smoking status with later comorbid depression and anxiety, of 
which 5 (71%) found evidence to support this association (Boyes, Girgis, D'Este, Zucca, & 
Lecathelinais, 2013; Fergusson, Boden, & Horwood, 2011; Patel, Kirkwood, Pednekar, 
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Weiss, & Mabey, 2006; Pedersen & von Soest, 2009; Wagena, van Amelsvoort, Kant, & 
Wouters, 2005), while 2 (29%) found no evidence of an association (Bjorngaard et al., 2013; 
D. B. Clark & Cornelius, 2004). These findings are summarised in Figure 2.2. 
2.3.5. Smoking Heaviness 
 A total of 11 studies investigated the association of baseline depression with 
subsequent heaviness of smoking, of which 8 (73%) found evidence that depression was 
associated with heavier rates of smoking (D. W. Brook, Brook, & Zhang, 2014; Fergusson, 
Goodwin, & Horwood, 2003; Holahan et al., 2011; Lekka, Lee, Argyriou, Beratis, & Parks, 
2007; Maslowsky, Schulenberg, & Zucker, 2014; van Gool et al., 2003; Whitbeck, Yu, 
McChargue, & Crawford, 2009; Windle & Windle, 2001), while 2 (18%) found that 
depression was associated with reduced heaviness of smoking (O'Loughlin et al., 2009; C. 
A. Patten et al., 2003), and 1 (09%) found no evidence of an association (Beal, Negriff, 
Dorn, Pabst, & Schulenberg, 2013). One study investigated the association of baseline 
anxiety with subsequent smoking heaviness and found no evidence of an association (Lekka 
et al., 2007). Eight studies investigated the association of heaviness of smoking with later 
depression, of which 7 (88%) found evidence to support this association (Beal et al., 2013; 
Clyde et al., 2014; Galambos, Leadbeater, & Barker, 2004; Kendler et al., 1993; Klungsoyr 
et al., 2006; Paffenbarger et al., 1994; Windle & Windle, 2001), while 1 (13%) found no 
evidence of an association (D. W. Brook, Brook, Zhang, Cohen, & Whiteman, 2002). One 
study investigated the association of heaviness of smoking with later anxiety, and found 
evidence to support this association (Okeke, Spitz, Forman, & Wilkinson, 2013). One study 
investigated the association of heaviness of smoking with later comorbid depression and 
anxiety, finding no evidence of an association (Bjorngaard et al., 2013). These findings are 
summarised in Figure 2.2. 
 
2.3.6. Tobacco Dependence 
 A total of 13 studies investigated the association of baseline depression with 
subsequent tobacco dependence, of which 12 (92%) found evidence to support this 
association (Bardone et al., 1998; Breslau, Kilbey, & Andreski, 1993; J. S. Brook, Brook, & 
Zhang, 2008; DiFranza, Savageau, Fletcher, Pbert, et al., 2007; Fergusson et al., 2003; 
Hamdi & Iacono, 2014; Denise B. Kandel, Hu, Griesler, & Schaffran, 2007; Karp, O'Loughlin, 
Hanley, Tyndale, & Paradis, 2006; Kendler & Gardner, 2001; Kleinjan et al., 2010; Racicot, 
McGrath, Karp, & O'Loughlin, 2012; Swendsen et al., 2010) while 1 (8%) found no evidence 
of an association (Tully, Iacono, & McGue, 2010). Six studies investigated the association of 
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baseline anxiety with later tobacco dependence, of which 2 (33%) found evidence to support 
this association (Goodwin, Fergusson, & Horwood, 2004; Denise B. Kandel et al., 2007), 
while 4 (67%) found no evidence of an association (Bardone et al., 1998; Breslau et al., 
1993; DiFranza, Savageau, Fletcher, Pbert, et al., 2007; Woodward & Fergusson, 2001). 
Five studies investigated baseline comorbid depression and anxiety with subsequent 
tobacco dependence, of which 3 (60%) found evidence to support this association (Goodwin 
et al., 2013; McKenzie, Olsson, Jorm, Romaniuk, & Patton, 2010; Patton, Coffey, Carlin, 
Sawyer, & Wakefield, 2006) while 2 (40%) found no evidence of an association (Griesler, 
Hu, Schaffran, & Kandel, 2008; Pedersen & von Soest, 2009). Three studies investigated 
the association of tobacco dependence with later depression, of which 2 (67%) found 
evidence to support this association (Boden et al., 2010; Breslau et al., 1993), while 1 (33%) 
found no evidence of an association (Hu, Griesler, Schaffran, & Kandel, 2011). Two studies 
investigated the association of tobacco dependence with later comorbid depression and 
anxiety, of which 1 (50%) found evidence to support this association (Jamal, Willem Van der 
Does, Cuijpers, & Penninx, 2012), while 1 (50%) found no evidence of an association 
(Griesler et al., 2008). These findings are summarised in Figure 2.2. 
2.3.7. Smoking Trajectory 
 A total of 7 studies investigated the association of baseline depression with smoking 
trajectory, of which 1 (14%) reported that depressive symptoms were associated with 
accelerated cigarette use (Hooshmand, Willoughby, & Good, 2012), 3 (43%) reported that 
depressive symptoms were associated with early smoking onset (Audrain-McGovern, 
Rodriguez, et al., 2004; J. S. Brook et al., 2006; Fuemmeler et al., 2013), 1 reported that 
depressive symptoms were associated with late onset smoking (Saules et al., 2004) and 2 
(29%) found no evidence of an association (Juon, Ensminger, & Sydnor, 2002; H. R. White, 
Violette, Metzger, & Stouthamer-Loeber, 2007). One study reported evidence of an 
association of baseline anxiety with early and late onset smoking patterns (Hu, Griesler, 
Schaffran, Wall, & Kandel, 2012). Another study reported evidence of an association of 
baseline comorbid depression and anxiety with late onset smoking as opposed to 
experimental smoking (J. S. Brook, Ning, & Brook, 2006). One study reported that 
individuals in (smoking) starter and maintaining groups were more likely to be depressed at 
follow-up compared to non-smoking groups (Steuber & Danner, 2006).  Finally, one study 
reported evidence that early onset smokers developed depression and anxiety 
approximately five years earlier than late onset smokers (Jamal, Does, Penninx, & Cuijpers, 
2011). These findings are summarised in Figure 2.2. 
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2.3.8. Bidirectional Studies 
 Sixteen (11%) of the 148 included studies investigated the association between 
smoking behaviour and mental health bidirectionally (i.e., both the association between 
baseline mental health and later smoking behaviour, and baseline smoking behaviour and 
later mental health). Of these, 7 (44%) reported evidence in support of a bidirectional 
relationship between depression and smoking (Audrain-McGovern et al., 2009; Breslau et 
al., 1993; Breslau et al., 1998; Brown et al., 1996; Leung et al., 2012; Needham, 2007; 
Windle & Windle, 2001), and 1 (9%) reported evidence in support of a bidirectional 
relationship between anxiety and smoking (Cuijpers et al., 2007). 
2.3.9. Sex Differences 
 A total of 8 studies (7% of all studies including both males and females) reported that 
the relationship between smoking and depression/anxiety differed between males and 
females. Two studies reported that depression was associated with subsequent smoking 
behaviour only in males (Killen et al., 1997; Repetto et al., 2005), while 1 study reported 
depression was associated with subsequent smoking only in females (Fleming et al., 2008) 
and 1 study reported that anxiety was associated with later smoking behaviour only in 
females (Denise B. Kandel et al., 2007). Additionally, one study reported evidence that 
smoking status in men was associated with later depression (Korhonen et al., 2007), and 2 
studies reported evidence that smoking status had a stronger association with later 
depression in females than males (Duncan & Rees, 2005; Steuber & Danner, 2006). Finally, 
one study reported a bidirectional relationship between smoking and depression that was 
only observed in females (Needham, 2007).  
2.3.10. Clinical Studies 
 Five studies investigated participants with cardiovascular problems. One study 
reported evidence that depression was associated with subsequent smoking behaviour 
(Brummett et al., 2003). The other 4 reported that smoking status was associated with later 
depression (Gravely-Witte et al., 2009; Kocer et al., 2011; Schrader et al., 2004; Schrader et 
al., 2006). Other studies of clinical populations generally reported evidence of an association 
between smoking and the onset of depression. 
2.3.11. Ethnic Differences 
 Five studies recruited participants of East Asian descent (China, Japan, and South 
Korea), with 2 studies reporting evidence that depression was associated with later smoking 
behaviour (Black et al., 2012; Park et al., 2009), and 1 studies reporting no evidence of an 
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association (Kang & Lee, 2010). Additionally, 2 studies reported evidence for an association 
between smoking status and later depression (Kang & Lee, 2010; Tanaka et al., 2011), while 
2 studies reported no evidence that smoking status was associated with subsequent 
depression (Park et al., 2009; Takeuchi et al., 2004). Three studies recruited African 
American participants, with 2 studies reporting evidence that depression was associated 
with later smoking behaviour (Miller-Johnson et al., 1998; Repetto et al., 2005), 1 study 
reporting no evidence that depression was associated with subsequent smoking onset (H. R. 
White et al., 2007), and 1 study reporting no evidence that smoking was associated with the 
onset of depression (Repetto et al., 2005). Four studies recruited both African American and 
Hispanic participants, with 3 studies reporting that depression and anxiety were associated 
with subsequent smoking trajectories (J. S. Brook et al., 2006; J. S. Brook et al., 2008; 
Judith S. Brook et al., 2006), while 1 study reported that smoking heaviness was associated 
with the onset of anxiety (Okeke et al., 2013). Other studies of specific ethnic groups 
generally reported evidence of an association between smoking and later depression and 
anxiety. 
2.3.12. Additional Analyses 
 No clear pattern of results was apparent when studies with different lengths of follow-
up were considered separately (see Appendix A page 168). Additionally, the findings did not 
vary substantially between studies using different tests (interview versus self-diagnostic test) 




 In general, the findings across the studies in this systematic review were 
inconsistent. Nearly half of the studies reported that baseline depression or anxiety was 
associated with some type of later smoking behaviour, whether it be the onset of smoking 
itself, increased smoking heaviness, or the transition from daily smoking into dependence. 
These findings support a self-medication model, suggesting that individuals smoke to 
alleviate psychiatric symptoms (Boden et al., 2010; Chaiton et al., 2009). However, over a 
third of the studies found evidence for a relationship in the opposite direction, whereby 
smoking exposure at baseline was associated with later depression or anxiety, supporting 
the alternative hypothesis that prolonged smoking increases susceptibility to depression and 
anxiety (Markou et al., 1998; Rose et al., 2001). Of course, these two putative causal 
pathways are not mutually exclusive, but interestingly there were relatively few studies 
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reporting evidence for a bidirectional model relationship between smoking and depression 
and anxiety. One possible reason for this is that many studies only measured or analysed 
the variables in the direction of their a priori hypothesis. For example, studies examining 
factors for depression in later life measured smoking as a possible factor, but typically did 
not analyse the association of baseline depression with later smoking. Moreover, few studies 
reported null results; often these were only included alongside positive results relating to 
another outcome. Additionally, it is possible the associations observed between smoking 
and mental health are a result of shared genetic and environmental factors (Boden et al., 
2010). 
2.4.1. Limitations 
 There are several limitations that should be considered when interpreting these 
results. First, the studies included in this review varied substantially in population sampled, 
with some recruiting from the general population, and others selectively recruiting by sex, 
ethnicity, clinical population, or some other characteristic (e.g., at-risk adolescents). This 
introduced substantial heterogeneity into the review, thus making meta-analysis 
inappropriate. The substantial heterogeneity between study populations could be 
responsible for the inconsistent results observed, and future reviews should consider 
analysing different populations individually. Second, there was also substantial variation in 
study designs, including in length of follow up (between 2 months and 36 years), and 
confounders adjusted for. Measurement of depression or anxiety was based on a wide 
range of different diagnostic tests, with different cut-offs for determining clinical status. 
Sample size also varied substantially between studies, ranging from 59 to 90,627, 
suggesting that some smaller studies may be inadequately powered. This may lead to an 
increased likelihood of false positives (Button et al., 2013) since, among statistically 
significant findings, as power declines the ratio of true positives to false positives decreases. 
This is because while 5% of null associations will be falsely declared as significant 
(assuming a 5% alpha level), the number of true positives correctly identified will decline as 
power declines (e.g., from 80% of true associations correctly declared as significant in high 
powered studies to, say, only 20% in low powered studies) (Button et al., 2013). However, it 
is also worth noting that very large samples may detect statistically significant associations 
which are unlikely to be of clinical or population health importance.  
Third, we only included published studies, and while the inclusion of unpublished studies 
may increase the likelihood of including lower quality work which has not been peer-
reviewed, it may also decrease publication bias, in which studies are only published if they 
have positive results. By expanding our search to include non-published studies, it is 
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possible we may have found more instances of null results. Fourth, we did not investigate 
whether quality of the individual studies was related to the nature of the results reported. 
However, this would be challenging given the diversity of study designs among the included 
studies. Fifth, while we were able to categorise and investigate a range of different smoking 
behaviours, the same level of detail was not available for depression and anxiety. Future 
reviews should investigate individual symptomology (e.g., negative affect, somatic features, 
etc.) and their relationship with smoking behaviour, as previous research has indicated that 
specific symptoms may be differentially associated with smoking motivations and tobacco 
withdrawal (Leventhal, Ameringer, Osborn, Zvolensky, & Langdon, 2013; Leventhal, 
Zvolensky, & Schmidt, 2011; Mickens et al., 2011b). However, this analysis was not possible 
with the data reviewed here. Sixth, we only focused on depression, anxiety, or comorbid 
depression and anxiety. However, several studies identified during screening included 
depression or anxiety subtypes (e.g. post-traumatic stress disorder or social anxiety). These 
were excluded, in order to maximise comparability among included studies. Future studies 
should explore whether there is a more consistent pattern of relationship between smoking 
behaviour and these other diagnostic categories. However, given the disparate results we 
observed in our more focused review, it is perhaps unlikely that clear relationships will 
emerge. 
2.4.2. Future directions 
Despite the advantages of longitudinal studies, they cannot by themselves provide strong 
evidence of causality. Future studies should therefore employ methods which enable 
stronger causal inference, such as Mendelian randomisation (S. H. Gage et al., 2013). Two 
studies which have used Mendelian randomisation have found no evidence to support a 
causal association between smoking and depression and anxiety (Bjorngaard et al., 2013; A. 
E. Taylor et al., 2014), while another found evidence to suggest that smoking was 
associated with lower odds of depression during pregnancy (S. J. Lewis et al., 2011). The 
results of these studies suggest that observational findings of an association of smoking 
status with later psychological distress may be a result of shared vulnerability, residual 
confounding, or reverse causality (e.g., psychological distress associated with later smoking 
behaviour) (A. E. Taylor et al., 2014). However, this review yielded the most findings in the 
direction of psychological distress associated with later smoking behaviour. This review 
found slightly more evidence to support a direction of psychological distress predicting later 
smoking behaviour, which is not inconsistent with these MR studies (S. J. Lewis et al., 2011; 
A. E. Taylor et al., 2014). However, while both depression and anxiety are highly heritable 
(Hamet & Tremblay, 2005; Norrholm & Ressler, 2009), genome-wide association studies 
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(GWAS) have not yet identified robust variants for anxiety, and have only recently identified 
variants strongly associated with depression (Power et al., 2017). An unpublished analysis 
conducted in the Tobacco and Alcohol Research Group found depression was highly 
associated with smoking initiation (Sallis, 2018). In summary, we found overall inconsistent 
findings regarding whether smoking leads to depression and anxiety, depression and anxiety 
results in smoking or increased smoking behaviour, or there is a bidirectional relationship 
between the two. 
2.5. Chapter summary 
In chapter 2 I conducted a systematic review of the current literature of longitudinal studies 
of mental health and cigarette smoking. The evidence was largely inconsistent regarding 
whether smoking leads to depression and anxiety, whether depression and anxiety results in 
increased smoking behaviour, or there if there is a bidirectional relationship between the 
two. No patterns emerged when we stratified by smoking behavior, gender, clinical status, or 
ethnicity. Additionally, I found studies were largely conducted in the direction of their a priori 
hypothesis, suggesting bidirectional associations will remain unmeasured subjecting findings 
to reverse causation. Taking this into account, my next analyses (Chapter 3-4) examine 
longitudinal association of substance use and mental health in both temporal directions.  
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3. Chapter Three: Avon Longitudinal Study of Parents and 
Children (ALSPAC) methods and materials 
3.1. Introduction 
3.1.1. Chapter aims 
In this Chapter, I will describe the prospective birth cohort that is used for the series of 
longitudinal analyses reported in Chapters 4-5 and a Mendelian randomisation analysis 
reported in Chapter 6. This will include details on cohort description, sample size, and 
variables used. Where possible variables remained consistent across chapters.  
3.2. Cohort description 
The Avon Longitudinal Study of Parents and Children (ALSPAC) alternatively known as 
‘Children of the 90s,’ is a longitudinal prospective birth cohort based in Bristol, UK and 
conducted by The University of Bristol. The study recruited pregnant women with delivery 
dates between 1 April 1991 and 31 December 1992. ALSPAC originally enrolled 14,541 
pregnancies, later excluding 674 for a final number of 13,867 pregnancies and 13,761 
unique women (Boyd, Golding, Macleod, Lawlor, Fraser, Henderson, Molloy, Ness, Ring, & 
Davey Smith, 2013). Second phases of recruitment occurring at offspring 7 and 8 years 
identified a further 706 pregnancies for a total of 15,247 enrolled pregnancies (Fraser et al., 
2013). 
The ALSPAC maternal sample was compared to the Avon population as well as the 
general British population using the 8-month prenatal questionnaire and the 1991 census. 
ALSPAC mothers were more likely than the general Avon and British populations to live in 
owner-occupied accommodation and overcrowded conditions, have access to a car, be 
married, and were of higher socioeconomic status. Additionally, cohort mothers were less 
likely to be non-white (Fraser et al., 2013). 
ALSPAC children were compared to national averages at age 16 using the National 
Pupil Database. ALSPAC children had higher educational attainment, were more likely to be 
white, and less likely to be eligible for free school meals. Attrition rates at age 18 indicate 
high responders are more likely to be female, white, and less likely to be eligible for free 
school meals, while individuals lost to attrition were more likely male and eligible for free 
school meals (Boyd, Golding, Macleod, Lawlor, Fraser, Henderson, Molloy, Ness, Ring, & 
Davey Smith, 2013).  
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ALSPAC assessments are frequently administered totaling 68 data collection time 
points from birth to age 18, including 34 child-completed questionnaires, 9 clinical 
assessments and 25 maternal-reported questionnaires about the child. Information collection 
in ALSPAC is rich and diverse including phenotypic, genetic, and biological sampling across 
different time points (Boyd, Golding, Macleod, Lawlor, Fraser, Henderson, Molloy, Ness, 
Ring, & Davey Smith, 2013).  
3.3. Sample sizes 
3.3.1. Observational studies  
Sample sizes varied across each analysis and temporal direction. Chapter 4 
investigates the temporal associations of mental health and substance use, with mental 
health variables obtained from ages 7, 12, and 18 and substance use variables from ages 
15 and 18. This Chapter also investigates the temporal association of social cognition and 
substance use, with social cognition obtained from ages 7, 8, and 18 and substance use 
from ages 15 and 18. Figures 3.1 to 3.4 display flow diagrams for the final sample sizes for 
each analysis: 
Figure 3.1 Flow diagram of the final sample size in the analysis of childhood mental health predicting 
substance use 
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
31  
Figure 3.2 Flow diagram of the final sample size in the analysis of childhood social cognition predicting 
substance use  
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
Figure 3.3 Flow diagram of the final sample size in the analysis of adolescent substance use predicting 
mental health 
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
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Figure 3.4 Flow diagram of the final sample size in the analysis of adolescent substance use predicting 
social cognition 
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
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Chapter 5 investigates the temporal association of mental health and social cognition with 
mental health variables obtained from ages 7, 12, and 18 and substance use from ages 15 
and 18. Figures 3.5 and 3.6 display the final sample sizes for each analysis: 
Figure 3.5 Flow diagram of the final sample size in the analysis of adolescent mental health predicting 
social cognition 
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
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Figure 3.6 Flow diagram of the final sample size in the analysis of adolescent social cognition predicting 
mental health 
 
Full  Cases: total sample  
Complete cases:  sample restricted to data available at all  t ime points  
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3.3.2. Genetic analyses 
Chapter 6 investigates the association of smoking genotype with mental health and social 
cognitive variables obtained from age 18. Figures 3.7 to 3.8 display flow diagrams for the 
final sample sizes for each analysis: 








My aim was to create variables that were consistent with previous studies using ALSPAC 
data, as well as comparable across earlier and later ages. However, some measures vary 
slightly due to differences in wording, availableness, and/or appropriate scales used for the 
age group. 
3.4.1. Substance use 
Current use (age 15): Current use of alcohol, tobacco, and cannabis at age 15 was 
collected via a computer session during a clinic visit. Initially, individuals were asked if they 
had tried each drug, and the frequency of recent use. The two questions for each drug were 
then merged to create a binary variable of ‘current use’ to capture individuals whom have not 
just tried a drug but have continued to use. Young persons’ reporting ≥ 20 drinks in the past 
6 months, smoking cigarettes in the past 30 days, and using cannabis within the past 12 
months were classified as current users of each respective substance. This variable was 
developed to capture individuals’ who were actively engaging in each substance, as 
opposed to those whom had only used once (ever/never use). However, it’s also possible 
some first-time users would be captured in this variable if those individuals had initially used 
within the time frame (specifically past 30 days for cigarettes and cannabis).  
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Current use (age 18): Current use of alcohol, tobacco, and cannabis at age 18 was 
collected via a computer session during a clinic visit. Initially, individuals were asked if they 
had tried each drug, and the frequency of recent use. The two questions for each drug were 
then merged to create a binary variable of ‘current use’ to capture individuals whom have not 
just tried the drug but have continued to use. Young persons’ reporting smoking cigarettes in 
the past 30 days and using cannabis within the past 12 months were classified as current 
users of each respective substance.  
Due to widespread acceptance of alcohol use in the UK, the alcohol variable was measured 
slightly different from the others, as non-users may differ in regards to other societal factors 
comparable to social drinkers (e.g., abstainers for religious reasons (Michalak, Trocki, & 
Bond, 2007; Wallace, Brown, Bachman, & LaVeist, 2003), or individuals with high anxiety 
(Pardini, White, & Stouthamer-Loeber, 2007)). Here we initially asked if the young person 
had tried alcohol, then merged this score with their score on the Alcohol Use Disorders 
Identification Test (AUDIT), to create a binary measure of current use (see Appendix B page 
170 for full questionnaire). The AUDIT is a 10-item questionnaire developed by the World 
Health Organisation (WHO) to assess alcohol consumption and drinking behaviour, where 
scoring ≥ 8 indicates hazardous drinking (Babor, 2001). 
Finally, a binary variable was created by merging the three new variables together to capture 
a measure of ‘multi-substance use.’ Here, individuals indicating they were current users of 
all three substances were categorized as ‘multi-substance users.’ Individuals using 1-2 
substances were categorized as non-multi-substance users.  
Frequency (age 18): Measures of frequency differed for each substance and questions 
were as follows (a) frequency young person has a drink containing alcohol (b) young person 
smokes every week (c) frequency young person smokes cannabis. Answers for each were 
collapsed into a binary measure of weekly versus non-weekly use to stay systematic across 
substances.  
Age of onset (age 18): Age of onset was a categorical measure based on self-reported age 
in years at first (a) full drink (b) smoked a whole cigarette, or (c) when they first took 
cannabis. Any ages below 6 were discarded on the unlikely event of substance use at such 
an early age.  
3.4.2. Mental health 
Childhood mental health (ages 7 and 15): Attention-deficit hyperactivity disorder (ADHD), 
depression, conduct disorder (CD), depression, and anxiety were assessed at age 7 via 
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parent- and teacher-report using the Development and Wellbeing Assessment (DAWBA) 
questionnaire (R. Goodman, Ford, Richards, Gatward, & Meltzer, 2000) (http://dawba.info/). 
Parent and teacher responses were combined for each child, and from each response 
‘bands’ created, ranging from unlikely to probable. The DAWBA bands have 6 ordered 
categorical variables corresponding to the likelihood of a positive diagnosis (<.01%, .05%, 
3%, 15%, 50%, and >70%) within the sample. The ‘bands’ have previously been validated in 
a sample of UK children (R. Goodman et al., 2000), while the DAWBA has been validated 
for use in both clinical and non-clinical samples. 
Childhood Psychosis-like symptoms (ages 12 and 18): Psychosis-like symptoms were 
assessed at age 12, slightly later than the other mental health variables. Psychosis-like 
symptoms were assessed via self-report at age 12 via the PLIKSi semi-structured interview 
(see Appendix B pages 171-174 for full questionnaire) (Zammit et al., 2008). A binary 
variable indicating suspected or definite symptoms was used as the psychosis exposure 
measure.  
Depression and anxiety (age 18): Measures of depression and anxiety were also assessed 
at age 18 using the Clinical interview schedule (CIS-R) via a self-administered computerised 
interview (see Appendix B pages 175-186 for full questionnaire) (G. Lewis, Pelosi, Araya, & 
Dunn, 1992). A binary variable indicating a primary diagnosis of major depression or a 
primary or secondary diagnosis of anxiety was taken as the outcome measures. 
Antisocial behavior (age 18): Information on antisocial behaviour was measured at age 18 
by via self-reported offenses in the past 12 months similar to the core offenses in the 2005 
Offending, Crime, and Justice Survey (mugging, shop lifting, breaking and entering, selling 
drugs, fire setting, buying stolen goods) (Boyd, Golding, Macleod, Lawlor, Fraser, 
Henderson, Molloy, Ness, Ring, & Smith, 2013; Kretschmer et al., 2014). If individuals 
responded positively to one or more items, they were rated as demonstrating antisocial 
behaviour.  
3.4.3. Social cognition 
Non-verbal communication (age 8): Non-verbal communication at age 8 was measured 
via computer session during a clinic visit using the faces subset of the Diagnostic Analysis of 
Nonverbal Accuracy (DANVA) (Nowicki & Duke, 1994). This contains 24 photographs of 
children’s faces displaying an either high or low intensity version of the following emotions: 
happy, sad, fear, or anger. Each photograph was displayed to the children for 2 seconds and 
they responded as to what emotion they perceived. Scoring ≥ 7 total errors on the DANVA 
was coded as poor performance (Nowicki & Duke, 1994). 
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Social communication (ages 7, 14, 18): Social communication was measured by maternal 
completion of The Social and Communication Disorders Checklist (SCDC) at offspring age 7 
via questionnaire (see Appendix B page 187 for full questionnaire). The SCDC is a 12-item 
questionnaire with responses ranging from 0-2 (i.e. ‘not true’, ‘quite or sometimes true’, and 
‘very often true’) designed to measure past 6 months’ social functioning. Scores range from 
0-24 with higher scores indicating more social cognitive difficulty. Scoring ≥ 8 out of a 
possible of 24 as poor performance (Robinson et al., 2011).  
Social reciprocity (ages 7, 14, 18): Social reciprocity at age 7 was derived from 5 sub-
questions on the SCDC that were specifically designed to measure social reciprocity (D. H. 
Skuse, Mandy, & Scourfield, 2005; D. Skuse et al., 2004). Responses of yes to ≥ 3 
questions was coded as poor performance. 
3.4.4. Confounders 
A range of variables were considered as potential confounders for substance use, mental 
health, and social cognition. These were comprised of established risk factors for all three 
variables which we felt the assumption of a causal predictive relationship could be justified. 
These were divided into 3 main categories: (1) pre-birth/ demographic confounders, (2) 
maternal substance use, and (3) childhood confounders 
 
Sex:  Previous evidence suggests there are sex differences in substance use behaviours 
[231, 232], for example males are more likely to be heavier cigarette smokers (West, 1999)  
In terms of mental health, internalising disorders are more prominent in females, while 
externalising disorders common among males (Seedat et al., 2009). Finally, there are sex 
differences in social cognition, as women perform better in affect recognition tasks 
compared to men (Hall & Matsumoto, 2004). Here, we used a binary male/female measure 
recorded at offspring birth. 
Parity: Evidence from longitudinal studies suggest birth order is associated with increased 
substance use, particularly for middle and last-born children (Argys, Rees, Averett, & 
Witoonchart, 2006; Warren, 1966). Birth order is associated with mental health as first-born 
children were more susceptible to mental health problems (Risal & Tharoor, 2012). 
Additionally, birth order was predictive of social cognition, specifically poor communication 
skills in children (Tomblin, Hardy, & Hein, 1991). Here, we used a continuous measure of 
parity that was recorded at baseline. 
3.4.4.1. Pre-birth/ demographic confounders  
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Socioeconomic status: Socioeconomic status is associated with substance use and 
mental health and social cognition, as lower socioeconomic status in childhood is associated 
with higher rates of mental health and substance use (Benjet, 2010; Bradley & Corwyn, 
2002; Buu et al., 2009; Coyne, Langstrom, Rickert, Lichtenstein, & D'Onofrio, 2013; Lopez-
Castroman, 2014; Stone, Becker, Huber, & Catalano, 2012)  and in adulthood and 
maladaptive social functioning (Bradley & Corwyn, 2002). The following variables were used 
as measures of socioeconomic status: 
Maternal social class: A categorical measure of maternal social class was recorded at 
baseline (Benjet, 2010; Bradley & Corwyn, 2002; Buu et al., 2009; Coyne et al., 2013; 
Lopez-Castroman, 2014; Stone et al., 2012). Maternal and paternal social occupation was 
recorded at baseline, and used to allocate mother and partner to social class groups using 
1991 Office of Population Censuses and Surveys (OPCS) classification (Surveys, 1991) with 
the following categories: (a) I Professional (b) II Managerial and technical (c) III Skilled (non-
manual) (d) III Skilled (manual) (e) IV Party-skilled (f) Unskilled.  
Maternal education status: A measure of maternal education status was recorded at 
baseline (Benjet, 2010; Bradley & Corwyn, 2002; Buu et al., 2009; Coyne et al., 2013; 
Lopez-Castroman, 2014; Stone et al., 2012), and categorized into the following categories: 
(a) Certificate of secondary education (CSEO (b) Vocational and skill qualifications (c) O 
level (examination taken and passed at 16 years) (d) A level (examination taken and passed 
at 18 years) (e) University degree. 
Maternal home ownership status: A measure of maternal home ownership status was 
collected at baseline (Benjet, 2010; Bradley & Corwyn, 2002; Buu et al., 2009; Coyne et al., 
2013; Lopez-Castroman, 2014; Stone et al., 2012) and categorized into the following 
categories: (a) Owned (b) subsidised rented (c) non-subsidised rented. 
 
Parental substance use is associated with increased likelihood of offspring substance use 
(242-243), mental health problems (Bountress & Chassin, 2015). Additionally, parental 
substance use can create a disharmonious environment subsequently altering offspring’s 
emotional and social competence (Engels, Finkenauer, Meeus, & Dekovic, 2001). 
Maternal binge drinking: Measures of maternal drinking behaviours were collected at 
offspring age 12 via questionnaire. These included the number of units each day per week of 
beers, wines, spirits, sherries, ready mixed, and/or low alcohol drinks the mother regularly 
consumes. These measures were combined to form a binary measure of maternal binge 
3.4.4.2. Maternal substance use confounders 
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drinking (>21 units per week / averaging 3 units per day) (Arria, Mericle, Meyers, & Winters, 
2012; Chassin, Pitts, & Prost, 2002). 
Maternal smoking: Maternal cigarette smoking behaviour (Arria et al., 2012; Chassin et al., 
2002) was collected at offspring age 12 via questionnaire. These measures were combined 
to form a binary ever/never measure of maternal smoking. 
Maternal cannabis use: Maternal cannabis use (Arria et al., 2012; Chassin et al., 2002) 
was collected at offspring age 9 via questionnaire. This was used to form a binary 
ever/never measure of maternal cannabis use.  
 
IQ: Low IQ in childhood is associated with early onset substance use (Kaplow, Curran, 
Dodge, & Gr, 2002) development of adult mental health problems (Koenen et al., 2009), and 
decreased social cognitive performance (D. H. Skuse et al., 2009). Here, we used 
Intelligence quotient (IQ) which was as collected at age 8 via the Wechsler Intelligence 
Scale for Children-III (WIS-C) (Lavin, 1996) results of which were categorized as follows: (a) 
Exceptionally low (b) Low (c) Low average (d) Average (e) High average (f) High (g) 
Exceptionally high. 
Victimization: Children whom experience bullying are more likely to develop mental health 
problems (Arseneault, Bowes, & Shakoor, 2010) engage in substance use behavior (Tharp-
Taylor, Haviland, & D'Amico, 2009) and have poor social skills (Crawford & Manassis, 2011). 
We used a binary measure of victimization (Dodge et al., 2003; Salmivalli, Lagerspetz, 
Bjorkqvist, Osterman, & Kaukiainen, 1996; Tharp-Taylor et al., 2009) that was collected at 
age 8 via a modified version of the Bullying and Friendship Interview Schedule (Wolke, 
Woods, Stanford, & Schulz, 2001) (see Appendix B page 188 for full questionnaire). 
Borderline personality disorder (BPD): Borderline personality disorder is highly comorbid 
with substance use disorders (Trull, Sher, Minks-Brown, Durbin, & Burr, 2000), and is 
characterized by a range of symptoms that are common across internalizing (apathy and 
anxiety), externalizing (anger and impulsivity), and psychotic-disorders (paranoid 
dissociative symptoms and identity disturbance) (Lieb, Zanarini, Schmahl, Linehan, & 
Bohus, 2004). Additionally, individuals with BPD have reduced emotional empathy (Roepke, 
Vater, Preissler, Heekeren, & Dziobek, 2013). We used a binary measure of borderline 
personality disorder (Roepke et al., 2013; Trull et al., 2000) that was collected at age 8 via 
interview. 
3.4.4.3. Childhood confounders 
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Peer problems: Childhood peer problems are associated with later life substance use 
(Fergusson, John Horwood, & Ridder, 2005; Heron, Maughan, et al., 2013; Mason, 
Campbell, King, & Sonenklar, 2016) increased externalizing behaviour, and poor emotion 
regulation and social understand (Hughes, White, Sharpen, & Dunn, 2000). We used a 
continuous 0-10 measure of peer problems (Murphy, Faulkner, & Farley, 2014) that was 
collected at age 8 via maternal-completed Strengths and Difficulties Questionnaire (SDQ) 
(R. Goodman, 2001) (see Appendix B page 189 for full questionnaire). 
In Chapter 4 one set of analyses examines the temporal direction of association of early 
substance use on subsequent mental health or social cognitive performance. In these 
analyses, we additionally adjust for childhood mental health or social cognition where 
appropriate.  
Previous mental health: Age 7 DAWBA and age 12 PLIKS as described above 
Previous social cognitive performance: Age 7 SCDC and SCDC sub-scores as described 
above 
3.4.5. Logistic regression 
Given the skew in the distribution of our data, binary variables were created and logistic 
regressions performed. Although dichotomising data in this way will result in some loss of 
information and power, logistic regression is subject to fewer assumptions than linear 
regression.  
3.5. Chapter summary 
In this chapter, we outlined details of ALSPAC, a prospective birth cohort based in Bristol. In 
ALSPAC mothers and their offspring are rigorously followed up through a series of 
questionnaires and clinic visits. This thesis is specifically interested in the temporal 
association of substance use, mental health, and social cognition in childhood to late 
adolescence. Where possible we attempted to keep variables consistent across ages, 
although there are some differences due to practicality and availability. ALSPAC will serve 
as the sample for the observational analyses in Chapters 4 and 5, and a Mendelian 
randomisation analysis in Chapter 6 (more genetic-specific information will be addressed in 
this chapter). 
  
3.4.4.4. Additional confounders 
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4. Chapter Four: Temporal associations of social 
cognition, mental health, and substance use  
4.1. Introduction  
 The current study, conducted in ALSPAC, attempted to build upon previous 
knowledge of an association between poor mental health and substance use by 
investigating both temporal directions, as highlighted in Chapter 2. I investigated multiple 
mental health conditions including internalising, externalising, and psychosis-like symptoms 
with the three most commonly consumed drugs globally. Each analysis was repeated 
replacing mental health with social cognitive variables, allowing a direct comparison of any 
similar patterns of association. Initially, I analysed poor mental health (exposure) at age 7 on 
subsequent substance use (outcome) at age 18, and again reanalyzed replacing social 
cognition as the age 7 exposure. The second analysis, in the opposing direction, examines 
substance use initiation (exposure) age 15 on subsequent poor mental health at age 18 
(outcome), and again reanalyzed with social cognition at age 18 (outcome).    
4.1.1. Chapter aims 
In this Chapter I investigated both temporal directions of mental health and substance use, 
and repeated each analysis replacing mental health with social cognition to examine 
common underlying patterns.  
This chapter is largely based on the published manuscript: Fluharty M, Heron J, Munafo M 
(2017) Longitudinal associations of social cognition and substance use in childhood and 
adolescence: Findings from the Avon Longitudinal Study of Parents and Children. European 
Child and Adolescent Psychiatry. doi: 10.1007/s00787-017-1068-x 
4.2. Temporal associations of childhood mental health and social 
cognition with adolescent substance use 
4.2.1. Methods 
Participants and variables from the Avon Longitudinal Study of Parents and Children have 




Participants for this analysis were drawn from the ALSPAC birth cohort, a prospective birth 
cohort based in Bristol, UK. The analysis of the association between childhood mental health 
and subsequent substance use was further restricted to parents who had completed the 
Development and Well-Being Assessment (DAWBA) (N = 8,201) when their offspring were 
age 7, offspring who had completed the psychosis-like symptoms semi-structured interview 
(PLIKSi) (N = 6,792) at age 12, and who had taken part in the substance use computerised 
assessment at age 18 (N = 8,058).  
The analysis of the association between childhood social cognition and subsequent 
substance use was restricted to the offspring of parents who had completed the Social and 
Communication Disorders Checklist (SCDC) (N = 3,007), SCDC sub-scale (N = 3,058) at 
age 7, and/or offspring who had completed the Diagnostic Assessment of Non-Verbal 
Accuracy (DANVA) (N = 2,985) at age 8, and offspring who had taken part in the substance 
use computerised assessment at age 18 (N = 3,820). Flow diagrams (Figures 3.1 and 3.2) 
display the final sample size for each temporal association analysis. 
Mental health diagnoses including attention-deficit hyperactivity disorder (ADHD), 
depression, conduct disorder (CD), and anxiety were assessed at age 7 via parent- and 
teacher-report using the DAWBA questionnaire (R. Goodman et al., 2000) (based on ICD-10 
and DSM-IV criteria). Parent and teacher responses were combined for each child and from 
each response ‘bands’ created, ranging from unlikely to probable. Psychosis-like symptoms 
were a binary variable variable indicating suspected or definite symptoms assessed via self-
report at age 12 via the PLIKSi semi-structured interview (Zammit et al., 2008).  
Non-verbal communication was assessed at age 8 via computer session during a clinic visit 
using the faces subset of the DANVA; scoring ≥ 7 total errors on the DANVA was coded as 
poor performance (Nowicki & Duke, 1994). Social communication was measured by 
maternal completion of SCDC at offspring age 7 via questionnaire; scoring ≥ 8 out of a 
possible of 24 was coded as poor performance (Robinson et al., 2011). Social reciprocity at 
age 7 was derived from 5 questions on the SCDC that were specifically designed to 
measure social reciprocity (D. H. Skuse et al., 2005; D. Skuse et al., 2004); responses of 
yes to ≥ 3 questions was coded as poor performance. 
Measures of alcohol, tobacco and cannabis use were collected at age 18 via a computer-
based assessment during a clinic visit. Individuals were classified as users of each 
4.2.1.2. Mental health exposures (age 7) 
4.2.1.3. Social cognition exposures (age 7/8) 
4.2.1.4. Substance use outcomes (age 18) 
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substance, and a user of all three substances if appropriate. Individuals scoring ≥ 8 on the 
Alcohol Use Disorders Identification Test (AUDIT), smoking cigarettes in the past 30 days, or 
using cannabis in the past 12 months were classified as users of each respective substance. 
Individuals using all three substances were further classified as multi-substance users. 
Frequency of use was categorised as either non-weekly or weekly use. Finally, age of onset 
was a categorical measure based on self-reported first use of each respective substance. 
Based on the literature, risk factors for poor mental health, social cognition, and substance 
use were considered as potential confounders, grouped into three categories: (1) pre-birth/ 
demographic (2) maternal substance use (3) offspring. The pre- birth/ demographic 
confounders adjusted for sex, parity, maternal social class, and maternal home ownership 
status. Maternal substance use confounders additionally adjusted for maternal binge 
drinking, maternal cannabis use, and maternal smoking. Offspring confounders additionally 
adjusted for IQ, peer problems, victimization, and borderline personality diagnosis.   
First, I examined the association of mental health at age 7 with subsequent substance use 
behaviour at age 18. Then, I examined the association of social cognition at age 7/8 with 
subsequent substance use behavior at age 18. I assessed both temporal relationships 
before and after adjustment for covariates using logistic regression. I examined the impact of 
confounding by comparing unadjusted results with those adjusted for pre-birth / 
demographics confounders (model 1), and then additionally and cumulatively maternal 
substance use (model 2), childhood confounders (model 3). Finally, I ran a second set of 
confounder-adjusted analyses only including the complete cases from model 3. Both 
analyses were conducted unstratified and stratified by sex. Analyses were conducted in full 
(total sample) and complete cases (sample restricted to data available at both time points). 
Analyses were conducted in Stata version 13 (Stata Corp LP, College Station TX USA). 
A secondary analysis was conducted after initial investigation of the DANVA exposure 
results. This followed the same statistical procedure as above but investigated response 
accuracy to individual emotions (happy, sad, fear anger) and level of affect intensity (low to 
high) of emotions as opposed to task accuracy as a whole.  
4.2.2. Results 
4.2.1.5. Confounders 
4.2.1.6. Statistical analysis 
4.2.1.7. Secondary analysis 
4.2.2.1. Characteristics of participants 
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Data were available on N= 3,820 participants for the analysis of childhood mental health with 
subsequent substance use, and N = 3,058 participants for the analysis of childhood social 
cognition with subsequent substance use. Characteristics of these participants are shown in 
Table 4.1. Confounder characteristics and associations with each outcome are presented in 
Table 4.2. The results presented below are from the fully adjusted models. Unadjusted and 
partially adjusted models, and a comparison of full (total number) and complete cases 
(number restricted to those with data in both time points), are presented in pages 190-195 of 
Appendix C. In general, sex-stratified analyses did not indicate any clear differences in the 
strength of association observed for males and females separately. The results are therefore 
presented unstratified, except where indicated, with sex stratified analyses presented in 
pages 196-201 of Appendix C.  
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Table 4.1 Participant demographics – childhood mental health/ social cognition on later substance use 
Childhood mental health (age 7)         
    Probability of disorder 
  N ~<0.1% ~0.5% ~3% ~15% ~50% ~>70% 
ADHD 8,201 63% (5,182) 25% (2,021) 6% (496) 4% (338) 1% (100) 1% (64) 
CD 8,109 0 60% (4,831) 38% (3,094) 2% (130) 0.4% (33) 0.3% (21) 
Depression 8,201 62% (5,041) 35% (2,798) 0 2% (190) 1% (52) 0.02% (2) 






        
 
 
Childhood social cognition (age 7/8) 
  N Normal Poor 
Social communication 7,907 90% (7,138) 10% (6,814) 
Social reciprocity 8,058 84% (6,757) 16% (1301) 
Non-verbal communication 8,201 16% (1,301) 22% (1,524) 
 
  Late adolescent substance use (age 18)         
  Current use Frequency of use   
  N No Yes N ≥ Weekly < Weekly 
Cannabis 3,820 70% (2,656) 30% (1,164) 1,187 85% (1,014) 15% (173) 
Tobacco 3,820 71% (2,702) 29% (1,118) 1,181 61% (716) 39% (465) 
Alcohol 3,820 57% (2,196) 43% (1,624) 3,887 74% (2,875) 26% (1,012) 
Multi-substance  3,820 86% (3,268) 14% (552)       
 
 
Age of first substance  
 
        
Age N Cannabis Tobacco Alcohol   
Six 1,443 0% (0) 0.10% (1) 0.20% (3) 
Seven 1,443 0% (0) 0.14% (2) 0.69% (10) 
Eight 1,443 0.10% (1) 0.30% (4) 0.90% (13) 
Nine 1,443 0.14% (2) 0.50% (7) 1% (21) 
Ten 1,443 0.14% (2) 2% (21) 6% (81) 
Eleven 1,443 1% (16) 5% (70) 7% (96) 
Twelve 1,443 4% (51) 11% (160) 17% (250) 
Thirteen 1,443 9% (133) 17% (246) 23% (335) 
Fourteen 1,443 17% (246) 21% (307) 25% (354) 
Fifteen 1,443 24% (345) 20% (293) 15% (212) 
Sixteen 1,443 31% (447) 17% (242) 4% (60) 
Seventeen 1,443 12% (447) 6% (81%) 0.50% (8) 
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Table 4.2 Descriptive statistics of confounders - childhood mental health/ social cognition on later 
substance use 
  Tobacco user Cannabis user Alcohol user 
  N (%) p N (%) p  N (%) p  
Demographic / pre-birth       
Sex           
Males 451 (40%) 0.006 582 (50%) <0.001 748 (46%) 0.015 
Female 666 (60%)  582 (50%)   876 (54%)   
Maternal home ownership status           
Owned 851 (83%) 0.003 903 (385) 0.302 1278 (86%) 0.524 
substidised rented 91 (9%)  75 (7%)   96 (6%)   
non-substidised rented 88 (9%)  89 (8%)   112 (8%)   
Maternal social class           
I Professional occupations 62 (7%) 0.152 91 (10%) 0.093 158 (9%) 0.370 
II Managerial and technical occupations 334 (37%)  377 (40%)   635 (36%)   
III Skilled non-manual occupations 348 (39%)  339 (36%)   716 (40%)   
III Skilled manual occupations 62 (7%)  54 (6%)   119 (7%)   
IV Partly-skilled occupations 77 (9%)  66 (7%)   130 (7%)   
V Unskilled occupations 13 (1%)  12 (1%)   24 (1%)   
Mothers highest qualification           
Certificate of secondary education (CSE) 145 (14%) <0.001 110 (11%) <0.001 160 (11%) 1.000 
Vocational and skill qualifications 73 (7%)  61 (6%)   104 (7%)   
O level (examination taken and passed at 
16 years) 357 (35%)  321 (32%)   501 (34%)   
A level (examinations taken and passed at 
18 years) 287 (28%)  250 (25%)   421 (28%)   
University degree 170 (16%)  250 (25%)   292 (20%)   
Maternal           
Maternal smoking           
Smoker 166 (20%) <0.001 157 (17%) <0.001 192 (15%) 0.001 
Non-smoker 683 (80%)  753 (83%)   1065 (85%)   
Maternal cannabis use           
Cannabis user 54 (6%) <0.001 66 (7%) <0.001 66 (5%) 0.001 
Non-user 845 (94%)  901 (93%)   1,271 (95%)   
Maternal harmful drinking           
Harmful drinker 305 (33%) <0.001 334 (37%) <0.001 454 (37%) <0.001 
Non-harmful drinker 526 (63%)  567 (63%)   779 (63%)   
Offspring            
Borderline personality disorder (BPD)           
BPD present 68 (8%) 0.001 59 (6%) 0.188 72 (6%) 0.753 
No BPD 817 (92%)  883 (94%)   1,213 (94%)   
Victimisation           
Childhood victimization 319 (35%) 0.200 339 (35%) 0.016 449 (34%) 0.091 
No victimization 595 (65%)  633 (65%)   891 (66%)   
IQ           
Exceptionally low 11 (1%) 0.007 8 (1%) <0.001 7 (1%) 0.389 
Low 37 (4%)  29 (3%)   41 (3%)   
Low average 89 (10%)  76 (7%)   120 (9%)   
Average 397 (42%)  374 (34%)   561 (41%)   
High average 209 (22%)  320 (29%)   301 (22%)   
High  111 (12%)  133 (12%)   173 (13%)   
Exceptionally high 82 (9%)  149 (14%)   172 (13%)   
  M (SD) p M (SD) p  M (SD) p  
Demographic / pre-birth           
Parity 0.82 (.90) <0.001 0.78 (.90) 0.013 0.78 (0.87) 0.005 
Peer Problems 0.98 (1.30) 0.622 0.92 (1.31) 0.237 0.91 (1.29) 0.074 
 
P-values were calculated by chi squared or analysis of variance.  
 
4.2.2.2. Association of childhood mental health with adolescent substance use  
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4.2.2.2.1.  Externalising disorders (attention-deficit hyperactivity disorder and 
conduct disorder).  
Probable diagnoses of ADHD and CD at age 7 were associated with increased odds of 
tobacco use at age 18 (ADHD: fully adjusted OR 1.25, 95% CI 1.09 to 1.43, P = 0.002; CD 
fully adjusted 1.26, 95% CI 1.26 to 1.56, P = 0.031); these results are shown in Tables 4.3-
4.5.  Probable diagnosis of ADHD at age 7 was associated with increased odds of more 
frequent tobacco use at age 18 (fully adjusted OR 1.31 95% CI 1.04 to 1.65, P = 0.021), and 
increased odds of trying tobacco at a younger age (fully adjusted OR 0.85 95% CI 0.73 to 
0.98, P = 0.030). Additionally, probable diagnoses of ADHD and CD at age 7 were 
associated with increased odds of cannabis use at age 18 (ADHD: fully adjusted OR 1.16, 
95% CI 1.02 to 1.33, P = 0.029 CD: fully adjusted OR 1.40 95% CI 1.14 to 1.73, P = 0.001). 
Probable diagnosis of ADHD at age 7 was associated with increased odds of trying cannabis 
at a young age (fully adjusted OR 0.82, 95% CI 0.70 to 0.97, P = 0.018), while probable 
diagnosis of CD at age 7 was associated with increased odds of more frequent cannabis use 
at age 18 (fully adjusted OR 1.62, 95% CI 1.03 to 2.45, P = 0.037). In stratified analyses, 
associations were slightly stronger for females with respect to cannabis outcomes (see 







4.2.2.2.2. Internalising disorders (depression and anxiety).  
Probable diagnosis of depression at age 7 was associated with increased odds of alcohol 
use at age 18 (fully adjusted OR 1.32, 95% CI 1.13 to 1.55, P ≤ 0.001); these results are 
shown in Tables 4.3-4.5. Probable diagnoses of depression and anxiety at age 7 were 
associated with increased odds of more frequent alcohol use at age 18 (depression: fully 
adjusted OR 1.24, 95% CI 1.04 to 1.47, P = 0.015; anxiety: fully adjusted OR 1.37, 95% CI 
1.11 to 1.69, P = 0.003). Additionally, probable diagnoses of depression and anxiety at age 
7 were associated with increased odds of all substance use at age 18 (depression: fully 
adjusted OR 1.36, 95% CI 1.11 to 1.67, P = 0.003; anxiety: fully adjusted OR 1.40 95% CI 
1.08 to 1.82, P = 0.012). 
4.2.2.2.3. Psychosis-like symptoms.  
There was no clear evidence of an association of probable diagnosis of PLIKS with current 
use, frequent use, or age of onset; these results are shown in Tables 4.3-4.5.   
4.2.2.3.1. Non-verbal communication 
Poor non-verbal communication at age 8 was associated with decreased odds of alcohol 
(fully adjusted OR 0.72, 95% CI 0.56 to 0.94, P = 0.011), tobacco (fully adjusted OR 0.66, 
95% CI 0.49 to 0.88, P = 0.005), and cannabis use at age 18 (fully adjusted OR 0.60, 95% 
CI 0.45 to 0.81, P = 0.001). These results are shown in Table 4.6. No clear evidence of 
association was observed for age of onset, or frequency of use (non-weekly/weekly) at age 
18 (See pages 194-195 in Appendix C). 
4.2.2.3.2. Social communication and social reciprocity 
There was no clear evidence of an association of either poor social communication or social 
reciprocity at age 7 with alcohol, tobacco, cannabis, or all substance use at age 18. These 
results are shown in Table 4.6. Additionally, no clear evidence of association was observed 
for age of onset, or frequency of use (non-weekly/weekly) at age 18 (See pages 194-195 in 
Appendix C). 





4.2.2.3.3. Exploratory analysis 
To further investigate the association of nonverbal communication and current substance 
use, I investigated the DANVA by individual emotion and intensity. There was no clear 
pattern of association across the individual emotions (see page 202 in Appendix C). 
However, individuals displaying reduced ability to identify emotions in general, as 
demonstrated by poor identification of both ‘low’ and ‘high’ intensity emotionally expressive 
faces, had decreased odds of substance use onset, similar to the results seen above. Poor 
identification of low and high intensity faces at age 7 was associated with decreased odds of 
alcohol, tobacco, and cannabis use at age 18, and this was robust to adjustment (see Table 




4.2.3. Summary  
These results indicate that, in this cohort, poor childhood mental health at age 7 is 
associated with subsequent substance use at age 18. Specifically, externalising disorders 
(ADHD and conduct disorder) were associated with tobacco and cannabis use behaviours, 
while internalising disorders (depression and anxiety) were associated with later alcohol use 
behaviours, and a range of disorders (conduct disorder, depression, and anxiety) contributed 
to use of all substances. These findings replicate previous ALSPAC evidence that 
externalising disorders are associated with alcohol (S. B. Cho et al., 2014; Heron, Maughan, 
et al., 2013), tobacco (Heron, Hickman, Macleod, & Munafo, 2011), and cannabis, (Heron, 
Barker, et al., 2013; Kretschmer et al., 2014; McGee, Williams, Poulton, & Moffitt, 2000; 
Zohsel et al., 2016) while internalising disorders are associated with later alcohol use 
(Edwards, Joinson, et al., 2014; Saraceno, Heron, Munafo, Craddock, & van den Bree, 
2012).  
In contrast, poor non-verbal communication at age 8 is associated with decreased alcohol, 
tobacco, and cannabis. Adjustment for pre-birth / demographic, maternal, and childhood 
confounders strengthened the associations for tobacco and cannabis use but weakened the 
associations for alcohol. We analysed individual emotions within the DANVA to identify 
whether sensitivity to specific emotions were driving this association. No pattern of 
association was found for individual emotions, although poor identification of both low and 
high intensity of emotional expression was associated with alcohol, tobacco, cannabis, and 
all substance use. Adjustment for confounders strengthened associations for alcohol, 
tobacco, and cannabis, but weakened the association for all substance use. Interestingly, 
poor non-verbal communication appeared to be protective against later substance use; thus 
the deficits in non-verbal communication previously reported in substance users are more 
likely to be the outcome of prolonged use (Adams et al., 2014; Bayrakci et al., 2015; 
Donadon & Osorio Fde, 2014; Kornreich et al., 2001; Townshend & Duka, 2003), as 
opposed to reflecting self-medication of these deficits. 
Taken together, poor childhood mental health and social cognitive performance have 
opposing relationship with adolescent substance use. While poor mental health is 
associated with increased substance use behaviours, poor social cognitive performance is 
associated with some decreased use behaviours.  
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4.3. Temporal associations of early adolescent substance use with 
mental health and social cognition 
4.3.1. Methods 
The analysis of the association between early adolescent substance use and subsequent 
mental health was restricted to offspring who had taken part in the substance use 
computerised task at age 15 (N = 5,009), offspring who had completed the CIS-R at age 18 
(N = 4,563), offspring who had completed the computerized task on self-reported criminal 
offenses (N = 4,017), and offspring who had completed the psychosis-like symptoms semi-
structured interview (PLIKSi) (N = 4,718) at age 18. 
The analysis of the association between early adolescent substance and subsequent social 
cognition was further restricted to the offspring who had taken part in the substance use 
computerised task (N = 5,009) at age 15, and offspring whose parents had completed the 
Social and Communication Disorders Checklist (SCDC) (N = 5,506) at age 17. Flow 
diagrams (Figures 3.3 and 3.4) show the final sample size for each temporal association 
analysis. 
4.3.1.1.1. Substance use exposures (age 15) 
Use of alcohol, tobacco, and cannabis at age 15 was collected via computer session during 
a clinic visit. Individuals were first classified as either current or non-users of each 
substance. Next, individuals reporting ≥ 20 drinks in the past 6 months, smoking cigarettes 
in the past 30 days, or using cannabis in the past 12 months were classified as ‘current’ 
users of each respective substance. 
4.3.1.1.2. Mental health outcomes (age 18) 
Binary measures of depression and anxiety were assessed at age 18 using the CIS-R via a 
self-administered computerised interview (G. Lewis et al., 1992).  Psychosis-like symptoms 
were a binary variable indicating suspected or definite symptoms assessed via self-report at 
age 18 via the PLIKSi semi-structured interview (Zammit et al., 2008). Information on 
antisocial behaviour was measured at age 18 by via self-reported offenses in the past 12 
months (Boyd, Golding, Macleod, Lawlor, Fraser, Henderson, Molloy, Ness, Ring, & Smith, 
2013; Kretschmer et al., 2014); individuals were classified as antisocial if they responded 
positively to one or more items. 
4.3.1.1. Participants  
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4.3.1.1.3. Social cognitive outcomes (age 18) 
Social communication was measured by maternal completion of SCDC at offspring age 18 
via questionnaire, scoring ≥ 8 out of a possible of 24 was coded as poor performance 
(Robinson et al., 2011). Social reciprocity at age 18 was derived from 5 questions on the 
SCDC that were specifically designed to measure social reciprocity (D. H. Skuse et al., 
2005; D. Skuse et al., 2004). Responses of yes to ≥ 3 questions was coded as poor 
performance. 
4.3.1.1.4. Confounders 
Based on the literature, risk factors for substance use, poor mental health, and social 
cognition were considered as potential confounders; grouped into three categories (1) pre-
birth/ demographic (2) maternal substance use (3) offspring. Additionally, for the analysis of 
the association between age 15 substance use and subsequent mental health we adjusted 
for (4) previous incidence of mental health problems (age 7 DAWBA probable diagnosis or 
age 12 PLIKSi semi-structured interview). For the analysis of the association between 
substance use at age 15 and subsequent social cognition at age 18 we adjusted for (4) 
previous incidence of poor social cognition (age 7 social communication or social 
reciprocity).  
First, I examined the association of early substance use behaviour at age 15 with 
subsequent mental health at age 18. Next, I examined the association of early substance 
behaviour use at age 15 with subsequent social cognition at age 18. I assessed both these 
temporal relationships before and after adjustment for covariates using logistic regression. I 
examined the impact of confounding by comparing unadjusted results with those adjusted 
for pre-birth / demographics confounders (model 1), and then additionally and cumulatively 
maternal substance use (model 2), childhood confounders (model 3), and (for the 
association of early adolescent substance use with subsequent social cognition) history of 
mental health or social cognition at age 7/8 (model 4). Finally, I ran a second set of 
confounder-adjusted analyses only including the complete cases from model 4.  Both 
analyses were conducted unstratified and stratified by sex. Each analysis was conducted in 
full (total sample) and complete cases (sample restricted to data available at both time 
points). Analyses were conducted in Stata version 13 (Stata Corp LP, College Station TX 
USA). 
4.3.1.2. Statistical analysis 
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4.3.2. Results 
Data were available on N = 5,009 participants for the analysis of early adolescent substance 
use at age 15 with subsequent mental health and social cognition at age 18. Characteristics 
of these participants are shown in Table 4.8. Confounder characteristics and associations 
with each outcome are presented in Table 4.9. The results presented below are from the 
fully adjusted models. Unadjusted and partially adjusted models and comparison of full (total 
number) and complete cases (number restricted to those with data in both time points) are 
presented are presented in pages 203-204 of Appendix C. In general, sex-stratified analyses 
did not indicate any clear differences in the strength of association observed for males and 
females separately. The results are therefore presented unstratified, except where indicated, 
with sex stratified analyses presented in pages 205-206 of the Appendix.  
  
4.3.2.1. Characteristics of participants 
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Table 4.8 Participant demographics - adolescent substance use on later mental health/ social cognition  
Early adolescent substance use (age 15) 
  N No Yes 
Cannabis 5,048 81% (4,064) 19% (984) 
Tobacco 5,107 83% (4,214) 17% (893) 
Alcohol 5,051 81% (4,077) 19% (974) 
        
Adolescent mental health (age 18) 
  N No Yes 
Antisocial behaviour 4,017 84% (3,355) 16% (662) 
Depression 4,053 92% (4,203) 8% (360) 
Anxiety 4,053 89% (4,041) 11% (522) 
PLIKS 4,718 91% (4286): none 9% (432): suspected or definite 
        
Adolescent social cognition (age 18) 
  N Normal Poor 
Social communication 5,468 88% (4,833) 12% (4,300) 




Table 4.9 Descriptive statistics of confounders - adolescent substance use on later mental health/ social 
cognition 
 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.2.2.1. Externalising disorders (antisocial behaviour) 
Current alcohol use at age 15 was associated with increased odds of antisocial behaviour at 
age 18 (fully adjusted OR 2.72, 95% CI 1.96 to 3.77, P ≤ 0.001); these results are shown in 
Table 4.10. Current tobacco use at age 15 was associated with increased odds of antisocial 
behaviour at age 18 (fully adjusted OR 4.34, 95% CI 3.04 to 6.20, P ≤ 0.001). Finally, current 
cannabis use at age 15 was associated with increased odds of antisocial behaviour at age 
18 (fully adjusted OR 4.79, 95% CI 3.48 to 6.60, P ≤ 0.001).  
  
4.3.2.2. Association of early adolescent substance use with mental health  
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4.3.2.2.2. Internalising disorders (depression and anxiety) 
Current alcohol use at age 15 was associated with increased odds of depression (fully 
adjusted OR 2.21, 95% CI 1.40 to 3.48, P = 0.001) and increased odds of anxiety at age 18 
(fully adjusted OR 1.75, 95% CI 1.18 to 2.57, P = 0.005); these results are shown in Table 
4.10. Current tobacco use at age 15 was associated with increased odds of depression (fully 
adjusted OR 1.83, 95% CI 1.15 to 2.93, P = 0.011) and anxiety at age 18 (fully adjusted OR 
1.81, 95% CI 1.23 to 2.68, P = 0.003). Finally, current cannabis at age 15 use was 
associated with increased odds of depression (fully adjusted OR 1.89, 95% CI 1.20 to 2.98, 
P = 0.006) and anxiety at age 18 (fully adjusted OR 1.42, 95% CI 0.96 to 2.10, P = 0.080). 
4.3.2.2.3. Psychosis-like symptoms 
Current tobacco use at age 15 was associated with increased odds of PLIKS at age 18 (fully 
adjusted OR 2.83, 95% CI 1.87 to 4.30, P ≤ 0.001); these results are shown in Table 4.10. 
Current cannabis use at age 15 was associated with increased odds of PLIKS at age 18 
(fully adjusted OR 2.35, 95% CI 1.57 to 3.54, P ≤ 0.001). 
4.3.2.3.1. Social communication 
Increased odds of poor social communication at age 17 was associated with earlier 
adolescent alcohol (fully adjusted OR 1.48, 95% CI 1.01 to 2.16, P = 0.046), and tobacco 
use (fully adjusted OR 1.86, 95% CI 1.27 to 2.72, P = 0.001) at age 15. These results are 
shown in Table 4.11. In stratified analyses, associations were slightly stronger for males, 
with respect to tobacco outcomes. 
4.3.2.3.2. Social reciprocity 
Increased odds of poor social reciprocity at age 17 was associated with earlier adolescent 
alcohol (fully adjusted OR 1.57, 95% CI 1.18 to 2.05, P = 0.002), tobacco (fully adjusted OR 
1.84, 95% CI 1.37 to 2.48, P = 0.001), and cannabis use at age 15 (fully adjusted OR 1.57, 
95% CI 1.18 to 2.08, P = 0.002). These results are shown in Table 4.11. In stratified 
analyses, associations were slightly stronger for males, with respect to tobacco outcomes 
(see page 206 in Appendix C) 
 
 
4.3.2.3. Associations of early adolescent substance use with social cognition 
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4.3.3. Summary 
Early cannabis and tobacco use were associated with later externalising, internalising, and 
psychosis-like disorders, while alcohol use was associated with later externalising and 
internalising disorders. These findings mirror previous findings within this cohort suggesting 
cannabis and tobacco use are associated with internalising disorders (Degenhardt et al., 
2013; S. H. Gage, Hickman, et al., 2015), and psychosis-like symptoms (S. H. Gage et al., 
2014; Zammit, Owen, Evans, Heron, & Lewis, 2011), while alcohol use is associated with 
internalising disorders (Edwards, Heron, et al., 2014; Pesola et al., 2015). Additionally, early 
alcohol, tobacco, and/or cannabis use at age 15 is associated with poor social 
communication and social reciprocity at 17. In all cases, adjustment for pre-birth, maternal, 
childhood, or previous indication of poor social cognition (age 7) did not substantially alter 
these associations. As both analyses adjust for previous poor mental health and social 
cognition prior to the onset of any substance use (age 7), this suggests that being a current 
user of alcohol, tobacco, and cannabis is associated with decreased mental health and 
social cognitive abilities.  
These results suggest, in this temporal direction, there are common patterns of substance 
use associated with both mental health and social cognitive capacities. There appears to be 
some evidence of a bidirectional association with externalising disorders with tobacco and/or 
cannabis, however generally more symptoms (both mental health and social cognitive) 
appear after the onset of substance use. However, following the onset of substance use the 
temporal direction of association of mental health and social cognitive performance is still 
unknown. 
4.4. Discussion 
4.4.1. Mental health and substance use 
This analysis suggests that externalising disorders show as association with cannabis and 
tobacco in both temporal directions, while internalising disorders display a similar 
bidirectional association with alcohol. However, the onset of cannabis and tobacco use was 
associated with a wider range of mental health problems in later years including internalising 
and psychosis-like symptoms. This suggests that while externalising disorders may work in 
both temporal directions, internalising and psychosis-like disorders have a different 
relationship to cannabis and tobacco use (either uni-directional, or as a result of shared 
genetic and/or environmental risk factors). One possible explanation is that individuals with 
externalising disorders may be drawn to tobacco and/or cannabis use through high levels of 
impulsivity or sensation seeking (Ortal et al., 2015). However, prolonged nicotine use may 
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result in the dysregulation of the hypothalamic-pituitary-adrenal systems, resulting in 
hypersecretions of cortisol and changes in monoamine neurotransmitter activity (Markou et 
al., 1998); similarly, sustained cannabis use may cause shifts in amygdala functioning 
resulting in hypersensitivity of perceived threat (Spechler et al., 2015). Subsequently 
suggesting the onset of tobacco and cannabis may aid in the development of internalising 
disorders such as anxiety and depression.  
4.4.2. Social cognition and substance use 
These analyses suggest that social cognitive deficits may result from the initiation and/or 
regular use of these substances. While previous literature has suggested these social 
cognitive deficits can arise during periods of acute intoxication (Curtin et al., 2001; Hindocha 
et al., 2015) or withdrawal (Adams et al., 2014), our results suggest these deficits remain 
present over longer periods of time among users. Alcohol dependence has been associated 
with impaired semantic memory (i.e., deficits general knowledge accumulated through 
personal experience). As semantic memory may be necessary for the maintenance of social 
networks (Labouvie-Vief & Blanchard-Fields, 1982), this may subsequently lead to more 
specific social cognitive deficits (Nandrino et al., 2014). Prolonged nicotine exposure may 
dysregulate the hypothalamic-pituitary-adrenal system, resulting in hypersecretions of 
cortisol and alterations in the activity of the associated monoamine neurotransmitter system, 
which contributes to stress-regulation (Markou et al., 1998). This may result in individuals 
being more susceptible to environmental stressors and associated difficulties with affect and 
emotional regulation (Joormann & Quinn, 2014; Joormann & Stanton, 2016). Finally, 
evidence from imaging studies indicate neuroanatomical changes in heavy cannabis uses 
associated with prolonged endocannabinoid exposure, and the subsequent desensitisation 
of CB1 receptors in the brain, requiring compensatory CB1 receptor activity elsewhere in the 
striatum (Marjoram et al., 2006; Romero et al., 1997; Roser et al., 2012; Sim-Selley, 2003). 
Previous literature indicates strong familial bonds and open communication within families 
and schools may serve as a protective factor, or help to delay adolescent substance 
initiation (A. D. Farrell & White, 1998; Kliewer & Murrelle, 2007; McArdle et al., 2002; Spoth, 
Redmond, Shin, & Azevedo, 2004). However, in the other temporal direction (i.e., poor 
social cognition and subsequent substance use) there is currently little evidence. Our 
analyses help to rule out the possibility of reverse causality and strengthen our findings that 
substance use is associated with later impaired social cognition. Additionally, this analysis 
suggested that poor non-verbal communication may in fact be protective with respect to 
subsequent substance use. While this is clearly an area that warrants additional research 
and replication, one possible explanation for this finding is that adolescents with poor 
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emotion recognition skills may be less likely to have larger social groups (Barth & Bastiani, 
1997; Leppanen & Hietanen, 2001) and therefore less likely to  engage in substance use 
due to less social inclusion (McCrady, 2004; Shadur & Hussong, 2014; Urberg, 
Degirmencioglu, & Pilgrim, 1997). 
4.4.3. Strengths  
There are several strengths of these analyses. First, as previously mentioned our recent 
systematic review of smoking and mental health concluded relatively few studies investigate 
both temporal directions rather than only that of their a priori hypothesis (M. Fluharty, Taylor, 
Grabski, & Munafo, 2016). Second, this analysis was conducted in a rich data set with 
multiple mental health, social cognitive and substance use variables collected at several 
time-points throughout the adolescence and early adulthood. Third, these analyses were 
conducted in both temporal directions and investigated the associations of commonly 
consumed drugs with a range of mental health disorders and facets of social cognition in 
parallel. Fourth, this study investigated a range of different substance use behaviours, 
mental health disorders, and social cognitive behaviours within the same cohort. Fifth, 
variables were systematic and comparable across category and age group. Finally, a robust 
approach was taken to minimise confounding by integrating a range of confounders from 
pre-birth throughout adolescence.  
4.4.4. Limitations 
There are also some limitations of this study to consider. First, our substance use variables 
rely on self-report and have not be biochemically verified. Additionally, we drew our 
outcomes from age 18, which provided us with a large sample size of individuals whom had 
ever used substances. However, there were notably fewer individuals answering questions 
regarding frequency of use, which may have contributed to the low power for these 
analyses. Second, as smoking cannabis in joints in the common consumption method within 
the United Kingdom, cannabis is rolled and smoked together with tobacco (as opposed to 
alone in pipes as is the predominate method in the United States). Therefore, it is difficult to 
differentiate effects from tobacco and cannabis, as cannabis-using individuals’ may 
underestimate their tobacco intake by not quantifying tobacco rolled with joints when 
answering tobacco consumption questions. This may explain why our cannabis and tobacco 
exposures yield many of the same outcomes, and suggests the possibility that the common 
outcomes for cannabis and tobacco use may be driven by effects of tobacco. Future studies 
should sample participants from cohorts where cannabis is primarily smoked alone to 
identify if results replicate. Third, some of our exposures were self-reported by the child 
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(DANVA) while others were parent-completed (SCDC and DAWBA). Previous studies have 
indicated parental rating of offspring well-being to be more positive compared to self-report 
by offspring (Waters, Stewart-Brown, & Fitzpatrick, 2003). Similarly, the maternal-reported 
measure of SCDC recorded when offspring were aged 17 may be capturing a breakdown in 
family communication or adolescent disobedience, as opposed to social cognition, due to 
the generally rebellious nature of the adolescent period. However, a genome-wide 
association study conducted in ALSPAC found evidence of a genome-wide association of 
SCDC measures at age 17, suggesting there is a genetic architecture of social 
communication that can be reliably captured by the maternal SCDC measure (St Pourcain et 
al., 2014). Fourth, SCDC scores are known to remain constant across age groups (Robinson 
et al., 2011), while studies have indicated DANVA scores to improve with age (Nowicki & 
Duke, 1994). This is a potential problem if the ranking of scores across the population is not 
consistent; however, previous ALSPAC studies have indicated a test-retest reliability in the 
DANVA of 0.84 (Barona, Kothari, Skuse, & Micali, 2015). Fifth, as maternal data are 
collected frequently and are more extensive than partner data within ALSPAC, we only 
investigated the impact of maternal confounding. Sixth, it is possible that our variable for 
multi-substance current use simply reflects current cannabis use, since cannabis users 
typically also consume alcohol and tobacco (Raphael, Wooding, Stevens, & Connor, 2005). 
Seventh, one temporal direction (childhood mental health/social cognition associated with 
later substance use) captured a longer time span, from age 7 to 18, while another (early 
substance use associated with mental health/social cognition) analysed data collected 
between the ages of 15 to 18 (i.e., a relatively short period). Therefore, despite the strong 
associations observed, further studies over larger age gaps may be required to fully tease 
apart the effects between differing temporal directions. However, these ages were chosen to 
capture an early measure of regular use in adolescence and the next available measure of 
mental health/ social cognition. Eighth, as our measures were not over a long course of time, 
we only measured effects of current users not withdrawal, or ex-substance users, and as 
previously noted – some effects only became apparent (particularly for tobacco) when the 
individual is in a period of acute withdrawal, additionally some deficits can linger months into 
sobriety for hardened users (Kornreich et al., 2001). Ninth, there was evidence of differential 
loss to follow-up, as some children with probable diagnoses of ADHD, conduct disorder, 
anxiety, and high SCDC were slightly more likely to drop out of the study before substance 
use at age 18 obtained, additionally individuals identifying as substance users at age 15 
were more likely to drop out before obtaining information on mental health and social 
cognition at age 18. However, this does not necessarily imply selection bias in the 
association between social cognition and later substance use (Carter, Imlach-Gunasekara, 
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McKenzie, & Blakely, 2012), and comparisons of full and complete cases display little 
change in results due to sample size.  
4.4.5. Conclusion 
Overall, childhood mental health and social cognitive ability had differing associations with 
later substance use initiation. While some mental health problems were specifically 
associated with substance use (i.e. internalising disorders and alcohol; externalising 
disorders and tobacco/cannabis), there was either no association between poor social 
cognition and substance use or (for emotional affect recognition) decreased substance use. 
In the opposing temporal direction, adolescent substance use initiation was associated in an 
overall decline of both mental health and social cognition.  
4.5. Chapter summary 
In this chapter, a series of longitudinal studies were conducted to identify the temporal 
associations of substance use with both mental health and social cognitive performance. 
This was done in to understand whether social cognition followed any similar patterns as 
those observed in substance use and mental health. Here, we found poor childhood mental 
health and social cognitive performance had opposing effects on later substance use. As 
mental health was generally associated with increased substance use, while there was no or 
decreased association of early social cognition with later substance use. However, in the 
opposing direction, following the onset of adolescent substance use, there was a general 
decline in all areas of mental health and social cognition. This suggests that substance use 
may be driving the decline of both mental health and social cognitive performance. However, 
the temporal relationship of mental health and social cognition (if any) following the onset of 






5. Chapter 5 Temporal associations of mental health and 
social cognition following substance use initiation  
 
5.1. Introduction 
The analyses in Chapter 4 indicated a similar decline in both mental health and social 
cognitive performance following the onset of substance use in adolescence. While mental 
health and social cognition have typically not been examined together with substance use, 
previous evidence has suggested that they are both independently associated with a decline 
following substance use (Baingana, al'Absi, Becker, & Pringle, 2015; Bayrakci et al., 2015; 
Leventhal et al., 2012). Furthermore, prior evidence suggests mental health and social 
cognition may be associated with one another, as many mental health disorders are 
characterised by poor social cognition such as poor affect recognition and theory of mind 
(Happe & Frith, 2014; Miers et al., 2013; Wagner et al., 2015). However, following the onset 
of substance use the temporal association of mental health and social cognition with one 
another is still unknown. 
5.1.1. Chapter aims 
In this Chapter I investigate both temporal directions of association of mental health and 
social cognitive performance in late adolescence in the ALSPAC birth cohort. 
5.2. Methods 
Participants and variables from the Avon Longitudinal Study of Parents and Children have 
previously been described in detail in Chapter 3; a summary of these methods will be 
included below. 
5.2.1. Participants 
Participants for this analysis were drawn from the ALSPAC birth cohort. The analysis of the 
association between mental health with subsequent social cognitive performance following 
the onset of substance use was further restricted to parents who had completed the 
Development and Well-Being Assessment (DAWBA) (N = 3,657) when their offspring where 
age 15, offspring who had completed the psychosis-like symptoms semi-structured interview 
(PLIKSi) (N = 6,792) at age 12, and who had taken part in Social and Communication 
Disorders Checklist at age 18 (N = 3,613).  
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The analysis of the association between social cognition with subsequent poor mental health 
following the onset of substance use was further restricted to offspring who had taken part in 
Social and Communication Disorders Checklist at age 15 (N = 5,468), and offspring who had 
completed the CIS-R at age 18 (N = 4,563), offspring who had completed the computerized 
task on self-reported criminal offenses (N = 4,017), and offspring who had completed the 
psychosis-like symptoms semi-structured interview (PLIKSi) (N = 4,718) at age 18). Flow 
diagrams Figures 3.5 and 3.6 display the final sample size for each temporal association 
analysis. 
5.2.2. Variables 
Mental health diagnoses including attention-deficit hyperactivity disorder (ADHD), 
depression, conduct disorder (CD), and anxiety were assessed at age 15 via parent- and 
teacher-report using the DAWBA questionnaire (R. Goodman et al., 2000) (based on ICD-10 
and DSM-IV criteria). Parent and teacher responses were combined for each child and from 
each response ‘bands’ created, ranging from unlikely to probable. Psychosis-like symptoms 
were coded as a binary variable indicating suspected or definite symptoms assessed via 
self-report at ages 12 and 18 via the PLIKSi semi-structured interview (Zammit et al., 2008). 
Binary measures of depression and anxiety were assessed at age 18 using the CIS-R via a 
self-administered computerised interview (G. Lewis et al., 1992). Information on antisocial 
behaviour was measured at age 18 by via self-reported offenses in the past 12 months 
(Boyd, Golding, Macleod, Lawlor, Fraser, Henderson, Molloy, Ness, Ring, & Smith, 2013; 
Kretschmer et al., 2014); Individuals were classified as antisocial if they responded positively 
to one or more items. 
Social communication was measured by maternal completion of the Social Communication 
Disorders Checklist (SCDC) at offspring ages 15 and 18 via questionnaire, scoring ≥ 8 out of 
a possible of 24 was coded as poor performance (Robinson et al., 2011). Social reciprocity 
at age 18 was derived from 5 questions on the SCDC that were specifically designed to 
measure social reciprocity (D. H. Skuse et al., 2005; D. Skuse et al., 2004). Responses of 
yes to ≥ 3 questions was coded as poor performance. 
Based on the literature, risk factors for poor mental health and social cognition were 
considered as potential confounders, grouped into three categories: (1) pre-birth/ 
demographic, (2) maternal substance use, and (3) offspring. The pre-birth/ demographic 
5.2.2.1. Mental health 
5.2.2.2. Social cognition 
5.2.2.3. Confounding variables 
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confounders adjusted for sex, parity, maternal social class, and maternal home ownership 
status. Maternal substance use confounders additionally adjusted for maternal binge 
drinking, maternal cannabis use, and maternal smoking. Offspring confounders additionally 
adjusted for IQ, peer problems, victimization, and borderline personality diagnosis.  
Additionally, for the analysis of the association between age 15 mental health and 
subsequent social cognition I adjusted for (4) previous incidence of poor social cognition 
(age 7 social communication or social reciprocity). Or for the analysis of the association 
between age 14 social cognition with the association between subsequent mental health I 
adjusted for (4) previous incidence of mental health problems (age 7 DAWBA probable 
diagnosis or age 12 PLIKSi semi-structured interview). 
5.2.3. Statistical analysis 
First, I examined the association of poor mental health on subsequent social cognition. Next, 
I examined the association of poor social cognition on subsequent mental health. I assessed 
both these temporal relationships before and after adjustment for covariates using logistic 
regression. I examined the impact of confounding by comparing unadjusted results with 
those adjusted for pre-birth / demographics confounders (model 1), and then additionally 
and cumulatively maternal substance use (model 2), childhood confounders (model 3), and 
previous mental health/ or social cognition (model 4). Finally, I ran a second set of 
confounder-adjusted analyses only including the complete cases from model 4. Each 
analysis was conducted in full and complete cases. Analyses were conducted in Stata 
version 13 (Stata Corp LP, College Station TX USA). 
5.3. Results  
5.3.1. Characteristics of participants  
Data were available on N = 1,883 participants for the analysis of mental health with 
subsequent social cognition in substance users, and N=1,763 for the analysis of social 
cognition with subsequent mental health in substance users. Characteristics of these 
participants are presented in Table 5.1 Confounder characteristics and associations with 
each outcome are presented in Table 4.9. The results presented below are from the fully 
adjusted models. Unadjusted and partially adjusted models and comparison of full and 
complete cases are presented in pages 207-207 of Appendix C.  
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Table 5.1 Participant demographics - adolescent mental health and social cognition 
Early adolescent mental health (age 15)         
    Probability of disorder 
  N ~<0.1% ~0.5% ~3% ~15% ~50% ~>70% 
ADHD 4,757 73% (3,458) 15% (729) 7% (350) 4% (176) 0.5% (23) 0.4% (21) 
CD 4,742 68% (3,213) 0 28%(1,340) 3% (118) 0.7% (31) 0.8% (40) 
Depression 8,083 63% (5,041) 35% (2,798) 0 2% (190) 0.6% (52) 0.02% (2) 




14% (927): suspected 
or definite 
        
  
Late adolescent mental health (age 18) 
  N No Yes 
Antisocial behaviour 4,017 84% (3,355) 16% (662) 
Depression 4,053 92% (4,203) 8% (360) 
Anxiety 4,053 89% (4,041) 11% (522) 
PLIKS 4,718 91% (4286): none 9% (432): suspected or definite 
Early adolescent social cognition (age 15) 
  N Normal Poor 
Social communication 6,293 91% (6,296) 9% (627) 
Social reciprocity 6,967 81% (5,649) 19% (1,318) 
Late adolescent social cognition (age 18) 
  N Normal Poor 
Social communication 5,468 88% (4,833) 12% (635) 
Social reciprocity 5,571 66% (635) 23% (1,271) 
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5.3.2. Association of mental health with subsequent social cognitive performance in 
substance users 
Diagnosis of depression at age 15 was associated with increased odds of poor social 
communication (fully adjusted OR 1.31, 95% CI 1.12 to 1.54, P = 0.001) and social 
reciprocity at age 18 (fully adjusted OR 1.24 95% CI 1.09 to 1.41, P = 0.001); these results 
are shown in Table 5.2. Diagnosis of anxiety at age 15 was associated with increased odds 
of poor social communication (fully adjusted OR 1.44, 95% CI 1.10 to 1.89, P = 0.008) and 
social reciprocity at age 18 (fully adjusted OR 1.50, 95% CI 1.23 to 1.84, P< 0.001). 
Diagnosis of ADHD at age 15 was associated with increased odds of increased odds of poor 
social communication (fully adjusted OR 2.10, 95% CI 1.75 to 2.51, P < 0.001) and social 
reciprocity at age 18 (fully adjusted OR 1.84, 95% CI 1.59 to 2.12, P < 0.001). Diagnosis of 
conduct disorder at age 15 was associated with increased odds of poor social 
communication (fully adjusted OR 2.23, 95% CI 1.76 to 2.83, P   0.001) and social 
reciprocity at age 18 (fully adjusted OR 2.07, 95% CI 1.70 to 2.52, P  0.001). There was no 




5.4.1. Association of social cognition with subsequent mental health in substance 
users 
There was no clear evidence of an association of adolescent social communication or social 
reciprocity with later depression, anxiety, antisocial behaviour, or psychosis-like symptoms; 





Adolescent mental health conditions including depression, anxiety, ADHD, and conduct 
disorder at age 15 were associated later poor social cognitive performance at age 18, and 
adjustment for pre-birth, maternal, childhood, or previous social cognitive performance did 
not substantially alter these associations. However, there was no evidence of an association 
of social cognitive performance at age 15 with later mental health problems at age 18. As 
these analyses adjust for previous incidence of poor social cognitive performance prior to 
the onset of substance use and mental health problems, this suggests that mental health 
problems are associated with subsequent decreased social cognitive performance.  
5.5.1. Strengths 
There are several strengths of this analysis. First, as in Chapter 4, these analyses 
investigate both temporal directions. Second, they are conducted in a rich dataset over 
multiple time-points. Third, variables were systematic and comparable across category and 
age group. Finally, a robust approach was taken to minimise confounding by integrating a 
range of confounding from pre-birth throughout adolescence.  
5.5.2. Limitations 
There are also several limitations to consider. First, some of the exposures were self-
reported by the child (CIS-R and PLIKS), while others were parent-completed (SCDC). 
Previous studies have indicated parental rating of offspring well-being to be more positive 
compared to self-report by offspring (Waters et al., 2003). Second, the maternal-reported 
measure of SCDC recorded when offspring were aged 17 may be capturing a breakdown in 
family communication or adolescent disobedience, as opposed to social cognition, due to 
the generally rebellious nature of the adolescent period. However, a genome-wide 
association study conducted in ALSPAC found evidence of a genome-wide association of 
SCDC measures at age 17, suggesting there is a genetic architecture of social 
communication that can be reliably captured by the maternal SCDC measure (St Pourcain et 
al., 2014). Third, as maternal data are collected frequently and are more extensive than 
partner data within ALSPAC, we only investigated the impact of maternal confounding. 
Fourth, there was some evidence of differential loss to follow-up, as some adolescents with 
ADHD and anxiety at 15 were slightly more likely to drop out of the study before social 
cognition was obtained at 18, likewise individuals with high SCDC at 15 were slightly more 
likely to drop out before obtaining information on mental health at 18. However, this does not 
necessarily imply selection bias in the association between social cognition and later 
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substance use (Carter et al., 2012), and comparisons of full and complete cases display little 
change in results due to sample size.  
5.5.3. Conclusion 
Previously, in Chapter 4, we investigated the common associations of mental health and 
social cognition with substance use, finding evidence that mental health and social cognition 
both declined following the onset of adolescent substance use. In this set of analyses, I 
investigated the temporal association of mental health and social cognition finding evidence 
that poor mental health was associated with subsequent social cognitive decline. Taken 
together, this suggests two possible pathways to social cognitive decline: (a) substance use 
is independently associated with decline in both mental health and social cognition (see 
figure 5.1), or (b) substance use is associated with decline in social cognition via mental 
poor mental health (see Figure 5.2).  
Figure 5.1 Substance use has independent effects on mental health and social cognition 
 
Figure 5.2 Substance use is associated with social cognition via mental health  
 
5.6. Chapter summary 
In this Chapter, I examined the temporal association of mental health and social cognition in 
late adolescence, finding evidence that mental health problems were associated with 
decreased social communication and social reciprocity. The evidence presented in Chapter 
4 suggests that substance use precedes decline in both mental health and social cognitive 
performance, there are two possible pathways. First, either substance use is independently 
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associated with decline in both mental health and social cognition. Second, that substance 
use is associated with decreased social cognition via poor mental health. The following 
Chapters will use additional methods to investigate causal inferences of these associations, 
particularly focusing on externalising disorders which have had the strongest evidence in my 





6. Chapter 6: A Mendelian randomisation analysis of 
associations between substance use with externalising 
disorders and social cognitive outcomes 
6.1. Introduction 
Previous longitudinal evidence suggests substance use initiation is associated with 
increased risk of later mental health problems (M. Fluharty et al., 2016). These findings were 
particularly robust for tobacco and cannabis use with later externalising disorders (i.e. 
antisocial behaviour). There is also evidence that substance use initiation is associated with 
increased risk of later poor social cognitive functioning, and again these findings are 
particularly robust for tobacco and cannabis and later social cognitive outcomes.  
However, as discussed in Chapter One, assessing causality solely from observational 
analysis is challenging due to a number of problems inherent to conventional 
epidemiological methods (Fewell et al., 2007; Phillips & Smith, 1992; Smith & Phillips, 1992). 
While researchers would ideally control for all possible confounding variables, these 
variables need to be both comprehensively identified and accurately measured to eliminate 
the possibility of residual confounding (S. H. Gage, Munafo, et al., 2015). However, 
researchers can never be completely positive all possible confounders of an association are 
known.  
Ideally, researchers would conduct a randomised control trial (RCT) to investigate causal 
associations. RCTs are typically the gold standard for assessing causality, as they minimize 
the risk of confounding and selection bias through randomisation (Akobeng, 2005). In RCTs, 
participants are randomised into either an active or control group. The active group would 
receive an intervention (exposure) while the control group receives a placebo. Each group 
would be followed up across a period of time, and the outcome of interested measured (S. 
H. Gage, Munafo, et al., 2015; Smith & Ebrahim, 2002). However, the use of RCTs in 
substance use research is often impractical or unethical. 
6.1.1. Mendelian randomisation 
When RCTs are not possible, we can turn to alternative methods to counteract residual 
confounding and reverse causality. Instrumental variable analysis, originally developed in 
the economics literature, assigns a proxy variable to the exposure which is not associated 
with confounders. A specific type of instrumental variable analysis, Mendelian 
randomisation, uses a genetic variant as the instrumental variable or proxy measure 
77  
(Burgess et al., 2015; S. H. Gage et al., 2013). This relies on two properties of how humans 
inherit their genotype. First, genes are inherited independently from one another through 
meiosis. Second, genes are inherited independently from the environment. Mendelian 
randomisation takes its name from Gregor Mendel’s first and second laws of inheritance. 
First, at gamete formation, each cell contains one allele per gene. Second, the law of 
independent assortment, states alleles will sort randomly and so the chances of inheriting a 
specific allele are independent of inheriting another (Smith & Ebrahim, 2003). Based on 
these assumptions, genetic instruments in Mendelian randomisation are not subject to the 
confounding typical of observational analyses.  
To identify an appropriate genetic variant as a proxy, the variant must be known to alter the 
effect of a modifiable risk factor. The genetic variant must meet four assumptions to be 
suitably used in a Mendelian randomisation analysis. First, the genetic variant must be 
robustly associated with an exposure of interest. Second, the variant should not directly 
affect the outcome of interest, except via the exposure. Third, the variant should be 
independent of all possible confounders affecting the relationship of interest. Fourth, the 
variant should not introduce any additional confounding into the association (Katikireddi, 
Green, Taylor, Davey Smith, & Munafo, 2017). Figure 6.1 shows a directed acyclical graph 
(DAG) of Mendelian randomisation.  
Figure 6.1 Model of Mendelian randomization 
 
Mendelian randomisation may be used to understand causal influences on behavioral 
outcomes, and with more GWAS there are better instruments for these phenotypes with the 
increasing availability of large biobanks.  
As discussed above, MR relies on the assumption that genes are randomly assorted at birth 
and inherited independently from the environment; therefore, genotypes of interest should 
not be associated with confounders (e.g., socioeconomic status). However, there are some 
situations in which the MR assumptions may still be violated.  
6.1.1.1. Mendelian Randomisation for behavioural outcomes 
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First, a suitable genetic variant must be identified for the exposure of interest. For MR 
analysis to be accurate, the phenotypes used need to accurately reflect the exposure of 
interest. Mental health phenotypes can be particularly noisy, given the range of symptoms 
experienced as part of a particular trait, the overlap between traits, and the range of 
methods used to measure them (S. H. Gage et al., 2013). 
Second, social pressures on certain behaviours may cause bias in the genotype-exposure 
associations. Individuals’ are unlikely to be aware of their physiological phenotypes and 
therefore their behaviour will not be affected. However, this may be different for some 
behavioural phenotypes. For example, using genes associated with adverse alcohol 
reactions as a measure for alcohol consumption may produce skewed results, specifically in 
heavy drinking populations as social standards may cause these individuals to continue 
drinking despite possible adverse reactions (D. A. Lawlor, Harbord, Sterne, Timpson, & 
Smith, 2008).  
Third, MR may be affected by population stratification, which may in turn result in bias as 
MR assumes population homogeneity with consistent allele frequencies. As populations 
combine there may be differences in ancestry and subsequent underlying genetic 
proportions; therefore, results may be distorted if there are different proportions of the proxy 
genotype across sub-populations (S. H. Gage et al., 2013; Lee, Wright, & Zou, 2011).To 
reduce population stratification the gene-exposure and gene-outcome associations should 
be ideally conducted in the same population (D. A. Lawlor et al., 2008).  
Fourth, linkage disequilibrium (LD) may complicate interpretation. LD occurs when some 
genotypes are more likely to be inherited together then by chance. As the proxy gene should 
only affect the outcome via the exposure, if a linked gene directly affects the outcome (i.e. 
pleiotropy) it may be driving an observed association instead of the exposure. In this case, 
there may be alternative pathways (other than that of the exposure of interest) directly 
influencing the outcome (Angrist, Imbens, & Rubin, 1996; Sheehan & Didelez, 2005). A 
strength of MR is genetic heterogeneity, in which multiple genes may be associated with a 
single phenotype, but are not in LD. This allows us to test for pleiotropy by producing 
estimates using different variants (S. H. Gage et al., 2013; Smith, 2011). If both instruments 
are independently associated with the outcome via the same pathway, this suggests a true 
causal association rather one than due to pleiotropy (Smith, 2011).  
Fifth, bias may be generated through assortative mating. Assortment results in an 
association of mother-father genetic variants generated through individual attraction based 
on specific heritable traits (i.e., smokers are more likely to reproduce with other smokers 
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(Watson et al., 2004)). If assortative mating occurs, this may violate the assumption of 
assortment on the exposure of interest, creating spurious associations (D. Lawlor et al., 
2017).  
Finally, it’s important to note that MR can be used to determine if an association is causal, 
but not necessarily display the underlying mechanisms. For example, while tobacco may be 
associated with mental health problems, this may be because it influences use of other 
substances via the gateway effects (S. H. Gage et al., 2013). 
 
Through the use of twin-studies, a number of different substances, including tobacco and 
cannabis use, have been identified as being moderately to highly heritable (Agrawal et al., 
2006; Li, Cheng, Ma, & Swan, 2003; Verweij et al., 2010). However, more recently, genome 
wide association studies (GWAS) have allowed us to identify specific genes responsible 
(Begum, Ghosh, Tseng, & Feingold, 2012; Cantor, Lange, & Sinsheimer, 2010). GWAS 
studies generally focus on identifying associations between single nucleotide polymorphisms 
and traits of interest. SNPs are variations occurring in a single nucleotide at a particular 
genome position.  For example, in a particular stretch of deoxyribonucleic acid (DNA) a 
guanine (G) base may be replaced by an adenine (A) base; see Figure 6.2. 
Figure 6.2 Example of a single nucleotide polymorphism 
 
The Tobacco and Genetics Consortium (TAG) conduced a GWAS meta-analysis across 16 
studies (N= 74,053). TAG harmonised smoking variables across each cohort to examine 
four aspects of smoking behaviour in individuals of European descent. These included 
smoking initiation, smoking quantity, age of onset, and smoking cessation. Eight SNPs were 
identified as genome-wide significant for smoking initiation located around brain-derived 
neurotrophic factor (BDNF) on chromosome 11. BDNF is highly expressed in the 
hippocampus and prefrontal cortex. These areas have been previously associated with 
6.1.1.2. Genetic instruments 
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cognitive enhancing effects of nicotine (Levin, McClernon, & Rezvani, 2006). Genetic 
variations in the BDNF may modify the rewarding effects of nicotine through dopamine 
reward modulation, subsequently leading to nicotinic salience and continued use.  
The International Cannabis Consortium (ICC) conducted a GWAS meta-analysis 
investigating lifetime cannabis use in 13 cohort studies (N= 32,330) of individuals of 
European descent. While no SNPs were identified as genome-wide significant, a number of 
SNPs were identified as approaching genome-wide significance. The most significant SNP 
identified was rs4984460 (P= 4.6 x10-7) on chromosome 15 in an intergenic region between 
the LOC400456/LOC145820 and MIR1469 and NR2F2 genes. However, the biological 
explanations behind cannabis use are still unclear. This may be due to the nature of how this 
phenotype was measured, as ‘ever/never use’ may capture both single use and prolonged 
heavier use (S. H. Gage et al., 2016).  
6.1.2. Chapter aims 
In this Chapter, I use Mendelian randomisation analysis to determine whether the previously 
observed associations between cigarette and cannabis use with externalising behaviours 
and social communication are causal. Based on the results in my previous Chapters, and 
the literature discussed, I hypothesis these associations will be causal.  
6.2. Methods 
6.2.1. Participants 
Participants were drawn from the ALSPAC cohort, as described in detail in Chapter 3. This 
sample is further restricted to individuals with genotypic information (N=7,870), and with 
information on antisocial behaviour (N = 2,919) and/or who had taken part in Social and 
Communication Disorders Checklist at age 18 (N = 3,613); see Figures 3.7 and 3.8. 
6.2.2. Phenotypic measures  
Antisocial behaviour was a binary measure of self-reported offenses at age 18 based on 
self-reported offenses in the past 12 months (Boyd, Golding, Macleod, Lawlor, Fraser, 
Henderson, Molloy, Ness, Ring, & Smith, 2013; Kretschmer et al., 2014). 
Social communication was measured by maternal completion of SCDC at offspring age 18 
via questionnaire, scoring ≥ 8 out of a possible of 24 was coded as poor performance 
6.2.2.1. Externalising disorder 
6.2.2.2. Social cognition 
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(Robinson et al., 2011). Social reciprocity at age 18 was derived from 5 questions on the 
SCDC that were specifically designed to measure social reciprocity (D. H. Skuse et al., 
2005; D. Skuse et al., 2004). Responses of yes to ≥ 3 questions was coded as poor 
performance. 
Tobacco and cannabis use were measured at age 18 via computerized-based assessment 
during a clinic visit. A binary variable indicating ever or never use (i.e., initiation) of each 
substance respectively was used as the exposure variable. These variables were chosen to 
mirror the variables used to determine the genetic association of tobacco and cannabis use 
within their respective GWAS.  
Confounding variables were grouped into three categories (1) pre-birth/ demographic (2) 
maternal substance use (3) offspring. The pre- birth/ demographic confounders adjusted for 
sex, parity, maternal social class, and maternal home ownership status. Maternal substance 
use confounders additionally adjusted for maternal binge drinking, maternal cannabis use, 
and maternal smoking. Offspring confounders additionally adjusted for IQ, peer problems, 
victimization, and borderline personality diagnosis.   
6.2.3. Genotype 
ALSPAC offspring were genotyped using the Illumina HumanHap550 Quad Array Platform 
(by 23andMe subcontracting the Wellcome Trust Sanger Institute, Cambridge, UK and the 
Laboratory Corporation of America, Burlington, NC, US) and imputed to the 1000 genomes 
reference panel (Paternoster et al., 2011). 
A total of 8 SNPs were identified from the Tobacco and Genetics Consortium (TAG) as 
reaching genomewide significance (P < 5 × 10-8) for tobacco initiation (Tobacco & Genetics, 
2010). As these SNPs were all in high linkage disequilibrium (LD) with one another, they 
were pruned based on values obtained in SNAP (http://www.broadinstitute.org/mgp/snap/) 
where r2 > 0.9 SNPs were randomly selected, and the other correlated SNPs removed from 
the analysis leaving 4 SNPs. These 4 SNPs were highly correlated; therefore, the strongest 
SNP, rs6265 (accounting for ~0.03% of the variance in smoking initiation) was selected. 
Then, using a less stringent P-value (P < 10-6), a further 21 SNPs were identified see Table 
6.2.2.3. Substance use 
6.2.2.4. Confounders 
6.2.3.1. Genetic sample 
6.2.3.2. Genetic risk scores for tobacco initiation 
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6.1. Polygenic risk scores were then created for tobacco initiation by summing the number of 
tobacco initiation increasing alleles across all 22 SNPs creating an additive genetic model.  
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Table 6.1 SNPs associated with tobacco initiation (P < 10-6) 
SNP Chromosome Reference allele OR SE 
rs926246 1 T 0.09 0.02 
rs7548367 1 C 0.06 0.01 
rs11892348 2 A -0.05 0.01 
rs10937751 4 A 0.07 0.01 
rs7663808 4 A -0.06 0.01 
rs10013579 4 T 0.06 0.01 
rs1448438 4 T 0.06 0.01 
rs13131292 4 A -0.11 0.02 
rs725695 5 A -0.05 0.01 
rs1986692 7 A 0.06 0.01 
rs2449222 8 T -0.09 0.02 
rs10108954 8 T -0.17 0.03 
rs16904189 8 T -0.15 0.03 
rs6265 11 T 0.06 0.02 
rs11030084 11 T -0.07 0.01 
rs1817648 12 T -0.05 0.01 
rs739484 12 T -0.09 0.02 
rs11067275 12 T 0.07 0.01 
rs11246771 12 T -0.08 0.02 
rs9521281 13 T -0.07 0.02 
rs241526 14 T -0.05 0.01 
rs11570441 17 C 0.11 0.02 
 
A total of 153 SNPs were identified from the International Cannabis Consortium (ICC) as 
reaching near genomewide significance (P < 10-5) for cannabis initiation (Stringer et al., 
2016). Explaining 13-20% of the phenotypic variance of ever/never cannabis smoking 
across the genome. The ALSPAC cohort was included in the original GWAS, and therefore 
removed from the analysis. A large number of the remaining SNPs were at high linkage 
disequilibrium (LD), they were pruned based on values obtained in SNAP 
(http://www.broadinstitute.org/mgp/snap/) where r2 > 0.9 SNPs were randomly selected, and 
the other correlated SNPs removed from the analysis. Following LD pruning, 21 SNPs 
remained, see Table 6.2. Finally, polygenic risk scores were created for cannabis initiation 
by summing the number of cannabis increasing alleles across all 21 SNPs.  
  
6.2.3.3. Genetic risk scores for cannabis initiation 
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Table 6.2 SNPs associated with cannabis initiation (P < 10-5) 
SNP Chromosome Reference allele β SE 
rs3738226 1 T 0.09 0.02 
rs73067624 1 T -0.20 0.04 
rs74944517 2 T 0.24 0.07 
rs2033867 2 A 0.26 0.06 
rs2326313 3 A 0.11 0.03 
rs13063578 3 A -0.10 0.03 
rs7675351 4 A -0.18 0.03 
rs6840574 4 T -0.14 0.04 
rs7700636 5 A -0.14 0.04 
rs12518098 5 C 0.11 0.02 
rs353253 5 A -0.13 0.03 
rs1554927 8 A -0.08 0.02 
rs12789616 11 A -0.09 0.02 
rs7107987 11 A 0.27 0.06 
rs12313672 12 T 0.13 0.03 
rs17237367 15 A -0.12 0.03 
rs4984458 15 A -0.11 0.02 
rs4984460 15 T -0.14 0.02 
rs8041045 15 A 0.11 0.02 
rs8102250 19 C -0.16 0.03 
rs113019398 20 T -0.17 0.04 
 
6.2.4. Statistical analysis 
I estimated the associations (odds ratios and 95% confidence intervals) between the 
observational tobacco and cannabis measures with antisocial behaviour and social cognitive 
(social communication and social reciprocity) outcomes after adjusting for potential 
confounders and restricting the sample to only include individuals with genetic data. Next, I 
estimated the associations between tobacco and cannabis polygenic risk scores with 
antisocial behaviour and social cognitive outcomes using two-stage least squares 
regression. Finally, an additional sensitivity analysis was conducted for tobacco initiation 
using only the strongest SNP (rs6265). Analyses were restricted to unrelated individuals and 
those of European descent. Analyses were conducted in Stata version 13 (Stata Corp LP, 




Of the 7,870 children on whom genetic data were available, 1,569 (52%) had ever smoked 
tobacco and 1,251 (41%) had used cannabis (see Figure 3.7-3.8); full characteristics of 
participants are displayed in Table 6.3.  
Table 6.3 Descriptive statistics 
 N Ever use Never use 
Tobacco 3,043 52% (1569) 48% (1474) 
Cannabis 3,015 41% (1,251)  59% (1,764)  
  N Positive diagnosis No diagnosis 
Antisocial behaviour 2,919 16% (478)  84% (2,441) 
  N Poor Normal 
Social communication 3,930 12% (458)  88% (3,472) 
Social reciprocity 4,013 23% (922)  77% (3,091)  
 
6.3.2. Assumptions of Mendelian randomisation 
The tobacco risk score was associated with tobacco ever use (OR 1.11, CI 1.03 to 1.19, P = 
0.004) and the cannabis risk score was associated with cannabis ever use (OR 1.18, CI 1.09 
to 1.27, P < 0.001), confirming the assumption that the polygenic risk scores were 
associated with expose of interest within this sample. Additionally, both tobacco and 
cannabis risk scores were not strongly associated with any potential confounders, as 
displayed in Table 6.4, confirming the assumption that the risk scores are not associated 
with potential confounders. 
Table 6.4 Association of risk scores with potential confounders 
Confounder Tobacco risk score Cannabis risk score 
  OR 95% CI p OR 95% CI p 
Sex 0.95 (0.92 to 0.99) 0.046 0.99 (0.95 to 1.03) 0.773 
Parity 1.02 (1.00 to 1.05) 0.044 1.00 (0.98 to 1.02) 0.704 
Maternal social class 0.99 (0.97 to 1.02) 0.848 0.01 (0.98 to 1.03) 0.405 
Mothers highest qualification 1.01 (0.99 to 1.03) 0.137 1.00 (0.98 to 1.02) 0.511 
Maternal home ownership status 0.99 (0.95 to 1.02) 0.686 1.01 (0.97 to 1.05) 0.522 
Maternal smoking 1.01 (0.95 to 1.08) 0.606 1.03 (0.97 to 1.10) 0.257 
Maternal cannabis use 1.02 (0.90 to 1.17) 0.665 1.10 (0.97 to 1.26) 0.115 
Maternal harmful drinking 0.94 (0.87 to 1.01) 0.113 1.04 (0.97 to 1.13) 0.223 
Borderline personality disorder 0.97 0.85 to 1.09) 0.628 0.95 (0.84 to 1.08) 0.474 
Peer Problems 1.00 (0.98 to 1.02) 0.792 0.99 (0.97 to 1.01) 0.414 
Victimisation 0.98 (0.92 to1.03) 0.404 0.98 (0.92 to 1.04) 0.550 
IQ 1.00 (0.98 to 1.03) 0.622 1.00 (0.98 to 1.02) 0.839 
 
86  
6.3.3. Observational analysis 
Ever use of tobacco was associated with increased odds of antisocial behaviour (OR 7.41, 
95% CI 5.10 to 10.76, P < 0.001); see Table 6.5. Additionally, ever use of cannabis was 
associated with increased odds of antisocial behavior (OR 7.36, 95% CI 5.20 to 10.71, P < 
0.001). 





Ever use of tobacco was associated with increased odds social communication (OR 1.79, 
95% CI 1.23 to 2.26, P = 0.003) and social reciprocity (OR 1.51, 95% CI 1.15 to 2.00 P = 
0.003); see Table 6.6. Additionally, ever use of cannabis was associated with increased risk 
of social communication (OR 2.05, 95% CI 1.42 to 2.98, P < 0.001) and social reciprocity 
(OR 1.81, 95% CI 1.37 to 2.39, P < 0.001).  
Table 6.6 Observational analysis of tobacco and cannabis on social cognition 
  Social communication Social reciprocity 
  N OR 95% CI p N OR 95% CI p 
Tobacco 1311 1.79 (1.23 to 2.62) 0.003 1331 1.51 (1.15 to 2.00) 0.003 
Cannabis 1301 2.05 (1.42 to 2.98) <0.001 1321 1.81 (1.37 to 2.39) <0.001 
 
6.3.4. Mendelian randomisation analysis 
There was no clear evidence of an association between the tobacco risk score and 
antisocial behavior, these results were similar when analysed in only rs6265. Similarly, there 
was no clear evidence of an association between the cannabis risk score and antisocial 
behaviour; these results are shown in Table 6.7.  
  
6.3.3.1. Antisocial behaviour 
 Antisocial behaviour 
 N OR 95% CI p 
Tobacco 1451 7.41 5.10 to 10.76 <0.001 
Cannabis 1450 7.36 5.20 to 10.41 <0.001 
6.3.3.2. Social cognition 
6.3.4.1. Antisocial behaviour 
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There was no clear evidence of an association between the tobacco risk score and either 
social communication or social reciprocity; these results are shown in Table 6.8. When only 
using rs6265 was used, results were similar for social communication, but the association 
with social reciprocity was reversed in direction. There was no clear evidence of an 
association between the cannabis risk score and either social communication or social 
reciprocity. 
Table 6.8 Mendelian randomisation analysis of tobacco and cannabis on social cognitive outcomes 
  Social communication Social reciprocity 
  N OR 95% CI p N OR 95% CI p 
Tobacco risk score  2190 0.84 (0.50 to 1.54) 0.575 2227 1.06 (0.46 to 2.41) 0.894 
Tobacco strongest SNP (rs6265) 2190 0.97 (0.52 to 1.80) 0.905 2227 0.57 (0.23 to 1.40) 0.219 
Cannabis risk score 2169 1.35 (0.94 to 1.91) 0.101 2206 1.27 (0.77 to 2.09) 0.335 
 
6.3.5. Power calculation 
Power calculations were conducted using an online power calculation tool 
(https://sb452.shinyapps.io/power/) (Burgess, 2014).I defined the coefficient of determination 
as the exposure on genetic variant as R2=0.03 (smoking); R2=0.13 (cannabis). For antisocial 
behavior, based on the proportion of cases in the sample (0.16) and on the causal effect 
observed (OR= 1.43 smoking; OR= 1.35 cannabis), I calculated a sample of ~12,000 would 
be needed for the analysis of tobacco risk score and ~4000 for the analysis of cannabis risk 
score to achieve 80% power. However, the current analysis only provides 27% power for the 
tobacco analysis and 63% for the cannabis analysis. For social communication, based on 
the proportion of cases in the sample (0.12) and on the causal effect observed (OR= 0.84 
smoking; OR= 1.35 cannabis), I calculated a sample of ~92,000 would be needed for the 
analysis of tobacco risk score and ~5,000 for the analysis of cannabis risk score to achieve 
80% power. However, the current analysis only provides 7% power for the tobacco analysis 
  Antisocial behaviour 
  N OR 95% CI p 
Tobacco risk score  2695 1.43 (0.86 to 2.36) 0.172 
Tobacco strongest SNP (rs6265) 2695 1.36 (0.28 to 6.56) 0.701 
Cannabis risk score 2693 1.19 (0.84 to 1.67) 0.348 
6.3.4.2. Social cognition 
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and 46% for the cannabis analysis. Therefore, the present analyses are likely to be 
considerably underpowered. 
6.4. Discussion 
Overall, our findings do not provide evidence for a causal effect of genetic risk for tobacco or 
cannabis initiation on antisocial behaviour. Additionally, there was no evidence of a causal 
effect of genetic risk for cannabis or tobacco initiation on social cognitive performance. This 
contrasts with the clear observational evidence in the previous chapters (using current use) 
and current analysis (using ever/never) of a strong association between tobacco and 
cannabis use with subsequent antisocial behaviour and poor social cognition.  
There are some limitation of this study to consider. First, while this study highlights the 
importance of using different statistical and methodological approaches when investigating 
causality, it also indicates that Mendelian randomisation analyses are likely to require very 
large sample sizes to achieve adequate statistical power. The point estimates are of interest 
and generally in the direction I would expect based on the previous observational evidence. 
However, much larger sample sizes would be required to narrow the confidence intervals to 
be certain of the effect. Secondly, it should be noted that I used a more liberal P-value 
threshold to increase the number of SNPs used for each polygenic risk score. Increasing the 
number of SNPs may introduce further variance into the model and increase the risk of 
pleiotropy (i.e., one SNP influences multiple unrelated phenotypes). Furthermore, the results 
are difficult to interpret due to low statistical power. In the following Chapter, we address the 
issues of pleiotropy and low sample sizes using two-sample MR.  
While there are no current MR studies investigating the association of tobacco and cannabis 
with antisocial behaviour, one study investigated the association of alcohol use on later 
antisocial behaviour in Asian adolescents. The aldehyde dehydrogenase 2 (ALDH2) gene 
was used to quantify alcohol ingestion, as ALDH2 is associated with decreased drinking due 
to unpleasant effects of alcohol. The authors hypothesized individuals without this variant 
would be associated with higher substance use and antisocial behaviour via a “gateway” 
effect (Pingault, 2016). However, there was no association between adolescent alcohol use 
and later antisocial behaviour (Irons, McGue, Iacono, & Oetting, 2007).  
There are also a number of studies that have investigated other mental health outcomes. A 
meta-analysis of MR studies investigating SNPs associated with smoking heaviness 
(rs16969968/rs1051730) with depression and anxiety found no causal association between 
smoking heaviness and increased risk of depression or anxiety, contrary to their 
observational analysis which found an association of smoking and risk of depression and/or 
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anxiety (A. E. Taylor et al., 2014). Additionally, two recent studies using two-sample MR to 
investigate tobacco and cannabis initiation with schizophrenia used the same initiation SNPs 
as the current study to generate polygenic risk scores (S. H. Gage et al., 2016; S. H. J. 
Gage, H.; Taylor, A.;  Burgess, S.; Zammit, S.; Munafo, M. , 2016). Two-sample MR benefits 
from large sample sizes and can allow the analysis of associations in both causal directions 
(further discussion of two-sample MR in Chapter 7). There was no evidence that risk of 
schizophrenia was associated with smoking initiation, although there was some evidence of 
a causal effect of smoking initiation on risk of schizophrenia, although this effect was 
attenuated when the P-value was relaxed to include variants across different genes (S. H. J. 
Gage, H.; Taylor, A.;  Burgess, S.; Zammit, S.; Munafo, M. , 2016). Additionally, there was 
evidence that risk of schizophrenia was associated with subsequent cannabis initiation, and 
conversely cannabis initiation was associated with risk of schizophrenia (S. H. Gage et al., 
2016).  
There are no current MR analyses investigating social cognitive outcomes of tobacco and 
cannabis use. Future studies with increased sample size or using two-sample MR will serve 
to replicate the current findings, as GWAS continue to identify genetic architecture for mental 
health and social cognitive outcomes. 
Overall, we found no clear evidence of a causal association of tobacco or cannabis initiation 
antisocial behaviour or social cognitive performance. However, it is difficult to draw firm 
conclusions from these findings due to low statistical power. Future studies should increase 
the sample size or consider two-sample MR to increase power.  
6.5. Chapter summary 
In this Chapter, I used Mendelian randomisation analysis to investigate the possible causal 
effects of tobacco and cannabis initiation with antisocial behaviour and social cognitive 
performance. Previous observational evidence suggested an association between tobacco 
and cannabis initiation with an increased risk of both antisocial behaviour and poor social 
cognitive performance. However, there was no evidence of a causal association between 
tobacco or cannabis polygenic risk scores with either outcome. Although these analyses 
were underpowered and therefore difficult to draw strong conclusions from, suggesting 
future analyses should increase sample sizes or use alternative methods such as two-
sample MR.  
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7.  Chapter 7: A two-sample Mendelian randomisation 
analysis of the associations of tobacco initiation with 
ADHD and social cognitive outcomes 
7.1. Introduction 
As discussed in Chapter Six, Mendelian randomisation (MR) analysis can be used to 
strengthen causal inference (Burgess et al., 2015; S. H. Gage et al., 2013). However, as the 
genetic instruments only explain a small percentage of the variation (e.g. rs6265 explains 
0.03% of the variance in tobacco initiation), MR analysis relies on large datasets (~>10,000) 
(Schatzkin et al., 2009). The MR analysis reported in Chapter 6, conducted in the Avon 
Longitudinal Study of Parents and Children (ALSPAC), was underpowered, therefore making 
the results difficult to interpret. Typically, to achieve the necessary power, studies recruit 
across multiple cohorts. For example, the Consortium for Causal Analysis Research in 
Tobacco and Alcohol (CARTA) examined the effects of smoking heaviness with a number of 
health-related outcomes across 21 cohorts in 8 countries (A. E. Taylor et al., 2014). 
However, as organising a consortium is beyond the scope of a PhD thesis, there are 
alternative methods to increase our power, including two-sample Mendelian randomisation.  
7.1.1. Two-sample Mendelian randomisation 
Genome wide association studies (GWAS) require large sample sizes, typically around 
~100,000 with publicly-available data sets reporting on summary (SNP-level) statistics. 
GWAS results report the association of a specific phenotype(s) that have reached a certain 
p-value threshold (Burgess, Butterworth, & Thompson, 2013). Two-sample MR works on the 
same basic principles and assumptions as one-sample MR (i.e., genetic instruments 
robustly associated with a specific exposure of interest are used an unconfounded proxy 
measure for that exposure). However, two-sample MR uses two GWAS to identify both 
variant-exposure associations and variant-outcome associations using publicly-available 
summary data (Burgess et al., 2015). The combination of both GWAS increases the 
statistical power, however (similar to all meta-analyses) the quality of the overall results 
relies on the quality of both individual GWAS. 
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Figure 7.1 Model of two-sample Mendelian randomisation 
 
Two-sample Mendelian randomisation uses GWAS summary statistics that robustly predict a phenotype of 
interest for both the exposure and outcome. 
 
7.1.2. Chapter aims 
This chapter examines the causal effects of tobacco initiation on attention deficit-
hyperactivity disorder (ADHD) and social communication. Here, we use two-sample MR to 
increase power and compare findings to the both previous observational and MR analysis. 
This Chapter is based largely on a manuscript currently being revised for resubmission at 
Drug and Alcohol Dependence: Fluharty M, Sallis H, & Munafo M. Investigating possible 
causal effects of externalising behaviours on tobacco initiation: A Mendelian randomisation 
analysis. 
7.2. Methods 
7.2.1. Exposure measures 
The Tobacco and Genetics Consortium (TAG) conducted a GWAS of smoking behaviour on 
a sample of 74,053 individuals (Tobacco & Genetics, 2010). Smoking initiation was a binary 
ever/never measure with 8 single nucleotide polymorphisms (SNP)s located on the BDNF 
gene region reaching genomewide significance (P < 5 x 10-8) for tobacco initiation (Tobacco 
& Genetics, 2010). As these SNPs were all in high linkage disequilibrium (LD) with one 
another, they were pruned based on R2 values obtained in SNAP 
(http://www.broadinstitute.org/mgp/snap/) leaving 4 SNPs. A correlation matrix was created 
for the remaining SNPs (Table 7.1). Two sensitivity analyses were conducted due to the high 
correlation of the SNPs. First, using only the strongest SNP (rs6265), and again with an 
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additional 21 independent SNPs that were identified using a relaxed P-value (P < 10-6) (See 
table 6.1). Finally, these SNPs were extracted from ADHD and social communication GWAS 
for outcomes and longevity and pigmentation GWAS for positive and negative controls. 




7.2.2. Outcome measures 
For our ADHD outcome, we used summary data available from the Initiative for Integrative 
Psychiatric Research (iPSYCH) and Psychiatrics Genomics Consortium (PGC) GWAS of 
ADHD on 55,354 individuals (ages 6 to 19). ADHD was measured using binary cohort-
specific diagnosis of ADHD (Demontis et al., 2017). 
For our social communication outcome, we used summary data available from a GWAS of 
9,912 individuals conducted in ALSPAC (age 17) (St Pourcain et al., 2014). Social 
communication was measured using the Social and Communication Disorders Checklist 
(SCDC) (Robinson et al., 2011). 
For our positive control outcomes, we used summary data available from a GWAS of 
longevity (N= 75,244) (Pilling et al., 2016), and our negative control we used summary data 
available from a GWAS on pigmentation (N= 32,826) (Han et al., 2008).  
7.2.3. Statistical analysis 
SNPs associated with ADHD and social communication were identified in their respective 
GWAS and subsequently extracted from the tobacco GWAS (see Tables 7.2 and 7.3). SNP-
exposure and SNP-outcome associations were combined using an inverse-variance 
weighted approach (IVW), weighted median approach, and MR-Egger regression. Here, we 
use multiple methods, each with differing underlying assumptions regarding instrument 
validity, to triangulate our results (D. A. Lawlor, Tilling, & Davey Smith, 2016). IVW weights 
regression of SNP-exposure and SNP-outcome coefficients restricting the intercept to zero, 
 rs6265 rs4923460 rs1304100 rs6484320 
rs6265 1 0.817 0.652 0.603 
rs4923460 0.817 1 0.798 0.775 
rs1304100 0.652 0.798 1 0.598 
rs6484320 0.603 0.775 0.598 1 
7.2.2.1. ADHD 
7.2.2.2. Social communication 
7.2.2.3. Positive and negative controls 
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and assumes all instruments are valid with no pleiotropy (Burgess et al., 2013). Weighed 
median provides a causal estimate if at least 50% of the instruments are valid (Mostafavi, 
2016). Finally, MR-Egger uses an intercept coefficient in the weighted regression to relax the 
assumption that the outcome works strictly via the exposure (i.e., up to 100% of the 
instruments may be invalid). The intercept term displays the overall pleiotropic effect, while 
the slope () coefficient displays a causal estimate under the assumption the pleiotropic 
effects of the SNP on the outcome are unrelated to the associations between the SNP and 
exposure (Corbin et al., 2016). All analyses were conducted in R (version 3.3.2). IVW and 
MR-Egger analyses will be presented in text. 
Additionally, to the best of our knowledge there was no overlap between samples. However, 
it is possible there are parents in one cohort and offspring in another. 
Table 7.2 SNPs associated with tobacco initiation (p < 10-8) 
 
 









OR SE OR SE β SE β SE OR SE 
rs6265 0.063 0.015 0.975 0.019 -0.029 0.028 -0.037 0.018 0.037 0.018 
rs1304100 0.056 0.014 1.020 0.020 -0.011 0.026 0.024 0.016 0.024 0.016 
rs4923460 0.060 0.014 0.969 0.032 -0.013 0.027 -0.030 0.017 0.030 0.017 







OR SE OR SE β SE 
rs10013579 0.058 0.013 0.992 0.016 0.296 0.257 
rs10937751 0.066 0.014 0.988 0.018 -0.738 0.255 
rs11030084 0.067 0.015 0.973 0.019 -1.517 0.304 
rs11067275 0.065 0.014 1.022 0.017 -0.075 0.277 
rs11246771 0.084 0.018 0.950 0.023 0.698 0.359 
rs11570441 0.110 0.024 1.049 0.030 -0.661 0.493 
rs11892348 0.054 0.012 0.982 0.016 -0.381 0.261 
rs13131292 0.107 0.024 1.036 0.024 -2.688 0.383 
rs1448438 0.063 0.014 1.006 0.018 -1.176 0.243 
rs1817648 0.052 0.012 0.980 0.015 -0.282 0.266 
rs1986692 0.058 0.013 1.050 0.016 -1.463 0.242 
rs241526 0.053 0.012 0.984 0.016 -0.915 0.451 
rs2449222 0.091 0.020 0.966 0.027 -1.486 0.301 
rs725695 0.055 0.012 0.985 0.016 1.225 0.249 
rs739484 0.088 0.020 1.020 0.024 -1.831 0.398 
rs7548367 0.056 0.013 1.036 0.016 0.984 0.259 
rs7663808 0.059 0.013 0.995 0.016 0.775 0.262 
rs926246 0.090 0.020 0.979 0.023 0.288 0.407 
rs9521281 0.069 0.015 1.000 0.019 -0.076 0.316 
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7.3. Results 
7.3.1. Association of tobacco initiation on ADHD 
The 4 SNPs associated with tobacco use provided no evidence of an association with ADHD 
(P= 0.157), with similar results for the strongest SNP (rs6265) (P= 0.197). However, MR-
Egger analysis was not possible due to the correlated SNPs. When using the 21 relaxed P-
value SNPs (P < 10-6), there was evidence of an association of tobacco use on later ADHD 
(OR= 1.30, 95% CI= 1.18 to 1.42, P= <0.001). MR-Egger displayed no evidence of 
pleiotropy (intercept: OR=1.08, 95% CI 0.98 to 1.04, P= 0.619), and little evidence of 
causality (slope: OR= 1.16, 95% CI 0.69 to 1.62, P= 0.554). See Table 7.4 for full results.  
Table 7.4 Estimates of causal effects of the risk of tobacco initiation on ADHD 
Method OR 95% CI P value N SNP 
Tobacco initiation (exposure) on ADHD (outcome)  
Wald ratio 1.501 (0.885 to 2.116) 0.197 1 
Likelihood based method 1.487 (0.936 to 2.038) 0.157 4 
IVW 1.297 (1.175 to 1.419) < 0.001 22 
Weighted median 1.378 (1.204 to 1.552) 0.002 22 
MR-Egger slope 1.155 (0.687 to 1.623) 0.554 22 
MR-Egger intercept 1.008 (0.977 to 1.039) 0.619 22 
 
7.3.2. Association of tobacco initiation on social communication 
The 4 SNPs associated with tobacco use provided no evidence of an association with social 
communication (β= 0.217, 95% CI= -0.571 to 1.005, P = 0.589), with similar results for the 
strongest SNP (rs6265) (β= 0.460, 95% CI= -0.440 to 1.360, P = 0.316). As above, MR-
Egger analysis was not available for these SNPs. When using the 21 relaxed P-value SNPs 
(P < 10-6) there was still no evidence of an association of tobacco use on social 





Table 7.5 Estimates of causal effects of the risk of tobacco initiation on social communication 
Method β 95% CI P value N SNP 
Tobacco initiation (exposure) on social communication (outcome)  
Wald ratio 0.460 (-0.440 to 1.360) 0.316 1 
Likelihood based method 0.217 (-0.571 to 1.005) 0.589 4 
IVW -0.056 (-0.204 to 0.092) 0.464 22 
Weighted median -0.077 (-0.312 to 0.157) 0.525 22 
MR-Egger slope -0.431 (-0.949 to 0.087) 0.119 22 
MR-Egger intercept 0.027 (-0.009 to 0.064) 0.156 22 
β = Standard deviation of the outcome (social communication) in the natural log odds of the 
exposure (smoking initiation) 
7.3.3. Positive and negative controls 
The 4 SNPs associated with tobacco use displayed evidence of an association with 
longevity (positive control) [mean difference of -0.10 in the natural log odds of longevity (95 
%CI -0.17 to -0.02, P = 0.009)] and weak association with light pigmentation (negative 
control) (OR 1.63, 95% CI 1.11 to 2.15, P = 0.064). 
7.3.4. Power calculation 
I conducted a Post-hoc power calculation using an online Mendelian randomisation power 
calculation tool (https://sb452.shinyapps.io/power/) (Burgess, 2014). The coefficient of 
determination of the exposure on the genetic variant was R2= 0.03. Based on the proportion 
of cases and controls (0.57 ADHD; 0.18 social communication) and the observed causal 
effect (OR= 1.29 ADHD; -0.06 social communication), the analysis of tobacco risk on ADHD 
was adequately sample sized to determine 99.9% power, and the analysis of tobacco 
initiation on social communication was adequately sample sized to determine 84% power. 
7.4. Summary 
Our results provide some evidence that tobacco initiation is causally associated with an 
increased risk of ADHD. However, these results are difficult to interpret because the ADHD 
GWAS was measured in childhood (age range 6-19) and it’s likely most individuals initiated 
smoking ~age 15 (Centre, 2016c). Additionally, there is some evidence that genetic effects 
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on externalising phenotypes differ across time (i.e., different age groups) (Pappa et al., 
2016). A small GWAS of adult ADHD characteristics (inattention and hyperactivity-
impulsivity) (N=1,851) (Ebejer et al., 2013) showed no overlap of SNPs with the adolescent 
GWAS we used. However, this data was neither publicly available nor could be obtained 
through author correspondence.  
As we cannot easily interpret these associations as adolescent tobacco use on adult ADHD 
(due to relatively young age of the ADHD GWAS), we may contextualize this association as 
intrauterine tobacco exposure via dynastic effects, in which parental genotypes affect the 
size and effect of an offspring’s traits. For example, an effect can be exaggerated or reduced 
in response to adverse prenatal environments (i.e., tobacco exposure (Millard et al., 2015)). 
There is a range of evidence from longitudinal (D. W. Brook, Zhang, Rosenberg, & Brook, 
2006), cross-contextual (Brion et al., 2010), and twin studies (Knopik, 2009) suggesting 
maternal smoking may be associated with offspring externalizing behaviors (Brion et al., 
2010; D. W. Brook et al., 2006; Gaysina et al., 2013; Knopik, 2009). First, women with 
antisocial or other behavioral problems are at higher risk of smoking during pregnancy and 
subsequently share the risk of externalising behaviour with their offspring through genetic 
transmission (Knopik, 2009). Secondly, this association may be further mediated via the 
adverse effects of intrauterine tobacco exposure on neurodevelopment. Studies suggest 
nicotine inhibition of the monoamine oxidase (MAO) system is associated with offspring 
behavioral disorders (Baler, Volkow, Fowler, & Benveniste, 2008). However, A study of 
maternal smoking and offspring ADHD in biological and surrogate mothers found a stronger 
effect in mother-offspring pairs suggesting this association may represent an inherited risk 
that is further exaggerated with intrauterine tobacco exposure (Thapar et al., 2009).  
While the GWAS does include individuals aged up to 19, we could examine this as tobacco 
exposure on the developing brain and its association with childhood ADHD. Rodent models 
have addressed the effects of adolescent nicotine exposure on the brain. Prolonged nicotine 
exposure in the developing brain produces persistent and widespread nAChR upregulation 
(compared to the mature brain). This results in behavioural effects, learning deficits 
(Fountain, Rowan, Kelley, Willey, & Nolley, 2008), and increased impulsivity (Counotte et al., 
2009). Assuming the effect of tobacco initiation on the older individuals in the GWAS cohort, 
our findings here suggest tobacco initiation is associated with increased risk of ADHD, which 
largely parallels observational evidence that tobacco exposure on the developing brain is 
associated with risk of ADHD (Brion et al., 2010; D. W. Brook et al., 2006; Gaysina et al., 
2013; Knopik, 2009), suggesting early tobacco exposure may have a causal association with 
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ADHD. However, as the mean age and number of individuals across age groups were 
unavailable, it’s difficult to determine what proportion of the effect is driven by the older ages.  
There was no evidence that tobacco initiation was causally associated with social 
communication performance. This conflicts with our earlier observational evidence (M. E. 
Fluharty, Heron, & Munafo, 2017), suggesting these previous findings may be a result of 
residual confounding. Additionally, I hypothesised that poor social cognition may arise from 
tobacco use via poor mental health. However, we were unable to obtain the necessary 
summary statistics to conduct this specific analysis (ADHD to social communication).  
Additionally, there was an unexpected association: the negative effect of tobacco initiation 
with skin pigmentation. With hindsight, there are biological processes that could explain this. 
Smoking may induce oxidative stress and change inflammatory cell function by releasing 
proteolytic enzymes (Y. H. Cho et al., 2012). Furthermore, smoking cessation is associated 
with changes in skin pigmentation (Y. H. Cho et al., 2012). Overall, it is difficult to find a 
phenotype to use as a negative control for tobacco as there are very few biological or 
cognitive systems that are not influenced in some way by tobacco (Newhouse, Potter, & 
Singh, 2004; Yildiz, 2004). 
A key strength of this analysis is the use of two-sample MR which both provides stronger 
causal inference than observational studies (S. H. Gage et al., 2016; S. H. Gage, Munafo, et 
al., 2015), and utilizes large sample sizes to provide sufficient the power required to detect 
small effects in complex phenotypes (Burgess et al., 2015). Additionally, by integrating other 
methods, such as positive and negative controls, strengths of one method will compensate 
and overlap with the limitations of another to provide us with true causal associations (S. H. 
Gage, Munafo, et al., 2015). A limitation of this study is the unavailability of a high powered 
GWAS for adult ADHD. Therefore, direct comparisons of tobacco initiation on subsequent 
ADHD could not be explored. If additional GWAS studies examine adult ADHD, replication of 
this study will help to strengthen these findings. Additionally, a GWAS on adult antisocial 
behaviour was recently published (Tielbeek et al., 2017), however I was unable to obtain the 
necessary summary data to run this analysis. Future studies may be able to utlise this 
GWAS to further investigate associations of externalising disorders on tobacco initiation.  
7.5. Chapter summary 
This chapter used two-sample MR to investigate the causal associations of tobacco initiation 
on ADHD and social communication. There was some evidence of an effect of tobacco 
initiation on ADHD, however due to the ages the GWAS were measured these results were 
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difficult to interpret. Secondly, there was no evidence of an association of tobacco initiation 
on social communication.  
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8. Chapter Eight: Discussion 
8.1. Thesis aim and hypotheses 
In this thesis, I aimed to investigate the direction of association between substance use and 
mental health problems in adolescence, and whether these are likely to be causal. I also 
examined the possible role of social cognition in this relationship due to its common 
associations with both substance use and mental health problems. I used a range of 
different methods to investigate these associations including a systematic review of the prior 
literature, observational analyses, and Mendelian randomisation (MR).  
8.2. Summary of studies conducted 
Initially I conducted a systematic review to identify the weight of evidence for each temporal 
direction and any current gaps in the literature. For this I focused specifically on tobacco use 
behaviours with depression and/or anxiety due to the abundance of literature available. The 
review examined all papers with smoking as an exposure and depression/anxiety as an 
outcome and vice versa. Overall, the results were mixed displaying largely conflicting 
evidence in the field. Furthermore, few studies investigated both temporal directions (rather 
than solely in direction of their a priori hypothesis) and even fewer published null results 
(often only reporting these alongside ‘significant’ findings).  
I therefore next conducted my own observational analysis on substance use and mental 
health investigating this association in both temporal directions. This analysis investigated a 
range of mental health problems with the three most popular consumed substances globally: 
alcohol, tobacco, and cannabis. Additionally, analyses were repeated replacing mental 
health with social cognitive variables, allowing a direct comparison of patterns of association. 
Here, I found that poor mental health at age 7 was associated with substance use at 18, but 
there was no association or a decreased association with social cognition at age 7/8 with 
substance use at 18. In the opposite temporal direction, both mental health and social 
cognition at 18 declined following substance use initiation at age 15.  
Next, I conducted a further observational analysis investigating the temporal direction of 
association of mental health with social cognition from ages 15 to 18 (likely following the 
onset of substance use). Here, I found evidence that poor mental health at age 15 was 
associated with subsequent social cognitive decline at age 18. There was no clear evidence 
of an association in the opposite direction (e.g. poor social cognition on later mental health 
problems).  
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With the evidence obtained from the longitudinal analyses, I hypothesised there were two 
possible pathways in the substance use, mental health, and social cognition relationship. 
First, that decline in both mental health and social cognition are independently associated 
with substance use initiation. Second, that substance use initiation is associated with poor 
social cognition via poor mental health. However, as all the evidence was from observational 
analyses, additional methods were required to investigate any possible causal assumptions. 
I therefore next used one sample MR to examine the causal nature of these associations, 
specially focusing on tobacco and cannabis initiation with later externalising disorders and 
social communication. Tobacco initiation and cannabis initiation were chosen due to the 
availability of associated SNPs at the time, and mental health was narrowed to externalising 
disorders as the most robust observational findings were for externalising disorders. I found 
no evidence of an association between genetic risk for tobacco or cannabis initiation with 
externalising behaviour or social communication. However, these analyses were likely 
underpowered making them difficult to interpret.  
For my final analyses, I used two-sample MR which utilises genome-wise association study 
(GWAS) summary statistics to achieve large sample sizes and increased power. Here, I 
found some evidence that tobacco initiation was casually associated with ADHD, although 
these results were slightly difficult to interpret due to the relatively young age range of the 
ADHD GWAS. I found no evidence that tobacco initiation was causally associated with 
social communication. Unfortunately, I was not able to investigate the association of ADHD 
on social communication due to unavailable data. 
Overall, I found some evidence of a causal association of tobacco initiation on ADHD, which 
supports my earlier observational evidence. There was no evidence of a causal association 
of tobacco initiation on social communication, which conflicts with earlier observational 
evidence, suggesting this may be due to environmental or confounding factors. I was unable 
to investigate the causal nature of the observational association that externalising disorders 
are associated with decreased social cognitive performance, and it is therefore possible that 
poor social cognition may arise due to poor mental health following tobacco initiation.  
8.3. Interpretations / Previous literature 
This thesis highlights the importance of utilising multiple methods to triangulate causal 
inferences. My systematic review demonstrated the extent of conflicting findings in the 
current filed using longitudinal analyses alone, and the need to identify alternative methods 
that provide stronger causal inference. Reverse causation was a high risk in many studies 
as many analyses were only conducted in the direction of their a priori hypothesis. 
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Furthermore, many of the studies controlled for differing confounding variables which may 
explain the inconsistent results observed. Future reviews may want to investigate the impact 
of specific confounders on the direction of association observed. Additionally, study quality 
was not assessed, therefore possible sample and measurement bias may be contributing to 
the inconsistent evidence. Overall, while the literature was largely mixed, there was slightly 
more evidence supporting the direction of depression and/or anxiety predicting smoking 
behaviour. These findings support recent MR analysis, as an unpublished analysis 
conducted in the Tobacco and Alcohol Research Group found depression has a causal 
effect on smoking initiation (Sallis, 2018), while two additional MR analyses have found no 
evidence to support a causal association between smoking and depression and anxiety 
(Bjorngaard et al., 2013; A. E. Taylor et al., 2014).   
The longitudinal analysis suggested a bidirectional pathway of both tobacco and cannabis 
with subsequent externalising disorders and vice versa. Additionally, tobacco and cannabis 
initiation was associated with later social cognitive decline (and all mental health problems).  
These findings are consistent with previous literature (Bosco et al., 2014; Donadon & Osorio 
Fde, 2014; Nandrino et al., 2014). However, there was no association of poor social 
communication/reciprocity with later substance use, and a negative association of affect 
recognition with substance use. These findings are important, as to my knowledge, this 
direction of association has not been investigated to date. Therefore, this suggests the 
associations of substance use with later social cognitive performance are not due to reverse 
causation. Furthermore, this analysis indicated an unpredicted finding of poor childhood 
facial affect recognition with decreased adolescent substance use. Although, it’s likely this 
association may arise due to the overall lack in social skills and subsequent exclusion from 
friendship groups that may begin experimenting with drugs during adolescence. However, 
this is unlikely to be the sole reason behind decreased substance use, as a similar effect is 
not seen in social communication or social reciprocity. There was no association observed 
between individual emotions (happy, sad, scared etc.) with decreased substance use, only 
poor affect recognition overall (low and high emotional intensity). Perhaps this facet of social 
cognition causes more difficulties in normative socialising at younger ages compared to the 
other variables measured in this study. This area would be worth pursing further in future 
studies to determine whether it replicates across different cohorts and different measures of 
facial affect recognition.  
The two-sample MR analyses suggest some evidence of a causal effect of tobacco initiation 
with ADHD, and no evidence of an association on social communication. Therefore, it’s likely 
the observed association of substance use with subsequent poor social cognitive 
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performance is not causal and may arise via poor mental health or other unmeasured 
factors. 
The association of tobacco initiation on subsequent ADHD is consistent with previous 
evidence from observational analyses (Brion et al., 2010; D. W. Brook et al., 2006) and twin 
studies (Knopik, 2009). However, this association is slightly difficult to interpret due to the 
young age of participants in the ADHD GWAS. Previous studies indicate the potentially 
harmful effect of repeated nicotine and tobacco exposure on the developing brain. Women 
who smoke during pregnancy expose their offspring to various compounds present in 
tobacco smoke during neurodevelopment; for example, tobacco exposure may alter 
expression of the monoamine oxidase (MAO) allele in the foetal brain, with low expression 
associated with violence and behavioural disorders (Baler et al., 2008). This is further 
observed in a surrogate study in which smoking mothers were more likely to give birth to 
children with ADHD (Thapar et al., 2009). Nicotinic systems may mediate the expression of 
ADHD as repeated nicotine administration leads to nigrostriatal and mesolimbic dopamine 
release, resulting in dopamine dysregulation and locomotor stimulant (Clarke, 1990; 
Faraone & Biederman, 1998). These findings are supported by rodent studies suggesting 
that nicotine administration associated with rat hyperactivity (Hagino & Lee, 1985). However, 
the age of the ADHD GWAS did extend from ages 8 to 19. Therefore, depending on the 
proportion of older age individuals, these findings may be reflecting tobacco exposure on the 
developing brain and its association with adolescent ADHD. These findings are consistent 
with previous evidence from observational and rodent studies (Brion et al., 2010; D. W. 
Brook et al., 2006; Gaysina et al., 2013; Knopik, 2009). Tobacco has increased rewarding 
effects, and decreased negative withdrawal effects on adolescents (compared to adult 
smokers) (O'Dell, 2009). During adolescence, dopamine neurones have heightened 
sensitivity to nicotine-induce potentiation in the ventral tegmental area (Placzek et al., 2009). 
Acute nicotine exposure in adolescence is associated with increased extracellular serotonin 
overflow in the nucleolus accumbens shell and decreased dopamine and serotonin in medial 
prefrontal cortex (Shearman et al., 2008). Adolescents are susceptible to increased self-
administration (Adriani et al., 2002), consume more nicotine than adults (H. Chen et al., 
2007; Levin et al., 2007; Natividad et al., 2013), and show less aversion to higher doses 
(Adriani et al., 2002; Shram et al., 2006; Torres et al., 2008). Furthermore, pre-clinical/rodent 
evidence suggests prolonged exposure of nicotine in developing brains produces more 
widespread nAChR upregulation and subsequent behavioral effects, learning deficits 
(Fountain et al., 2008), and increased impulsivity (Counotte et al., 2009). 
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While I only focused on externalising disorders in the final Chapters, other MR studies have 
examined the impact of tobacco initiation on other mental health problems. An unpublished 
MR analysis conducted in the Tobacco and Alcohol Research Group found no evidence of a 
causal association of tobacco initiation on depression (Sallis, 2018). Additionally, a MR 
analysis of tobacco initiation with schizophrenia risk found weak evidence of a causal 
association, although this effect was attenuated when the p-value was relaxed and variants 
from further genes were incorporated which allows from a more powerful instrument, but at a 
greater risk of pleiotropy (S. H. J. Gage, H.; Taylor, A.;  Burgess, S.; Zammit, S.; Munafo, M. 
, 2016). These results highlight the importance of using additional methods, alongside 
traditional observational methods when investigating causal inferences. There was no 
causal association of tobacco use on social communication, suggesting the observed 
associations may be a result of residual confounding, measurement error, or bias. It is 
possible that tobacco use affects social communication via poor mental health; for example, 
poor interpersonal connections, increased stress response in social interactions, and social 
withdrawal in mentally ill individuals may lead to development of poor social skills (Drusch et 
al., 2013). However, I was unable to investigate the possible causal effects of ADHD on 
social communication due to the necessary GWAS summary data not being available. 
Additionally, out of the three measures of social cognition I used in this thesis, I only 
investigated the causal associations in social communication; therefore, it is possible there 
may be a causal effect of tobacco initiation on social reciprocity or affect recognition. 
Unfortunately, I could not investigate the observational association of tobacco initiation on 
affect recognition as affect recognition data was unavailable for older adolescents in 
ALSAPC. However, new data on affect recognition in older individuals in ALSPAC has been 
collected and will be available imminently for analysis. Additionally, a small GWAS has 
identified some SNPs associated with approaching genomewide significance for affect 
recognition (J. R. I. Coleman et al., 2017), and future studies may investigate this 
association.  
8.4. Implications 
In this thesis, I examined the possible role of social cognition in the relationship between 
mental health and substance use. In doing so, I explored the temporal relationship of social 
cognition and substance use in more depth. To my knowledge, the literature to date focuses 
on the acute intoxication (Adams et al., 2014; Curtin et al., 2001), withdrawal (Leventhal et 
al., 2012; Townshend & Duka, 2003), or prolonged and heavy use (Bayrakci et al., 2015; 
Romero et al., 1997) of substances on social cognition. However, I made sure to investigate 
both temporal directions, using relatively light substance use variables in an adolescent birth 
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cohort. Interestingly I found that early social cognition was not associated with later 
substance use, and in particular affect recognition was associated with decreased substance 
use. This analysis helped rule out the possibility of reverse causality and strengthened my 
finding that substance use is associated with later impaired social cognition. Additionally, this 
analysis suggested that poor non-verbal communication may in fact be protective with 
respect to subsequent substance use. While this is clearly an area that warrants additional 
research and replication, one possible explanation for this finding is that adolescents with 
poor emotion recognition skills may be less likely to have larger social groups (Barth & 
Bastiani, 1997; Leppanen & Hietanen, 2001) and therefore less likely to  engage in 
substance use due to less social inclusion (Alfaro et al., 2017; McCrady, 2004; Shadur & 
Hussong, 2014; Urberg et al., 1997). 
Furthermore, the evidence in this thesis suggests there is a small causal effect of smoking 
initiation on risk of ADHD. These findings are supported by observational evidence (Brion et 
al., 2010; D. W. Brook et al., 2006) twin studies (Knopik, 2009), and animal models (Hagino 
& Lee, 1985). One possible pathway of this association is via dynastic effects. Here, the 
adverse effects of intrauterine tobacco exposure on neurodevelopment may be associated 
with behavioural disorders (Baler et al., 2008). This information may be helpful in educating 
and encouraging mothers to stop smoking before pregnancy and preventing early 
adolescent tobacco use.  
While the prevalence of smoking during pregnancy has generally declined with time (~20-
35% in 1980 to ~<10% in 2010), the rates differ across socio-economic status, with the 
slowest rates of decline in areas of low social disadvantage (Graham, Hawkins, & Law, 
2010; Lanting, van Wouwe, van den Burg, Segaar, & van der Pal-de Bruin, 2012). 
Additionally, smoking in pregnancy is more prevalent in some ethnic and aboriginal 
minorities (Johnston, Thomas, McDonnell, & Andrews, 2011; Wood, France, Hunt, Eades, & 
Slack-Smith, 2008). These difference in smoking rates are driven by tobacco companies 
increased production and marketing in low and middle-income countries, and targeted 
advertisement towards women (Kaufman, 2001). This suggests specific attention should be 
given to women in these minority groups to aid cessation attempts during pregnancy. 
However, the tobacco and ADHD GWAS used in this thesis were conducted in high income 
countries suggesting smoking during pregnancy may still be an issue in these areas. Current 
National Institute for Health and Care Excellence (NICE) guidelines contain advice on 
stopping smoking in pregnancy and childbirth. Initially, midwives should assess mothers’ 
smoking through a carbon monoxide (CO) test, providing the mother with a physical 
measurement of her own smoking and its effect on others. Information should be presented 
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to the mother highlighting the risks smoking can have on her unborn child. Current smokers 
and those whom have stopped within the last 2 weeks are to be referred to local authority 
stop smoking services. Stop smoking advisors should then contact all referred mothers 
either via phone or in person and gather information on mothers’ smoking heaviness and 
smoking behaviours of other smoking household members. Intensive support should be 
given to the mother throughout pregnancy and following birth, including regular monitoring of 
smoking status through CO tests. Finally, NRT may be prescribed following cessation 
(NICE, 2010). 
Furthermore, Cochrane Reviews have reported on several smoking cessation interventions, 
both psychosocial and pharmaceutical for pregnant women. One Cochrane Review on found 
psychosocial interventions increased quit rates by 35% in late pregnancy with little adverse 
effects, proving counselling, contingency management (financial incentives), and feedback 
methods most successful (Chamberlain et al., 2017). A second Cochrane Review examined 
pharmacological interventions, finding some evidence that nicotine replacement therapy 
(NTR) may reduce smoking rates in late pregnancy, however this may be no more effective 
than placebo, with inconclusive evidence of possible adverse effects on the infant (T. 
Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2015).  My findings also suggest 
that early adolescent cigarette smoking may be associated with increased risk of ADHD. 
Therefore, there should be a focus on preventing uptake of smoking in childhood and 
adolescence, and further be educating individuals on the negative psychological effects as 
well as physiological. Children should be targeted at a young age and educated about the 
possible long-term effects of smoking. Current NICE guidelines indicate several possible 
pathways to prevention in childhood. Prevention programmes in school may be ‘adult-led’ or 
‘peer-led.’ Adult-led interventions include integrating information about the harmful effects of 
tobacco into the curriculum. These interventions should be entertaining and interactive, 
specifically tailored to the age group, and help develop decision making skills and strategies 
to reject peer pressure (NICE, 2008). Alternatively, peer-led interventions are led by 
individuals nominated by the students and may be delivered in or outside the classroom. 
The nominated students are trained and receive support by experts to discuss society norms 
on smoking and benefits of not smoking (NICE, 2008). Additionally, ‘organisation or school-
wide’ policies on smoking, such as prohibiting smoking on any area of the grounds will help 
minimise smoking exposure to young people. Outside schools, there should be strict 
prohibition of illegal tobacco sales to underage individuals. Local authorities should conduct 
inspections of retailers to ensure they are requesting proof of age for individuals’ appearing 
younger than 18 (NICE, 2008).  
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Additionally, there is evidence that several further strategies may be effective in preventing 
early smoking initiation in children and adolescents. Within the family, strong parental-child 
bonds and open communication may help delay or prevent initiation. Media advocacy and 
mass media campaigns can be to change individuals’ perception on tobacco use (Wallack & 
Dorfman, 1996). For example, the ‘Truth Initiate’ based in the United States runs a series of 
television commercials and YouTube videos exposing deceptive tobacco industry strategies 
(i.e. marketing to minorities or mentally ill) (Hair et al., 2017). Some government regulations 
may help prevent individuals from early onset smoking. Smoking bans in public places 
increase the perception that smoking is socially unacceptable (Wakefield et al., 2000), while 
restrictions on tobacco-industry advertisement (i.e. in film and television) reduce the 
exposure to smoking in daily life. Large adverse pictorial warning labels on cigarette packs 
are associated with decreased smoking rates among adolescents and non-smokers 
(Peebles et al., 2016; V. White, Webster, & Wakefield, 2008). Furthermore, some countries 
including Australia and the UK have introduced plain packaging which greatly restricts 
advertising on packages and increases attention drawn to pictorial warning labels, further 
decreasing the likelihood of adolescent smoking uptake (Germain, Wakefield, & Durkin, 
2010; Maynard et al., 2014; Maynard, Munafo, & Leonards, 2013). Finally, there is evidence 
that increasing the price of cigarettes, known as ‘price elasticity’ can affect adolescent 
smoking consumption. While price increases may not affect adolescent experimentation, 
evidence suggests the price effects whether adolescents will progress to buying their own 
cigarettes (Nonnemaker & Farrelly, 2011; Powell, Tauras, & Ross, 2005).  
Finally, many of these tobacco-prevention strategies focus on preventing sales, decreasing 
exposure, and providing education of long term health effects. However, education on long-
term risks should consider addressing psychological and mental health outcomes alongside 
the well-known physiological ones (i.e. lung cancer).  
8.5. Thesis strengths  
Strengths of each individual study were addressed in their specific Chapter. However, there 
are some overarching themes across Chapters. First, this thesis utilises large rich datasets 
including the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort and 
summary data from multiple GWAS to investigate the associations of substance use, mental 
health, and social cognition. Secondly, due to the comprehensive data collection in ALSPAC 
I was able to keep variables relatively consistent across ages groups, although sometimes 
using a different variable was more practical for specific ages (i.e. Development and 
Wellbeing Assessment (DAWBA) to examine mental health in younger ages versus the 
Clinical Interview Schedule (CIS-R) in older ages). Third, in my observational studies I made 
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a robust attempt to adjust for possible confounders by examining a range of confounders in 
three different categories: pre-birth/ demographic, maternal substance use, childhood, and 
where necessary previous incident of the outcome. Fourth, I used a range of different 
methods each with differing underlying assumptions regarding instrument validity to 
triangulate the evidence across studies. 
8.6. Thesis limitations 
Again, individual study limitations are discussed in depth in each respective Chapter. 
However, there are a number of overall limitations to reiterate. First, this thesis was entirely 
conducted on secondary data, therefore I was limited to the variables and ages they were 
previously collected. While the substance use and mental health variables were robust and 
frequently collected in ALSPAC, there was less attention on social cognitive variables. I was 
limited to the DANVA and SCDC to create my social cognition variables, and unfortunately 
DANVA was not measured in older ages so I could not investigate both temporal directions 
for facial affect recognition. Secondly, I was limited by the availability of some datasets, in 
particular access to some GWAS. While a majority of the GWAS I used were publicly 
available, some required contacting authors, and even so I was not always able to obtain 
access for the entire dataset. For example, I was able to analyse tobacco initiation with 
social communication although I was unable to obtain the SNPs required to further analyse 
ADHD on social communication. Additionally, I was limited to the ages in which the GWAS 
were conducted. As ADHD was measured in childhood (age range 6-19) this made the 
analysis of tobacco initiation with ADHD difficult to interpret. While there were some adult 
GWAS of externalising disorders, these were either underpowered or the data could not be 
obtained. Third, I only examined positive or negative diagnosis of mental health disorders, 
rather than investigating individual symptomology (e.g. anhedonia, negative affect, etc.). 
Previous evidence suggests specific symptoms may be differentially associated with 
smoking behaviour (Leventhal et al., 2013; Leventhal et al., 2011; Mickens et al., 2011a). 
Future research may consider investigating GWAS associated with individual symptoms as 
they become available. For example, a GWAS on inattention and hyperactivity is available; 
however, it is relatively low powered (Ebejer et al., 2013). Additionally, a GWAS on delay 
discounting has recently been published (Sanchez-Roige et al., 2018). Fourth, I had very 
similar results for smoking and cannabis use in all my observational analyses, possibly 
resulting from the cannabis use culture in the UK, as the predominate form of smoking 
cannabis is rolled together with tobacco in spiffs. As nearly all the cannabis users were also 
tobacco users, this made teasing apart the effects of cannabis versus tobacco difficult in the 
observed associations. I chose to analyse the causal effects of smoking on externalising 
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disorders in the two-sample MR, under the assumption that tobacco was likely driving the 
effect. However, as I have not run an adequately powered MR on cannabis use with mental 
health and social cognitive outcomes I cannot be completely positive of cannabis’ effect.  
8.7. Future Directions 
In this thesis, I used a range of methods to triangulate possible causal associations in the 
relationship between mental health, substance use, and social cognitive performance. My 
systematic review suggests future studies should look to alternative methods to replicate 
findings in tobacco and mental health. Additionally, observational studies should consider 
investigating both temporal directions to reduce the risk of reverse causation. Furthermore, 
the lack of null results reported suggests a possibility of publication bias. Therefore, journals 
should be open to accepting and publishing studies reporting null results. Some journals 
have been actively trying to reduce the risk of publication bias though pre-registration, in 
which analysis protocols are reviewed (prior to beginning the study) and the final 
manuscripts are re-reviewed and cannot be rejected on the basis of the study outcome. This 
helps reduce the risk of publication bias by the journal as well as helping to avoid poor 
research practices such as p-hacking (manipulating data to obtain significant 
effects)(Gonzales, 2015). 
Furthermore, I found observational evidence that substance use was associated with 
subsequent externalising disorders and social cognitive decline. However, there was only a 
causal effect observed for the association of tobacco initiation with ADHD. This further 
highlights the need to integrate multiple methods with stronger causal inference.  First, as 
higher-powered adult ADHD GWAS data become available it will be important to identify if 
these findings replicate. While I did find a causal effect, the effect was small and difficult to 
interpret due to the age range in the ADHD GWAS. Second, future studies should identify if 
the effect observed is due to prenatal nicotine exposure or early tobacco exposure in 
adolescents. This suggests the need to investigate the genetic architecture of ADHD in 
adulthood. Evidence from other externalising disorders (e.g. aggression) GWAS have 
displayed a difference in genetic associations across different ages (Pappa et al., 2016). 
Therefore, this may be a worthwhile investigation for future ADHD GWAS studies. Third, it is 
important to identify if this association is found in other externalising disorders such as 
aggression or antisocial behaviour. Currently, both an aggression (Pappa et al., 2016) and 
antisocial behaviour (Tielbeek et al., 2017) GWAS have identified SNPs of interest for each 
respective phenotype, although I was unable to obtain the necessary SNPs for this analysis. 
Fourth, as discussed above, the ADHD-associated SNPs were associated with presence or 
absence of diagnosis and not symptoms. Future GWAS may consider investigating SNPs 
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associated with individual symptoms rather than binary diagnosis to obtain a further 
understanding on the direct effect an exposure may be having on the outcome (i.e. 
anhedonia as opposed to purely depression). There are currently some adult GWAS 
available of specific symptoms including impulsivity and hyperactivity (Ebejer et al., 2013) 
and delay discounting (Sanchez-Roige et al., 2018) which could be used to investigate these 
associations. Fifth, the observational evidence suggests similar effects of tobacco and 
cannabis with externalising disorder and social cognitive outcomes. However, I chose to only 
investigate tobacco use in our higher-powered MR analysis. As the majority of cannabis 
users in ALSPAC were likely to be using it together with tobacco, I decided to only 
investigate genetic risk of smoking as I hypothesised this to be driving the effect. However, 
it’s possible cannabis use may have been driving the effect and therefore may explain the 
small effect on externalising disorders and no effect on social cognition. Therefore, this 
association should be tested using cannabis associated SNPs from the International 
Cannabis Consortium. Sixth, this thesis used smoking initiation and age of onset associated 
SNPs to stay consistent with my earlier observational analyses in adolescence. Future 
studies may want to examine this association in heaviness of smoking and cessation SNPs 
which are also available from the TAG GWAS. Seventh, I was unable to test the hypothesis 
that substance use was associated with poor social cognition via mental health problems 
due to restricted access to the social communication GWAS. This analysis is currently being 
conducted by another group and the necessary data were therefore unavailable for me to 
use. This upcoming analysis may help identify any missing links in this association of 
interest.  
Finally, my observational associations of childhood social cognitive performance on 
adolescent substance use were unexpected and worth further investigation. I found 
evidence that poor facial affect recognition was associated with decreased adolescent 
substance abuse, while there was no association of social communication or social 
reciprocity with later substance use. As far as I am aware, these analyses were the first to 
examine this temporal direction; therefore, future studies may want to examine these 
associations to determine if they replicate. I hypothesised that individuals with poor facial 
affect recognition may be less likely to be included in social groups and subsequently less 
likely to be exposed to substances during an experimental period. However, this does not 
explain why this result was only observed for one facet of social cognition. Future studies 
examining this association may want to examine these associations using different social 
cognitive variables to determine if this association is observed only in non-verbal 
communication deficits. While this study used the emotional faces task of the Diagnostic 
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Analysis of Nonverbal Accuracy (DANVA), further studies may consider using the body 
language tasks including postures and gestures.  
8.8. Conclusions 
Overall, this thesis identified several areas of interest in the association of substance use, 
mental health, and social cognition. First, I identified a lack of longitudinal studies 
investigating both temporal directions and publishing null results. Second, I found no 
observational evidence that poor social cognition lead to later substance use. There was 
evidence that substance use initiation was associated with a decline in both mental health 
and social cognitive performance with further evidence displaying social cognitive 
performance additionally declined following poor mental health. My MR analyses displayed a 
small causal effect of tobacco initiation on ADHD, and no causal effect of tobacco initiation 
on social communication. Overall, this thesis highlighted the importance in utilising multiple 
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 Details of excluded studies in the Systematic review 
 First Author Year Journal Reason for exclusion 
1 Brook 2008 Nicotine Tob Res 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
2 Grenard 2006 Nicotine Tob Res 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
3 Malmberg 2013 Addict Behav 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
4 Orlando 2001 J Consult Clin Psychol 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
5 Sorensen 2011 Nordic Journal of Psychiatry 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
6 Tjora 2014 Addiction 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
7 Wu 1999 Am J Public Health 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
8 Wu 2008 J Stud Alcohol Drugs 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
9 Xie 2013 Nicotine Tob Res 
Depression and anxiety were not defined, or an 
unreliable diagnostic test was used 
10 Bares 2012 Addict Behav 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
11 Berk 2010 Journal of Dial Diagnosis 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
12 Breslau 1999 Arch Gen Psychiatry 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
163  
13 Brook 2013 Am J Public Health 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
14 Brook 2012 Am J Addict 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
15 Conwell 2003 J Paediatr Child Health 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
16 Dierker 2001 
J Am Acad Child Adolesc 
Psychiatry 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
17 Dodd 2010 Compr Psychiatry 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
18 Fagan 2009 Nicotine Tob Res 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
19 Georgiades 2007 J Child Psychol Psychiatry 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
20 Goodman 2010 Addiction 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
21 Goodwin 2011 Drug Alcohol Depend 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
22 Griesler 2011 Addiction 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
23 Heffner 2012 Bipolar Disord 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
24 John 2004 Drug Alcohol Depend 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
25 Johnson 2000 JAMA 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
26 Johnson 2009 Drug Alcohol Depend 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
27 Korhonen 2011 Nicotine Tob Res 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
28 Lien 2009 J Adolesc Health 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
29 Makinen 2010 Psychiatry Research 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
30 Malmberg 2012 J Youth Adolesc 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
31 Malmberg 2013 Addict Behav 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
32 Mino 2001 Prev Med 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
33 Mojtabai 2013 Am J Public Health 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
34 Nay 2013 Psychiatry Research 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
35 Schneider 2014 J Affect Disord 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
36 Smith 2014 J Addict Med 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
37 Smith 2014 Am J Public Health 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
38 Trautmann 2015 Addict Behav 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
39 Tucker 2003 J Adolesc Health 
Depression or anxiety subtypes included, or were 




2008 Drug Alcohol Depend 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
41 Waldrop 2014 Am J Addict 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
42 Weinstein 2008 Addict Behav 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
43 Winefield 1992 Psychol Rep 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
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44 Zehe 2013 Addict Behav 
Depression or anxiety subtypes included, or were 
comorbid with other psychiatric illnesses 
45 Bhome 2014 Curr Opin Pulm Med Does not present new data 
46 Cavailles 2013 Eur Respir Rev Does not present new data 
47 Gage 2013 Depress Anxiety Does not present new data 




2012 Drug Alcohol Depend Other smoking category 
50 Chaiton 2010 Addict Behav Other smoking category 
51 Chung 2010 Addict Behav Other smoking category 
52 Polen 2004 Psychol Addict Behav Other smoking category 
53 Beijers 2014 Addict Behav Pregnant cohort 
54 Beijers 2014 PloS one Pregnant cohort 
55 Bogaerts 2013 Obes Facts Pregnant cohort 
56 DeWilde 2013 Nurs Res Pregnant cohort 
57 Gavin 2011 Women Health Pregnant cohort 
58 Lewis 2011 PloS one Pregnant cohort 
59 Meyer 1994 Paediatr Perinat Epidemiol Pregnant cohort 
60 Paarlberg 1999 Psychol Health Pregnant cohort 
61 Pritchard 1994 J Epidemiol Community Health Pregnant cohort 
62 Rubio 2008 Alcohol Clin Exp Res Pregnant cohort 
63 Solomon 2007 Drug Alcohol Depend Pregnant cohort 
64 Zambrana 1997 Pediatr Nurs Pregnant cohort 
65 Hermes 2012 Addiction Smokeless tobacco 
66 Sihvola 2008 Addiction Smokeless tobacco 
67 Akechi 2001 Cancer 
Smoking or depression/anxiety not exposure or 
outcome 
68 Albers 2003 Pediatrics 
Smoking or depression/anxiety not exposure or 
outcome 
69 Artaud 2013 BMJ 
Smoking or depression/anxiety not exposure or 
outcome 
70 Atkinson 2015 PloS one 
Smoking or depression/anxiety not exposure or 
outcome 
71 Bolognini 2003 Subt Use Misuse 
Smoking or depression/anxiety not exposure or 
outcome 
72 Broms 2012 Nicotine Tob Res 
Smoking or depression/anxiety not exposure or 
outcome 
73 Brook 2010 Nicotine Tob Res 
Smoking or depression/anxiety not exposure or 
outcome 
74 Brook 2004 J Genet Psychol 
Smoking or depression/anxiety not exposure or 
outcome 
75 Brook 2014 Nicotine Tob Res 
Smoking or depression/anxiety not exposure or 
outcome 
76 Brooker 2008 Subt Use Misuse 
Smoking or depression/anxiety not exposure or 
outcome 
77 Brunet 2014 BMC Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
78 Brunet 2014 Prev Med 
Smoking or depression/anxiety not exposure or 
outcome 
79 Copeland 2014 
J Am Acad Child Adolesc 
Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
80 Costello 2008 Health Psychol 
Smoking or depression/anxiety not exposure or 
outcome 
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81 Crane 2015 Addict Behav 
Smoking or depression/anxiety not exposure or 
outcome 
82 Damen 2013 Eur J Prev Cardiol 
Smoking or depression/anxiety not exposure or 
outcome 
83 Ernst 2006 Pediatrics 
Smoking or depression/anxiety not exposure or 
outcome 
84 Fergusson 1996 Arch Gen Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
85 Haller 2014 Drug Alcohol Depend 
Smoking or depression/anxiety not exposure or 
outcome 
86 Hamer 2013 Brain Behav Immun 
Smoking or depression/anxiety not exposure or 
outcome 
87 Kandel 1987 J Youth Adolesc 
Smoking or depression/anxiety not exposure or 
outcome 
88 Kirisci 2004 Drug Alcohol Depend 
Smoking or depression/anxiety not exposure or 
outcome 
89 Kulsoon 2015 Neuropsychiatr Dis Treat 
Smoking or depression/anxiety not exposure or 
outcome 
90 Lemonge 2013 Am J Epidemiol 
Smoking or depression/anxiety not exposure or 
outcome 
91 Lillehoj 2004 Subst Use Misuse 
Smoking or depression/anxiety not exposure or 
outcome 
92 Lundin 2015 Epidemiol Psychiatr Sci 
Smoking or depression/anxiety not exposure or 
outcome 
93 Miller 2013 Respir Med 
Smoking or depression/anxiety not exposure or 
outcome 
94 Moller 2013 Addiction 
Smoking or depression/anxiety not exposure or 
outcome 
95 Mun 2008 Dev Psychopathol 
Smoking or depression/anxiety not exposure or 
outcome 
96 Newcomb 1986 Am J Public Health 
Smoking or depression/anxiety not exposure or 
outcome 
97 Newcomb 1986 Am J Public Health 
Smoking or depression/anxiety not exposure or 
outcome 
98 Paunesku 2008 J Cogn Behav Psychother 
Smoking or depression/anxiety not exposure or 
outcome 
99 Poutanen 2008 Nord J Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
100 Purcell 2014 Early Interv Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
101 Rottenberg 2013 J Am Med Dir Assoc 
Smoking or depression/anxiety not exposure or 
outcome 
102 Samuelsson 2013 BMC Public Health 
Smoking or depression/anxiety not exposure or 
outcome 
103 Scourfield 2003 J Child Psychol Psychiatry 
Smoking or depression/anxiety not exposure or 
outcome 
104 Shanahan 2011 Psychol Med 
Smoking or depression/anxiety not exposure or 
outcome 
105 Sieber 1990 Drug Alcohol Depend 
Smoking or depression/anxiety not exposure or 
outcome 
106 Smith 2013 PloS one 
Smoking or depression/anxiety not exposure or 
outcome 
107 Smokowski 2009 J Prim Prev 
Smoking or depression/anxiety not exposure or 
outcome 
108 Tait 2013 J Clin Psychol 
Smoking or depression/anxiety not exposure or 
outcome 
109 Vie 2015 Eur J Public Health 
Smoking or depression/anxiety not exposure or 
outcome 
110 Weekes 2011 J Natl Med Assoc 
Smoking or depression/anxiety not exposure or 
outcome 
111 Weinberger 2012 Addiction 
Smoking or depression/anxiety not exposure or 
outcome 
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112 Weinberger 2013 Drug Alcohol Depend 
Smoking or depression/anxiety not exposure or 
outcome 
113 White 1996 Psychol Health 
Smoking or depression/anxiety not exposure or 
outcome 
114 Angst 1996 Br J Psychiatry 
Smoking was not distinguished from other 
substance use 
115 Baggio 2013 Int J Adolescent Med Health 
Smoking was not distinguished from other 
substance use 
116 Brook 2014 Am J Public Health 
Smoking was not distinguished from other 
substance use 
117 Mason 2008 Drug Alcohol Depend 
Smoking was not distinguished from other 
substance use 
118 Salom 2015 Addiction 
Smoking was not distinguished from other 
substance use 
119 Sung 2004 Drug Alcohol Depend 
Smoking was not distinguished from other 
substance use 
120 Yamaguchi 1984 Am J Public Health 
Smoking was not distinguished from other 
substance use 
121 Alt 2013 Laryngoscope Study is not longitudinal 
122 Benjamin 2013 J Consult Clin Psychol Study is not longitudinal 
123 Berlin 2008 Prev Med Study is not longitudinal 
124 Bonevski 2014 Drug Alcohol Review Study is not longitudinal 
125 Breslau 2004 Psychol Med Study is not longitudinal 
126 Callaghan 2014 J Psychiatr Res Study is not longitudinal 
127 Capron 2014 Cogn Behav Ther Study is not longitudinal 
128 Cervilla 2004 Psychol Medicine Study is not longitudinal 
129 Cohen 1991 Prev Med Study is not longitudinal 
130 Collins 2013 J Child Fam Stud Study is not longitudinal 
131 Dierker 2007 Drug Alcohol Depend Study is not longitudinal 
132 Ditre 2013 Exp Clin Psychpharmacol Study is not longitudinal 
133 Edwards 2012 J Affect Disord Study is not longitudinal 
134 Forray 2014 Addict Behav Study is not longitudinal 
135 Hanna 1999 Alcohol Clin Exp Res Study is not longitudinal 
136 Ismail 2000 Am J of Epidemiology Study is not longitudinal 
137 Keuthen 2000 Psychother Psychosom Study is not longitudinal 
138 Korhonen 2014 PloS one Study is not longitudinal 
139 Koval 1999 Addict Behav Study is not longitudinal 
140 Larsen 2009 J Psychosom Res Study is not longitudinal 
141 Lazary 2014 PloS one Study is not longitudinal 
142 Leventhal 2012 Nicotine Tob Res Study is not longitudinal 
143 Libby 2005 Addict Behav Study is not longitudinal 
144 Maniecka 2013 
Int J Occup Med Environ 
Health 
Study is not longitudinal 
145 McCaffery 2008 Health Psychol Study is not longitudinal 
146 Mistry 2014 Drug Alcohol Depend Study is not longitudinal 
147 Moselhy 2012 Epidemiol Psychiatr Sci Study is not longitudinal 
148 Munhoz 2013 J Affect Disord Study is not longitudinal 
149 Murphy 2003 Am J Psychiatry Study is not longitudinal 
150 Onge 2014 J Gerontol B Psychol Sci Soc Sci Study is not longitudinal 
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151 Othieno 2014 J Affect Disord Study is not longitudinal 
152 Prochaska 2014 Health Psychol Study is not longitudinal 
153 Ritt-Olson 2005 Subt Use Misuse Study is not longitudinal 
154 Strong 2007 Nicotine Tob Res Study is not longitudinal 
155 Turan 2014 Prim Health Care res Dev Study is not longitudinal 
156 Valera 2014 Nicotine Tob Res Study is not longitudinal 
157 Weinstein 2013 Psychol Addict Behav Study is not longitudinal 
158 Wilens 2013 Drug Alcohol Depend Study is not longitudinal 
159 Woolf 1999 Prev Med Study is not longitudinal 




2014 Adicciones Study not in English 
162 Dupre 2013 J Gynecol Obstet Biol Reprod Study not in English 
163 Heger 2014 
Prax Kinderpsychol 
Kinderpsych 
Study not in English 
164 Park 2009 J Korean Acad Nurs Study not in English 









Studies with different length to follow-up 
 
Direction of association Finding ≤ 1 years > 1 to 5 years 6 to 10 years > 10 years  
Depression/anxiety 
exposure into smoking 
outcome 
Evidence for 16 (48%) 28 (42%) 11 (35%) 14 (29%) 
Evidence 
against 
3 (9%) 14 (21%) 1 (3%) 11 (23%) 
Smoking exposure into 
depression/anxiety 
outcome 
Evidence for 7 (20%) 13 (20%) 14 (45%) 17 (35%) 
Evidence 
against 
5 (14%) 8 (12%) 3 (10%) 6 (13%) 
Bidirectional smoking and 
mental health outcome 
Evidence for 4 (11%) 3 (46%) 2 (6%) 0 (0%) 
Evidence 
against 
- - - - 
 
Studies with different diagnostic test or scales of depression and anxiety 




test Continuous Categorical 
Depression/anxiety 
exposure into smoking 
outcome 
Evidence for 20 (33%) 51 (43%) 38 (41%) 29 (32%) 
Evidence 
against 
11 (18%) 16 (14%) 12 (13%) 17 (19%) 
Smoking exposure into 
depression/anxiety 
outcome 
Evidence for 18 (30%) 32 (27%) 25 (27%) 29 (32%) 
Evidence 
against 
8 (13%) 13 (11%) 11 (12%) 12 (13%) 
Bidirectional smoking and 
mental health outcome 
Evidence for 3 (5%) 6 (5%) 6 (7%) 3 (3%) 
Evidence 
against 
- - - - 
 
















Depression and anxiety questions from the Clinical Interview Schedule Revised (CIS-
R) interview 
This computerised questionnaire has been designed to assess your health and general well-
being over the WEEK which means the 
PAST SEVEN DAYS. Your answers will be kept confidentially, like any medical notes. 
 
"To begin with, I would like to ask you about your gender and physical health"   
 












"Were you trying to lose weight or on a diet?" 
 
No, I was not trying to lose weight/Yes, I have been trying to lose weight 
 
"Did you lose half a stone or more, or did you lose less than this (in the PAST MONTH)? 
 
(NOTE: Half a stone = 7 pounds or 3 kg)" 
 
I lost half a stone or more/I lost less than half a stone 
 




"Have you gained any weight in the PAST MONTH?"  
 
No/Yes/Yes, but I am pregnant 
 
"Did you gain half a stone or more, or did you gain less than this (in the PAST MONTH)? 
 
(NOTE: Half a stone = 7 pounds or 3 kg)" 
 
I gained half a stone or more/I gained less than half a stone 
 
 
"In the past SEVEN DAYS have you experienced any nausea (feeling as though you were going 










































"What do you think is the main reason for feeling tired?" 
 
Problems with sleep/Tablets or medication/Physical illness/Working too hard, including looking 
after children/Stress, worry or other psychological reason/Physical exercise/Other cause/Don't 
know 
 
"On how many days have you felt tired during the PAST SEVEN DAYS?" 
 
None/Between one and three days/Four days or more 
 
"Have you felt tired for more than 3 hours in total on ANY day in the PAST SEVEN DAYS?" 
 
No, less than 3 hours/Yes, I felt tired for more than 3 hours on at least one day 
 
"Have you felt so tired that you've had to push yourself to get things done during the PAST 
SEVEN DAYS?" 
 
No/Yes, on one or more occasion 
 
"Have you felt tired when doing things that you enjoy during the PAST SEVEN DAYS?" 
 
No, not tired during enjoyable activities/Yes, tired during an enjoyable activity/I haven't done 
anything enjoyable in the past week 
176  
 




"What do you think is the main reason for lacking in energy?" 
 
Problems with sleep/Tablets or medication/Physical illness/Working too hard, including looking 
after children/Stress, worry or other psychological reason/Physical exercise/Other cause/Don't 
know 
 
"On how many days have you felt lacking in energy during the PAST SEVEN DAYS?" 
 
None/Between one and three days/Four days or more 
 
"Have you felt lacking in energy for more than 3 hours in total on ANY day in the PAST SEVEN 
DAYS?" 
 
No, less than 3 hours/Yes, I felt lacking in energy for more than 3 hours on at least one day 
 
"Have you felt so lacking in energy that you've had to push yourself to get things done during the 
PAST SEVEN DAYS?" 
 
No/Yes, on one or more occasion 
 
"Have you felt lacking in energy when doing things that you enjoy during the PAST SEVEN 
DAYS?" 
 
No, not lacking in energy during enjoyable activities/Yes, lacking in energy during an enjoyable 
activity/I haven't done anything enjoyable in the past week 
 
"Do you feel better after resting?" 
 
Not a lot/Only a little/Definitely better 
 
"Does exercise make you feel exhausted the following day?" 
 
Not at all/Sometimes/Always 
 
"How long have you been feeling tired or lacking in energy in the way you have just described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"In the PAST MONTH, have you had any problems in concentrating on what you are doing?" 
 
No/Yes, problems concentrating on what I am doing 
 




"On how many days have you noticed problems with your concentration OR your memory during 
the PAST SEVEN DAYS?" 
 
None/Between one and three days/Four days or more 
 
177  
"In the PAST SEVEN DAYS could you concentrate on all of the following without your mind 
wandering?: 
 
     a whole TV programme 
     a newspaper article  
     talking to someone?" 
 
Yes, I could concentrate on all of them/No, I couldn't concentrate on at least one of these things 
 
"In the PAST SEVEN DAYS, have these problems with your concentration actually STOPPED 




"How long have you been having problems with your CONCENTRATION as you have 
described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Have you forgotten anything important in the PAST SEVEN DAYS?" 
 
No/Yes, I have forgotten something important 
 
"How long have you been having the problems with your MEMORY as you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"In the PAST MONTH, have you been having problems with trying to get to sleep or with getting 




"On how many nights in the SEVEN NIGHTS did you have problems with your sleep?" 
 
None/Between one and three nights/Four nights or more 
 
"Thinking about the night you had the LEAST sleep in the PAST 
SEVEN DAYS, how long did you spend trying to get to sleep? 
 
Only include time spent lying awake in bed TRYING to return to sleep." 
 
Less than 15 minutes/Between 15 minutes and 1 hour/Between 1 and 3 hours/Three hours or 
more 
"In the PAST SEVEN DAYS, how many nights did you spend 3 or more hours trying to get to 
sleep?" 
 
None/Between one and three nights/Four nights or more 
 
 
"In the PAST SEVEN DAYS, have you woken more than two hours earlier than you needed to 
and found that you couldn't get back to sleep?" 
 
No/Yes, and I couldn't get back to sleep 
 
"What are your sleep difficulties caused by?" 
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Noises (babies crying, busy roads etc.)/Shift work or late nights/Pain or illness/Worries/Reason 
not known/Other 
 
"Has sleeping more than usual been a problem for you in the PAST MONTH?" 
 
No/I have slept more than usual but this is not a problem/Yes 
 
"On how many nights in the PAST SEVEN NIGHTS did you have problems with your sleep?" 
 
None/Between one and three days/Four days or more 
 
"Thinking about the night you slept the longest in the PAST SEVEN DAYS, how much longer did 
you sleep compared with how long you normally sleep for?" 
 
Less than 15 minutes/Between 15 minutes and 1 hour/Between 1 and 3 hours/Three hours or 
more 
 
"In the PAST SEVEN DAYS, on how many nights did you sleep for more than 3 hours longer 
usual?" 
 
None/Between one and three nights/Four nights or more 
 
"How long have you had these problems with your sleep as you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Many people become irritable or short tempered at times, though they may not show it. 
 
Have you felt irritable or short tempered with those around you in the PAST MONTH?" 
 
No/Yes, I have felt irritable or short tempered recently 
 
"During the PAST MONTH, did you get short tempered or angry over things which now seem 




"On how many days have you felt irritable, short tempered or angry in the PAST SEVEN DAYS?" 
None/Between one and three days/Four days or more 
 
"In total, have you felt irritable, short tempered or angry for more than one hour on any day in the 
PAST SEVEN DAYS?" 
 
No/Yes, I felt this way for more than one hour on at least one day 
 
"During the PAST SEVEN DAYS, have you felt so irritable, short tempered or angry that you 
have wanted to shout at someone, even if you haven't actually shouted?" 
 
No/Yes, but I didn't actually shout at someone/Yes, and I actually shouted 
 
"In the past SEVEN DAYS, have you had arguments, rows or quarrels or lost your temper with 
anyone?" 
 
No/Yes, but this was justified/Yes 
 
179  
"How long have you been feeling irritable, short-tempered or angry as you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Almost everyone becomes low in mood or depressed at times. 
 




"In the PAST SEVEN DAYS, have you had a spell of feeling sad, miserable or depressed?" 
 
No, not in the past seven days/Yes 
 
"During the PAST MONTH, have you been able to enjoy or take an interest in things as much as 
you usually do?" 
 
Yes/No, less enjoyment than usual/No, I don't enjoy anything 
 
"In the PAST SEVEN DAYS, have you been able to enjoy or take an interest in things as much 
as usual?" 
 
Yes/No, less enjoyment than usual/No, I don't enjoy anything 
 
 
"In the PAST SEVEN DAYS, on how many days have you felt sad, miserable or depressed OR 
unable to enjoy or take an interest in things?" 
 
None/Between one and three days/Four days or more 
 
"Have you felt sad, miserable or depressed OR unable to enjoy or take an interest in things for 
more than 3 hours in total on any day in the PAST SEVEN DAYS?" 
 
No, less than 3 hours/Yes, for 3 hours or more on at least one day 
"What is the MAIN thing that made you feel sad, miserable or depressed OR unable to enjoy or 
take an interest in things in the PAST 
SEVEN DAYS?" 
 
Family members, including spouse or partner/Relationships with friends or people at school of 
work/Housing/Money or bills/Your own physical health, including pregnancy/Your own mental 
health/Work or lack of work (including studying)/Legal difficulties/Political issues or the news 
 
 
"In the PAST SEVEN DAYS when you felt sad, miserable or depressed OR unable to enjoy or 
take an interest in things, did you ever become happier when something nice happened, or when 
you were in company?" 
 
Yes, always/No, I did not cheer up on one or more occasions/No, nothing cheered me up 
 
"How long have you been feeling sad, miserable or depressed OR unable to enjoy or take an 
interest in things as you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years"/Two years or more 
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"I would now like to ask you about when you have been feeling sad, miserable or depressed OR 
unable to enjoy or take an interest in things. 
 
In the PAST SEVEN DAYS, was this worse in the morning, in the evening, or did this make no 
difference?" 
 
Worse in the morning/Worse in the evening/Sometimes worse in the morning sometimes in the 
evening/No difference between morning and evening 
 
"Many people find that feeling sad, miserable or depressed, OR unable to enjoy or take an 
interest in things can affect their interest in sex.  
 
Over the PAST MONTH, do you think your interest in sex has increased, decreased or stayed 
the same?" 
 
Not applicable/No change/Increased/Decreased 
 
"In the PAST SEVEN DAYS, when you have felt sad, miserable or depressed OR unable to 




"In the PAST SEVEN DAYS, when you have felt sad, miserable or depressed OR unable to 
enjoy or take an interest in things have you been doing things more slowly than usual, for 




"In the PAST SEVEN DAYS have you on at least one occasion felt guilty or blamed yourself 
when things went wrong, even when it hasn't been your fault?" 
 
Never/Only when it was my fault/Sometimes/Often 
"In the PAST SEVEN DAYS have you been feeling you are not as good as other people?" 
 
No, I've been feeling as good as anyone else/Yes, I've NOT been feeling as good as others 
 
"Have you felt hopeless at all during the PAST SEVEN DAYS, for instance about your future?" 
 
No/Yes, I have felt hopeless sometimes 
 









"How many times have you harmed yourself in the last year?" 
 
Not in the past year/Once/2-5 times/6-10 times/More than 10 times 
 
"In the PAST SEVEN DAYS, have you had thoughts of harming yourself?" 
 




"Have you talked to your doctor about these thoughts of harming yourself?"  
 
Yes/No, but I have talked to other people/No  
 
"You have said that you have thought about harming yourself.  
 
Since this is a serious matter we would recommend that you talk to your doctor about these 
thoughts."  
 
"Thank you for answering those questions on feeling unhappy or depressed. The next section is 
about worrying and anxiety." 
 








"On how many of the PAST SEVEN DAYS have you been worrying about things?" 
 
None/Between one and three days/Four days or more 
 
"In your opinion, have you been worrying too much in view of your circumstances?" 
 
No/Yes, worrying too much 
 
"How unpleasant has your worrying been about things in the PAST SEVEN DAYS?" 
 
Not at all/A little unpleasant/Unpleasant/Very unpleasant 
 
"Have you worried about something for more than three hours in total on any day in the PAST 
SEVEN DAYS?" 
 
No, Less than 3 hours/Yes, 3 hours or more on at least one day this week 
 
"How long have you been worrying about things in the way that you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"What is the MAIN thing you have been worried about in the PAST SEVEN DAYS?" 
 
Family members, including spouse or partner/Relationships with friends or with people at school 
or work/Housing/Money or bills/Your own physical health, including pregnancy/Your own mental 
health/Work or lack of work (including studying)/Legal difficulties/Political issues or the news 
 









"Some people have phobias; they get nervous or uncomfortable about specific things or 
situations when there is no real danger. For example they may get nervous when speaking or 
eating in front of strangers, when they are far fom home or in crowded rooms, or they may have 
a fear of heights. Others get nervous at the sight of things like blood or spiders. 
 
In the PAST MONTH, have you felt anxious, nervous or tense about any specific things or 




"In the PAST MONTH, when you have felt anxious, nervous or tense was this ALWAYS brought 
on by the phobia about some SPECIFIC thing or did you sometimes feel GENERALLY anxious, 
nervous or tense?" 
 
These feelings were ALWAYS brought on by specific phobia/I sometimes felt generally anxious, 
nervous or tense 
 
"The next questions are concerned with GENERAL anxiety, nervousness or tension ONLY. 
Questions about the anxiety which is brought on by the phobia(s) about specific things or 
situations will be asked later." 
 
"On how many of the PAST SEVEN DAYS have you felt GENERALLY anxious, nervous or 
tense?" 
 
None/Between one and three days/Four days or more 
 
"How unpleasant has your anxiety, nervousness or tension been in the PAST SEVEN DAYS? 
 
Not at all/A little unpleasant/Unpleasant/Very unpleasant 
 
"In the PAST SEVEN DAYS, when you've been anxious, nervous or tense, have you had ANY of 
the following symptoms? 
 
 
heart racing or pounding, hands sweating or shaking, feeling dizzy                       difficulty 
getting breath, butterflies in your stomach, dry mouth " 
 
No/Yes, one or more of the symptoms 
 
"Have you felt anxious, nervous or tense for more than 3 hours in total on any day in the PAST 
SEVEN DAYS?" 
 
No/Yes, more than 3 hours on at least one day 
 
"How long have you had these feelings of general anxiety, nervousness or tension, as you have 
described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Sometimes people AVOID a specific situation or thing because they have a phobia about it. For 
instance, some people avoid eating in public or avoid going to busy places because it would 
make them feel nervous or anxious. 
 
In the PAST MONTH, have you AVOIDED a specific situation or thing because it would have 





"Here is a list of specific situations or things that some people feel nervous about or might avoid.  
 
 Which one of these are you MOST afraid of?"  
  
Travelling alone by bus or train/Being far from home/Eating or speaking in front of strangers/The 
sight of blood/Going into crowded shops/Insects, spiders or animals/Being watched or stared 
at/Enclosed spaces or heights/I am not frightened of anything on this list but I am frightened of 
something else 
 
"On how many days in the PAST SEVEN DAYS have you felt nervous or anxious about the 
situation or thing you are most frightened of?" 
 
None/Between one and three days/Four or more days 
 
"In the PAST SEVEN DAYS, on those occasions when you felt anxious, nervous or tense about 
this, did you have ANY of the following symptoms? 
 
    heart racing or pounding, hands sweating or shaking, feeling dizzy  
    difficulty in getting breath, butterflies in the stomach, dry mouth"  
     
 
No/Yes, at least one symptom 
 
"In the PAST SEVEN DAYS, have you AVOIDED any situations or things because it would have 
made you feel anxious, nervous or tense, even though there was no real danger?" 
 
No/Yes, on one or more occasion 
 
"How many times have you avoided such situations or things in the 
PAST SEVEN DAYS?" 
 
None/Between one and three times/Four times or more 
 
"How long have you been having these feelings about the situations or things as you have just 
described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Thinking about the PAST MONTH, did your anxiety or tension ever get so bad that you got in a 
panic, for instance make you feel that you might collapse or lose control unless you did 
something about it?" 
 
No, my anxiety never got that bad/Yes, sometimes/Yes, often 
 
"How often has this panic happened in the PAST SEVEN DAYS?" 
 
Not in the past week/Once/More than once 
 
"In the PAST SEVEN DAYS, how unpleasant have these feelings of panic been?" 
 
A little uncomfortable/Unpleasant/Unbearable, or very unpleasant 
 





"In the PAST SEVEN DAYS, did the worst of these panics last for longer than 10 minutes?" 
 
Less than 10 minutes/10 minutes or more 
 

























"In the PAST SEVEN DAYS when you had the panic: Did you have pain, pressure or discomfort 




"In the PAST SEVEN DAYS when you had the panic: Did you have nausea (feeling as though 









"In the PAST SEVEN DAYS when you had the panic: Did things around you feel strange, unreal 














"In the PAST SEVEN DAYS when you had the panic: Did you have tingling or numbness in parts 












"How long have you been having these feelings of panic as you have described?" 
 
Less than 2 weeks/Between 2 weeks and 6 months/Between 6 months and 1 year/Between 1 
and 2 years/Two years or more 
 
"Thank you for answering those questions on anxiety and worry." 
 
 
"How have ALL of these things that you have told me about affected you overall? 
 
In the PAST SEVEN DAYS, has the way you have been feeling actually  
STOPPED you from getting on with the tasks and activities you used to do or would like to do?" 
 
"This is the end of the interview. Thank you for taking part." 
 
186  
Social and Communication Disorders Checklist (SCDC)  
187  
Bullying and Friendship Interview Schedule 
1. Having belongings stolen      [no] [yes] 
2. Having been threatened or blackmailed    [no] [yes] 
3. Having been beaten up or hit      [no] [yes] 
4. Having been called nasty names     [no] [yes] 
5. Having nasty tricks played on them     [no] [yes] 
6. Other children not wanting to play with them   [no] [yes] 
7. Trying to get them to do something they didn’t want to do  [no] [yes] 
8. Spreading lies or rumors about child     [no] [yes] 





Strengths and Difficulties questionnaire (SDQ)
 
 Observational Tables 




Full and complete cases in the association of childhood mental health with adolescent 
frequency of use 
Full and complete cases in the adjusted association of childhood mental health with age of 
first substance use 




Full and complete cases in the association of childhood social cognition with adolescent 
frequency of use 
191  




Sex stratified association of childhood mental health with adolescent substance use 
 
 
Sex stratified association of childhood mental health with adolescent frequency of use 
193  
Sex stratified association of childhood mental health with age of first substance use 
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Sex stratified association of childhood social cognition with adolescent substance use 
195  
Sex stratified association of childhood social cognition with adolescent frequency of use 
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Sex stratified association of childhood social cognition with age of first substance use 
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Full and complete cases in the association of adolescent substance use with mental health 
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Full and complete cases in the association of adolescent substance use with social cognition 
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Sex stratified association of adolescent substance use with mental health 
201  
Sex stratified association of adolescent substance use with social cognition 
202  
Full and complete cases in the association of mental health with social cognition 
203  
Full and complete cases in the association of social cognition with mental health 
 
